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1.1 Molecular Mechanisms of Development
1.1.1 Developmental stages
From an embryologic point of view the development of the vertebrate embryo can 
be divided in more or less virtual phases that contain developmental processes of the 
same type. From a molecular point of view this distinction in phases is less clear. The 
beginning of development shows similar aspects in all animal classes. Here we can deﬁne 
three phases: cleavage or segmentation, gastrulation and organogenesis. Fecundation or 
fertilisation is followed by segmentation or cleavage (the ﬁrst phase), where the single 
egg cell divides into a number of smaller cells, the blastomers (from gr. Blastós, embryo, 
cell, germ, and méros, part). These cells continue to divide till their volume reaches a 
value that is typical for the animal that has generated them. During this process, there is 
an increase of the nuclear matter (in geometrical progression) not necessarily followed 
by a total mass increase. The segmentation phase also sees the spreading of particular 
egg-contained substances that will determine the alleged territories of the embryonic 
layers. At the end of segmentation (the blastula stage) the body plan process starts. It is 
a short phase that deﬁnes the cephalic and lateral parts together with the antero-posterior 
(A/P) and dorso-ventral (D/V) axes. Almost at the same time begins the process of 
formation of the embryonic layers and of the dorsal cord. This is the second phase, the 
gastrulation. The neural plate and, successively, the neurotube appear. Later commences 
the organogenesis, the phase where the organ primordia start to arise. Starting with this 
phase the embryology of chordata and of the other metazoans divides. 
 Descriptive embryology has pointed out many different morphological aspects of 
the early embryonic development of chordata. For example, there is the amphioxus egg: 
small, oligolecytic, with total and unequal division. And there are the eggs of reptiles 
or birds: big, rich of yolk, without the appearance of a real blastopore at gastrulation 
and with a rudimentary archenteron. Yet underneath these differences lies a common 
organisation. The similarities are particularly remarkable in the topography of the cell 
domains that will be formed at the end of gastrulation. Moreover, in vertebrates there is a 
stage common to all embryos, the phylotypic stage. At this stage the head, the neural tube 
running along the dorsal midline, the notochord that stands under the neural tube and is 
ﬂanked by the somites are all present.
Fertilisation
 Fertilisation begins with the fusion of the sperm to the egg. Sperm-egg interaction 
can be divided into four sequential steps, sperm binding, acrosomal reaction, egg coat 
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penetration and binding and fusion with the egg plasma membrane. The last step will 
activate the quiescent egg and begin the developmental program. 
 Cell-surface molecules mediate the initial binding. Despite the big variety of molecules 
composing the egg coat and the sperm in different species, a general theme for sperm-egg 
coat interacting molecules can be found. Carbohydrate-binding proteins on the sperm 
surface bind to glycosylated molecules present on the egg coat, such as ZP3 in mammals. 
The binding of the sperm to the egg coat receptors triggers a release of enzymatic 
substances, the acrosomal reaction, from the sperm tip (acrosome)  (Figure 1.1)1. The 
acrosomal reaction helps the transient binding between the sperm and the egg coat (zona 
pellucida in mammals) and, together with the ﬂagellar motility, the penetration through 
the egg coat. After the sperm has penetrated the egg coat, direct cell-cell interactions 
take place and ultimately lead to the fusion of the membranes. The sperm entry triggers 
a massive release of free Ca2+ ions in the egg that spread like a wave through all the 
egg starting from the penetration point. At this stage the egg surface undergoes speciﬁc 
changes (cortical reaction) aimed to avoid the possibility of polyspermy. The calcium 
wave triggers egg activation and the egg (in most vertebrates) completes the second 
meiotic division. In the mean time there is the release of the sperm nucleus in the egg 
cytoplasm. Together sperm and egg pronuclei form the zygote nucleus.
 The molecular mechanisms that underlie the germ cells interactions have parallels 
in somatic tissue development and function. For example the initial interaction of the 
sperm with the egg coat is similar to the interaction that somatic cells have with their 
surrounding extracellular matrix. Two main models have been proposed for explaining the 
egg activation by the spermatozoa. In the ﬁrst one the sperm activates a plasmamembrane 
receptor that stimulates the release of Ca2+ via the IP
3
 cascade. The other, more recent, 
model hypothesises that a soluble sperm factor, realised after the gamete fusion, is the 
activating factor of the Ca2+ wave2.
Cleavage
The ﬁrst step of embryonic development is the segmentation or cleavage phase. This 
phase is characterised by short cell cycles: rapid repetitive series of mitosis, without any 
intervals for cell growth. Therefore in this phase there is no signiﬁcant increase of the 
embryo’s mass. 
 Comparative embryology data showed that the pattern of the ﬁrst cleavages may vary 
widely between different groups of animals3. The amount of yolk present in the egg can 
inﬂuence the cleavage pattern. The plane of cleavage is dictated by the orientation of 
the mitotic spindle, which in turn is due to the action of the asters, whose position is 
determined by the chromosomes. The importance of the plane of cleavage has been shown 
in studies on nematodes and molluscs. In these animals the plane of cleavage determines 
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the position of speciﬁc blastomers and the distribution of cytoplasmatic determinants3. 
 During the cleavage there is ﬁrst a compact mass of dividing cells, the morula. 
Cleavage stage ends with the formation of the blastula, a sphere-like structure of polarised 
epithelium that surrounds a ﬂuid ﬁlled cavity (blastocoel). The ﬂuid accumulation is 
partly due to active transport from the surrounding cells. In the blastula epithelium an 
inner cells mass can be distinguished. This inner cells mass gives rise to the hypoblast and 
the epiblast. The epiblast gives rise to the germ layers and consequently to the embryo4-
6. The remaining cells will give rise to supporting structures of the embryo, such as the 
placenta. 
 Molecular events leading to pattern formation of the embryo start very early. 
Experiments have shown that β-catenin, a protein required for Xenopus dorsal axis 
formation, accumulates in the presumptive dorsal cystoplasm already at the two cell 
stage, and that by the 16-cell stage it accumulates in the dorsal nuclei7. After fertilisation 
microtubules that extend from the centriole and the aster at the sperm entry point, are 
Figure 1.1
Schematic diagram of some molecular aspects of the sperm acrosome reaction in mammals (adapted from 
Wassarman, 1999, ref. 1):
Egg binding proteins (EBP) on the sperm surface bind with acrosome inducers present on the egg coat (Zona 
Pellucida), such as ZP3. This interaction initiates the acrosome which activates G proteins and voltage-sensitive 
T type Ca2+ channels, resulting in a depolarization of sperm membrane, and in intracellular Ca2+ elevation. 
Although the G protein activating receptor has been found most of the players in the pathway still remain 
elusive. It has been proposed that ZP3-induced opening of T type channels in sperm leads to a sustained release 
of Ca2+ from an internal store, possibly via inositol-3,4,5-triphosphate (IP3) pathway (ref. 1 and references 
therein; ref. 170). 
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involved in the 30° rotation of the egg cortex and the consequential formation of the 
dorsal crescent  (Figure 1.2). Microtubules originating from the same location transport 
small membrane vesicles from the vegetal pole towards the presumptive dorsal region 
(Figure 1.2)8. Very interestingly, these membrane vesicles are able to transport the protein 
Dishevelled (Dsh). This protein is part of the Wnt cascade, which leads to the stabilisation 
and subsequent translocation to the nucleus of β-catenin  (Figure 1.3). This model for the 
early induction of dorsalisation is also conﬁrmed from studies on zebraﬁsh and mouse9 and 
references therein. 
Pattern formation
Before the germ layer formation, cells have already begun to differentiate, so that a 
speciﬁc spatio-temporal organisation of cells (pattern formation) is present in the embryo. 
This pattern lays the body plan for the development of well ordered structures. Patterning 
Figure 1.2
Reorganisation of cytoplasm in the newly fertilised frog egg:
(A) Schematic cross section of an unfertilised frog egg. Mature frog egg has a dark pigmented animal region 
and a lighter, yolky, vegetal region. (B) After fertilization, arrays of microtubules extend from the centriole and 
aster at the sperm entry point towards the dorsal side, and transport small membrane vesicles from the vegetal 
towards the dorsal animal pole. (C) Towards the end of the ﬁrst cleavage the cortical layer at the animal pole 
rotes 30° towards the site of the sperm entry over the internal cytoplasm. This exposes a region of the egg that 
was covered by dark cortical cytoplasm of the animal hemisphere The underlying cytoplasm has only diffuse 
pigment granules and appears gray - called the gray crescent. This rotation is important because gray crescent 
cells initiate gastrulation. 
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mechanisms and times are variable, and different organisms may use a variety of molecular 
and cellular mechanisms to achieve them. 
 The ﬁrst clear sign of patterning is the formation of body axes which are almost always 
perpendicular to each other, therefore forming a kind of co-ordinates. 
 All vertebrates have similar body plans: the vertebral column surrounds the spinal 
cord, the brain is positioned at the anterior end and is contained in a skull (either bony 
or cartilagineous). The anterior-posterior (A/P) axis is the main body axis of vertebrates, 
with the head at the anterior end, followed by a trunk, from where paired appendages will 
Figure. 1.3
Simpliﬁed diagram of Wnt signalling pathway involved in stabilization and subsequent translocation to the 
nucleous of β-Catenin (from De Robertis et al., 2000, ref. 9):
Membrane vesicles are associated with Dishevelled (Dsh). The Wnt receptor Frz7 is required for dorsal axis 
formation, but the Wnt molecules shown inside the vesicles are entirely hypothetical. Kinesins are molecular 
motors that can transport vesicles towards the plus ends of microtubules. β-Catenin is found in a large 
cytoplasmic complex that includes Axin, APC (adenomatous polyposis coli) and GSK-3 (glycogen synthase 
kinase 3). GSK-3 negatively regulates β-Catenin through phosphorylations that target β-Catenin for degradation 
by the proteasome. GSK-3 can be inhibited by treatment with lithium chloride (LiCl). On stimulation of the Wnt 
pathway, β-Catenin is stabilized on the dorsal side and can be found in the nucleus, where, together with TCF-3, 
it activates various target genes, including homeobox and Nodal-related genes (Xnrs ). 
Wnt ?
Dsh
Frz 7
Dorsal genes
(homeobox and
Nodal-related)TCF-3
GSK-3
�-catenin
APC
Axin
Free
�-catenin
�-catenin
LiCl
Degradation
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develop (limbs or ﬁns), in most cases with a tail at the posterior end. The dorso-ventral 
(D/V) axis is given by the position of the mouth, which marks the ventral part of the body. 
A/P and D/V axes permit also to deﬁne left and right. 
 The overall similarity in the body plan of vertebrates (especially clear during the 
phylotypic stage) suggests that the developmental processes which establish the body 
plan are similar in different animals. On the other hand, there are clear morphological 
differences between vertebrate embryos in the earlier stages. 
 The various vertebrates use different strategies for setting up the primary embryonic 
axes. The best understood model is that of amphibians, where there is a maternally 
induced polarisation of the egg (animal and vegetal poles, A/V). The site of sperm entry 
determines the D/V axis position, but also maternal proteins and mRNAs with dorsalising 
and ventralising effects have been found (e.g. glycogen synthase kinase-3, GSK-3 and 
VegT). The tadpole A/P axis is related to the A/V axis (head originates from the animal 
pole region) but its position depends on the speciﬁcation of the D/V axis. 
 In the chicken the D/V axis is speciﬁed in relation to the yolk, where the side of the 
blastoderm that faces the yolk will become ventral. The formation of A/P axis is induced 
by gravity during the egg extrusion, where the anterior end looks downward.  
 In the mouse egg there is no sign of polarity, no evidence of maternal factors affecting 
the later development, and the early embryonic stages are very different from amphibians 
or chicken, due to the absence of yolk. Although the mouse early cleavages do not show 
any well-ordered pattern (in contrast to Xenopus egg for example) some cleavages are 
parallel to the egg surface. These lead to the constitution of a morula with an inner and an 
outer cell population. These two populations then roughly divide into the outer cells mass 
or trophoectoderm and the inner cells mass, forming the blastocyst (32 cell stage). The 
speciﬁcation of cells as inner cell mass or trophoectoderm depends only on their position 
in the cleaving embryo. This is only a positional fate because, at this stage, each of the 
cells is capable of producing a normal blastocyst. The determination of cell fate occurs 
only after the 32-cell stage. The establishment of the D/V axis is related to the position of 
the inner cell mass. The cells facing the blastocoel cavity will have a ventral destiny. This 
D/V axis will persist until the beginning of gastrulation, where the epithelial movements 
cause a considerable cell mixing and it is not possible to identify individual cells that will 
become dorsal or ventral. The A/P axis will be established only after implantation, the 
mechanism is unknown. It seems probable that it is regulated by cell-cell interactions and 
that there could be signals from the uterus at the time of implantation. The fact that the 
A/P axis of the embryo is almost perpendicular to the long axis of the uterus might be in 
agreement with the uterus signalling hypothesis3. Left and right are only established after 
the formation of the two main axes. 
 Despite their exterior symmetric body, vertebrates show internal organ asymmetry. 
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This asymmetry at the organ, multi-cellular and cellular levels reﬂect an asymmetry at the 
molecular level. The asymmetry of molecules or molecular structures is caused by their 
speciﬁc orientation with respect to the A/P and D/V axes. Experiments on chick embryo’s 
and mouse models, as well as genetic studies on human syndromes, such as Kartagener 
syndrome, have shown that organ handedness is under genetic control. 
 From a molecular point of view axis formation and germ layer induction are strictly 
correlated. In particular mesoderm and the second axis induction pathways are tightly 
bound. The probable common evolutionary appearance of mesoderm and of the second 
body axis during the transition from diploblastic to triploblastic animals may account for 
the use of overlapping molecular pathways. An agreed hypothesis is that these novelties 
have evolved from pre-existing structures, modifying and recruiting developmental control 
genes from existing pathways. In accordance with this theory is the present dual role of 
the T-box Brachyury gene in axis formation and mesoderm induction10. The ancestral 
function of Brachyury in early metazoans (Cnidaria) was the speciﬁcation of the mouth/
blastopore region and the induction of the body axis. The mouth/blastopore region is 
thought to be the one where mesoderm arose during evolution. Cells from the blastopore 
regions acquired the new capacity of inducing mesoderm. Germ layer patterning has been 
studied in several model organisms as Xenopus, zebraﬁsh and mouse. These studies show 
that the same molecular mechanisms are utilised for pattern formation. 
 Probably the most studied vertebrate axis and pattern induction mechanism is that 
of Xenopus. In Xenopus, the key activator of mesoderm and endoderm induction is a 
maternally inherited T-box transcription factor, VegT. VegT is expressed in the vegetal 
pole and is able to activate at least four members of the TGF-β family: the Nodal-related 
Xnr1, Xnr2 and Xnr4 and Derriere. While Xnr4 and Derriere are directly activated, 
additional molecules, as another maternally derived TGF-β factor Vg1, are required 
for the activation of Xnr1 and Xnr2. An autoregulatory loop seems to be involved too. 
Xnr1 and Xnr2 expression in the dorsal side is up-regulated by β-catenin. In this way a 
gradient of Nodal-related molecules (Xnrs) is created, that will induce different types of 
mesoderm: where low levels of Xnrs are present ventral mesoderm will develop, while 
high doses of Xnrs will induce dorsal mesoderm  (Figure 1.4). For Xenopus endoderm 
induction two main models have been proposed. The ﬁrst one suggests that high levels 
of TGF-β signalling could induce endoderm, in contrast with mesoderm induced by low 
doses. Moreover, as VegT is present at the highest level in the prospective endoderm, it 
could induce a higher transactivation of Xnrs there than at the equator, creating a Xnrs 
gradient that will induce endoderm at the vegetal pole and mesoderm at the equator. 
The second hypothesis implies that VegT is expressed only in prospective endodermal 
cells, and that it could activate endoderm-speciﬁc transcription factors and endodermal 
speciﬁc genes cell autonomously, in combination with VegT-induced Nodal signalling. In 
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contrast, mesoderm will be induced non-autonomously through Xnrs9,11 and references therein. 
 In zebraﬁsh the situation is not much different. A main difference is that the source 
of mesoderm inducing factors is not the prospective endoderm but the underlying yolk 
syncytial layer (YSL), which induces also the zebraﬁsh endoderm. Another difference can 
be found in the role of Nodal-related molecules, Squint and Cyclops, in ventral mesoderm 
induction. Although these are needed for the involution of all mesoderm, initial induction 
of ventral mesoderm seems to be due to another, yet unknown member of the TGF-β 
family  (Figure 1.5)9,11 and references therein.
Fig.ure 1.4
Schematic view of the Axis and pattern induction mechanism of Xenopus (modiﬁed from Kimelman and 
Grifﬁn, 2000, ref. 11):
Maternally inherited VegT activates the transcription of the TGF-β family members involved in dorsal 
patterning. Xnr4 and Derrière, directly, and Xnr1, Xnr2, together with additional molecules, as the maternally 
derived TGF-β factor Vg1. Xnr1 and Xnr2 require intercellular signalling for their transcription, possibly acting 
through an autoregulatory loop. Xnr1 and Xnr2 are expressed at higher levels dorsally than ventrally, because 
of the presence and activity of nuclear β-catenin on the dorsal side of the embryo. The Xnrs gradient created by 
β-catenin will induce different types of mesoderm:  high doses of Xnrs will induce dorsal mesoderm formation, 
while low levels will determine ventral mesoderm. Xnrs are functionally different than Derrière; Xnrs are 
required throughout the body, while Derrière is important for only trunk and tail development.  
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Gastrulation
Gastrulation is a dynamic process that comprises the movement of the alleged territories 
from the embryo surface to the site from which the various embryonic organs will develop. 
Cell repositioning and migration creates irreversible changes in embryo morphology, 
and the conversion of an epithelial monolayer into a multilayered three-dimensional 
structure consisting of three germ layers, ectoderm, mesoderm and endoderm. At the end 
of gastrulation a three-dimensional body plan has emerged. 
 All the germ layers originate from the epiblast. The exact mechanisms by which 
endodermal and mesodermal layers are formed from the epiblast are still not well 
understood. The endoderm seems principally formed by the more anterior cells of the 
epiblast, which are inserted, as a continuous layer, into the hypoblast, which in turn gets 
displaced laterally. Interactions between epiblast and hypoblast induce a portion of the 
epiblast cells to differentiate into mesodermal cells. Prospective mesodermal cells migrate 
Figure 1.5
Schematic view of the TGF-β signalling pathways in early Xenopus development (modiﬁed from Hill, 2001, 
ref. 21):
The BMP and the Activin-like signalling pathways are shown on the left and on the right. Different ligands 
of the TGF-β superfamily signal and are required for the speciﬁcation and patterning of the three germ layers 
as well as for gastrulation in the early Xenopus embryo. An example of how the same signalling pathway can 
activate completely different sets of genes in different regions of the embryo.
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inside the epiblast and position themselves between the epiblast and the hypoblast. 
Epiblast cells that remain on the surface will form the ectoderm. At this stage endoderm 
and mesoderm are capable of self-organisation into derivatives such as notochord, somites 
and muscle12, while ectoderm remains undifferentiated. Differentiation of ectoderm will 
be induced by cells from the other two layers. Each layer will now differentiate to give 
rise to all animal organs  (Figure 1.6).
 At this stage, a central role in axis deﬁnition and patterning is played by the organiser 
(Spemann’s organiser in amphibians, Hensen’s node in amniotes, node in mouse), a centre 
of inductive interactions for cellular morphogenic movements and axis stabilisation. The 
organiser is induced by a blastula signalling centre, the Nieuwkoop centre (NC) in Xenopus, 
the proximal marginal zone (PMZ) in chick and ﬁsh, through the combined signalling of 
TGF-β and Wnt pathways. The organiser is located close to where gastrulation movements 
start: the dorsal lip of the blastopore in Xenopus, the anterior primitive streak tip in chick 
and mouse. In the chick gastrula evidence of a new node-inducing centre (NIC) present in 
the middle streak has been found. The NIC functions during gastrulation, while the early 
inducers NC and PMZ are present only at the blastula stage. NIC takes over the node 
inducing role from the PMZ. NIC and PMZ are not derived from the same population of 
cells9,10,13. The node secretes growth factor antagonists, mainly BMPs, which act in the 
extracellular space preventing the docking to the receptors (Table 1.1).
Table 1.1 Inhibitors factors involved in axis deﬁnition and patterning
Antagonist Growth factor Mode of action
Frzb-1 Wnts Extracellular blocking
Dickkopf-1 Wnts Extracellular blocking
Crescent Wnts Extracellular blocking
Cerberus Wnt-8; Xnrs; BMPs Extracellular blocking
Chordin BMPs Extracellular blocking
Noggin BMPs Extracellular blocking
Follistatin BMPs Extracellular blocking
Lefty/Antivin Nodal signalling
Competition for TGF-β/ Nodal 
receptor
ADMP TGF-β and Wnt signalling Unknown
 The node also produces an inhibitor, ADMP (anti dorsalising morphogenic protein), 
which ensures that surrounding cells do not respond to the inducer’s signals. Curiously, 
ADMP is a member of the BMP subfamily. These signals have the effect to induce 
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Figure 1.6
Derivatives of the three germ layers.
Origin of many cell types is quite straightforward as in the case of the epithelial components of the skin that 
derive from the surface ectoderm. Other tissues, as the skeletal tissue or the connective tissues, have a more 
complicated origin.
*minor components of these tissues may have a different origin.
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dorsalisation by antagonising ventral development promoted by BMPs. BMPs have a 
dual role in early development: an early function, the inducing of ventralisation, and 
a later function, in the late streak embryo, opposing to the node inducers13. BMP is 
also essential in ectoderm speciﬁcation. Ectoderm cells will differentiate to neural and 
epidermal (non-neural) cells. The “neural default model” posits that all ectodermal 
cells have a default developing pathway that brings them to differentiate as neural 
cells, unless instructed otherwise. The BMPs are such instructors. In the “neural default 
model” BMPs repress neural and promote epidermal differentiation of ectoderm, if not 
blocked by antagonist factors14,15. Recently ∆Np63 has been demonstrated to be the BMP 
downstream transcription repressor that is speciﬁcally active in ventral ectodermal cells 
of zebraﬁsh16.
 Recent works have pictured the node more as a zone deﬁned by molecular interactions 
than by intrinsic properties of its composing cells. Time-lapse microscopy has shown 
that the node is not a cell producing department but more a “fate determining” conduit 
through which cells migrate during gastrulation. The fact that the node properties have 
been attributed to a ﬁxed position more than to a ﬁxed cell population does not rule out 
the possibility that small numbers of node-resident stem cell may exist13,17 and references therein. 
 Although the presence of the organiser and the cell movement through it are a 
developmental characteristic of chordates, some of the signalling, as well as morphogenic 
cell movements, are used by other metazoans. In Drosophila, the D/V patterning is 
regulated by Dpp (the homologue of vertebrate BMP2 and BMP4) and Sog (the homologue 
of chordin), and mesodermal cells move upon invagination of the embryo to the vicinity 
of the Dpp source13,18. 
 Whereas the appearance of the somites in the posterior paraxial mesoderm, towards the 
end of gastrulation, makes the morphological distinction between anterior and posterior 
mesoderm particularly evident, the rostro-caudal domains of the posterior paraxial 
mesoderm remain morphologically similar. Nevertheless, there is a clear molecular 
difference between the two domains. Different T-box transcription factors induce different 
rostral- or caudal-speciﬁc signalling pathways  (Figure 1.7). 
 While the TGF-β family pathway plays a critical role from the very early stages of 
development, the FGF family of molecules acquires a critical role towards gastrulation. 
FGF signalling is required for mesoderm induction, and for patterning formation. 
In contrast with the TGF-β pathway, that has relatively few intermediates, FGF has a 
much more crowded signalling cascade. All its components are involved in germ layer 
development, although not for all of them the speciﬁc function has been found. FGFs 
play critical roles in germ layer formation. The remarkable fact that a wide variety of 
cell responses can be induced by a few FGFs also resides in the presence of different 
FGF receptors (FGFR) and their different isoforms, which are differentially responsive to 
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FGFs19-21.
 Other answers to the question of how the same signalling pathway can activate 
differentially expressed genes came from studies on the TGF-β signalling pathway in 
early Xenopus  (Figure 1.5). For example speciﬁcity of response can be acquired by the 
recruitment of different combinations of SMAD proteins by the transcription machinery. 
For example XFast-1 will recruit active Smad2/Smad4 complexes to the Mix2 promoter, 
whereas the same Smad2/Smad4 complex will be recruited by MiX family trancription 
factors, as Mixer, Milk and Bix3, to the Goosecoid promoter. Therefore, in the TGF-β 
responding cells, the expression of one or the other transcription factor will cause the 
activation of different genes by the same signal. As a matter of fact, during the early 
gastrula stages, XFast-1 is expressed mainly in the prospective ectoderm and the 
prospective mesoderm, while Mixer is expressed in a ring in deeper mesodermal cells. 
Therefore they are expressed in almost mutually exclusive domains. 
Cell differentiation 
At the end of gastrulation, when the three germ layers have been established, the process 
of cell differentiation has already started. This will lead the embryonic cells to become cell 
types that have a clear-cut identity in the adult, such as fat cells, muscle cells, nerve cells 
and skin cells. Mammals can account for more than 200 clearly recognisable differentiated 
cell types3. Characteristics of differentiated cells are 1) a specialised function and 2) a 
Figure 1.7
Transcription factors inducing rostral- or caudal-speciﬁc signalling of the posterior paraxial mesoderm:
Although morphologically similar the rostro-caudal domains of the posterior paraxial mesoderm show clear 
molecular differences. These can be seen in the induction of the domain speciﬁc signalling pathways. The 
PDGFαR will induce signalling pathways speciﬁcally involved in the rostral domain, while Brachyury, Tbx6, 
Wnt3a, Tcf/Lef1 and Integrin α5 induce the caudal domain speciﬁc signalling pathways.
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terminal and stable state. Although the origin of many cell types is straightforward (e.g. 
myoblasts, skeletal muscle cells), some cell types forming particular tissues as the skeletal 
and connective tissues have a more complicated origin  (Figure 1.6). Moreover, there are 
certain cell types, especially those of the general connective tissues, that all sources seem 
to be capable of forming22. 
 The main feature of cell differentiation is the change in gene expression. A differentiated 
cell is characterised by the production of cell speciﬁc proteins that accompany the 
expression of housekeeping genes. During the early stages of differentiation, cells have 
not yet acquired those morphological characteristics that are typical of the terminal 
differentiated stage, but their fate is already determined. Such “committed” cells carry 
subtle alterations created by the change of activity of only a few genes3. Once a cell 
becomes committed, it will pass its committed state, represented by a speciﬁc pattern 
of gene activity, to all its progeny. Various mechanisms are used for the transmission 
of the differentiated state. Chemical and structural modiﬁcation of the DNA, such as 
methylation or changes in the chromatin state, but also regulatory proteins, that may 
exert positive feedback control of gene expression and interact with other regulatory 
complexes may be involved in this speciﬁc pattern transmission. Cell differentiation is 
a generally gradual process that involves successive generations of cells. It is controlled 
by a variety of external factors and signalling molecules, including cell surface proteins, 
secreted polypeptide cytokines and molecules from the extracellular matrix. 
Organogenesis
The morphogenetic movements are not terminated at the end of gastrulation. In the ﬁnal 
stage of gastrulation the three-dimensional body plan is completely established. The embryo 
will be a mosaic of cellular territories that are not yet histologically differentiated, but all 
committed. These are the organ-formative territories and organogenesis may begin. This 
is the phase of the development where the embryo becomes a fully functional organism, 
capable of independent survival. The cellular mechanisms involved in organogenesis are 
similar to the ones used in earlier stages of development. Differences can be encountered 
mainly in their spatial and temporal pattern of employment3. 
Growth 
Growth occurs mainly in the post embryonic period, after the main body plan has been 
laid down, and results in an increase of mass or overall size of a tissue or organism. But 
there are important examples of growth connected to early organogenesis, as in vertebrate 
limb formation (limb bud) and neurogenesis. Growth will determine the ﬁnal size and 
shape of organisms and of their parts. Growth can begin at different times in different 
animals. In mammals growth takes place in the late embryonic stage, through the foetal 
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period, and continues after birth. Growth may also have a morphogenic function, as 
different growth rates in different body parts or organs, or at different times, during early 
development, can affect the shape of organs or of the entire organism. There are three 
different methods through which growth can be achieved. Cell multiplication is the most 
common mechanism. Cell enlargement, where single cells increase their mass without 
cell division (e.g. skeletal and heart muscle cells). And growth by accretion, where 
there is an increase of extracellular material (e.g. bone matrix). Cell proliferation can 
be controlled by an intrinsic program and also by external factors. Individual organs and 
bones have their own intrinsic growth program. Examples of external factors are growth 
hormones that are needed for growth in mammals, or the tension dependent growth of 
striated muscle3. 
1.1.2 Evolutionary conservation of gene function and pathways
It has been long known that embryos of different vertebrate species are highly similar to 
one another, and this suggests evolutionary conservation of early developmental programs. 
Further proof came with the discovery that different animals use common genetic systems 
for embryonic patterning (reviewed in ref. 23). During evolution, nature has tended to 
retain good working systems for animal development rather than create a completely 
new system every time. As a consequence, genetic studies on animal models can provide 
us with knowledge on genes regulating development also in humans. Some examples of 
highly conserved developmental patterning genes are discussed below. 
 Probably the best studied example of highly conserved developmental patterning 
genes are the Hox genes (homeotic selector genes). Bateson introduced the term homeosis 
in 1894, describing it as the phenomenon in which one element of a segmentally repeated 
pattern of structures is transformed toward the identity of another (i.e. the replacement 
of a body part by another). Hox genes have been identiﬁed in many metazoans, from the 
nematodes and echinoderms, through Drosophila to the amphioxus and the vertebrates. 
The characteristic chromosomal organisation and regulation, i.e. their temporal and spatial 
activation corresponds to their positioning order on the chromosome, which together 
with their protein sequence and expression pattern are highly conserved from ﬂies to 
vertebrates. Characteristic of the Hox genes is the Homeobox sequence that encodes a 
helix-loop-helix DNA binding domain, designated the homeodomain. The Hox genes are 
thought to have formed from a common ancestor through gene duplication and divergence 
processes. Therefore they all resemble each other, but the homology is particularly marked 
in the homeodomain. Hox genes are primarily expressed in overlapping domains along 
the anterior-posterior axis of the embryo in multiple tissues, including the hindbrain, 
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Figure 1.8
Scheme of genomic conservation, organization and expression patterns of Hox genes (from Veraksa et al., 2000, 
ref. 23). 
The upper half of the ﬁgure shows Drosophila Hox genes (the Drosophila Hox cluster is split into two parts, 
located on the same chromosome), and corresponding expression patterns in the adult ﬂy.
Lower half of the ﬁgure depicts the four clusters of Hox genes in mammals and the expression patterns (inferred 
from mouse expression studies) of the orthologous genes in stage 19. Posterior boundaries of the expression 
domains overlap in more caudal regions. Schematic drawing of the human embryo shows expression patterns 
of the nervous system and of the segmented mesoderm; note the shift of the anterior expression boundaries, 
while the relative order of Hox gene expression is conserved. Limb primordia express several of the posterior 
HOXA and HOXD genes.
A hypothetical ancestral Hox cluster is presented in the middle, with arrows indicating the predicted evolutionary 
origins of Drosophila and mammalian Hox genes. The proposed minimal number of Hox genes present in a 
common ancestor of all bilateral animals is seven171. Precise homology relationship for some of the central 
and posterior Hox genes is not yet well deﬁned; brackets indicate groups of genes with equal homology to an 
ancestral gene.
* Drosophila bcd and zen genes are not members of the Hox A/P patterning system. They represent fast-evolving 
insect homeodomain genes171.
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gut and limb buds  (Figure 1.8). The Hox genes are differentially activated along the 
anterior-posterior embryo axis after segmentation has occurred24,25. Hox genes encode 
transcription factors that act on the repeating structural units formed by segmentation 
giving them individual properties. However their function appears to be in part mediated 
by their spatio-temporal expression. But their function is not limited to the modiﬁcation 
of repeating body units on the A/P axis. For example, they are active in blood cells, in 
limb development, and in the sexual bud. Hox genes are present in humans as in all 
bilateral animals. 
 Another class of genes that have highly conserved developmental functions are the 
“master control genes”26,27. The master control genes are genes that control the development 
of one organ. NKx2.5 or Csx (tinman in Drosophila) is required for the development of 
the heart and for visceral muscle development in a large variety of animals. Moreover, 
in spite of the extremely different morphologies between insects and mammalian hearts, 
the genetics underlying the development of the mesodermal zone that will give rise to the 
heart/blood-pumping organ seems to be the same. 
 Eyes and photoreceptor cells also show conservation of developmental mechanisms. 
Mammalian Pax6 (a member of the paired box/homeodomain family), and its ﬂy 
homologues ey and toy, are both necessary and sufﬁcient to promote eye development27-
30. Not only is Pax6/ey function and expression conserved in eye development but also 
other genes participating in the eye developmental process are highly conserved (e.g. 
Six/so, Eya/eya and Dach/dac). Therefore, it seems that there is a common pathway 
initiating the development of the visual system in metazoans despite enormous variability 
in morphology. 
 Another example of conservation of animal developing mechanisms is given by 
the involvement of proteins of the TGF-β class in the D/V patterning of ﬂies and early 
vertebrate embryos. dpp in ﬂy, and BMP-2 and -4 in vertebrates act in concert with their 
antagonists sog and Chordin to direct the D/V polarisation of the embryo. The fact that 
the action of the homologues spreads from opposites poles (i.e. dpp and Chordin are 
dorsally expressed while the BMPs and sog are expressed ventrally) have suggested that 
there could have been a ﬂipping of axes during evolution31.
 Further, FGF molecules have a role in the control of branching morphogenesis also in 
animals separated by hundreds of millions of years of evolution. FGFs are used for many 
purposes, but always with great speciﬁcity of a certain FGF for a speciﬁc process. Also 
the action of FGFs is highly “conserved” in evolution. For example FGFs are involved, at 
multiple stages, in the branching of trachea in ﬂies and lungs in vertebrates. The driving 
force of this common genetic mechanism underlying the respiratory system development 
seems to be the oxygen (low) tension.  
 More examples of conserved developmental pathways can be found in Table 1.2.
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 The sharing of many common pathways between distantly related organisms 
encouraged DeRobertis and Sasai, in 1996, to create Urbilaterian, a hypothetical 
primordial metazoa containing all genetic pattern systems that are common to bilateral 
metazoan species41. It would be interesting to make a computerised 3D update of the 
hypothetical animal and see what kind of more complete and complex picture comes 
out. 
Table 1.2 Examples of conserved developmental pathways
Developmental pathway Gene(s) References
Early neural development bHLH and LIM homeobox genes Ref. 32,33
Appendage primordia Dlx Ref. 34
Metamerisation in ﬂy and vertebrates Engrailed-related Ref. 35
Anterior and posterior ends of the 
body determination
Otx-, Emx- and Cdx-related Ref. 36-39
Early muscle development in insects 
and vertebrates (in derivatives of the 
mesodermal layer)
Mef2 Ref. 40
1.1.3 Limb development
Hox genes are important players in the formation of limbs. In mammals the last (most 
posterior) members of several clusters of Hox genes are expressed in the developing 
limb buds. Mutations of these genes have been associated with several developmental 
disorders of limbs, notably synpolydactyly42, hand-foot-genital syndrome43 and recently 
also brachydactyly44. Moreover, the association between most posterior position in the 
cluster and most terminal position in the limb is clearly visible in mouse mutants, where 
the damage increases as more and more genes are removed from the cluster going in 
reverse order. There is also an interesting relationship between the appearance of new 
Hox clusters and the evolution of limbs45 (see below). Comparative studies of teleost 
ﬁns (zebraﬁsh, Danio rerio) and tetrapods limbs have shown a striking conservation of 
the genetic control of pattern formation46-48. There is only limited information on the 
molecular basis of ﬁn formation in the lobe-ﬁnned ﬁshes, phylogenetically the closest 
taxa to tetrapods. The indications about the use of the same genetic network for the 
patterning of their homologous appendages, obtained by the comparative studies between 
teleost and tetrapods, should not make us forget that the genetic kit used for ﬁns and limbs 
development is much older than the chordates. Invertebrates use the same gene circuit for 
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their appendages too. 
 Development of ﬁns and limbs shares many genes, as Shh, Bmp4, Bmp2, Hoxa, 
Hoxc, Hoxd, En-1 and many others. However, the developmental similarity between ﬁns 
and limbs goes beyond the sharing of genes. In fact the precise spatial relationship and 
cellular interactions between these shared genes during early development of ﬁns highly 
resembles that seen in early limb development49 and references therein.
 Fins are the most ancient paired appendages in vertebrates, Anaspid ﬁshes carried 
them at least 450 million years ago50,51. Although Anaspid ﬁshes are jawless, they branch 
from the same lineage unique to gnathostomes and they evolved after the evolutionary 
split from the jawless ﬁshes such as lampreys. Throughout evolution, vertebrate ﬁns 
and limbs have conserved anatomical patterns around which there have been repeated 
diversiﬁcations. Recently, striking genetic similarities have been found in the basic 
control mechanism of the shared anatomical conﬁgurations52 and references therein. 
 Fins, wings and limbs develop from a thickening of the ectoderm that will form small 
protrusions (buds)  (Figure 1.9) which arise on the lateral body wall (lateral plate) of the 
Figure 1.9
Limb Bud.
At the apex of the bud there is the apical ectodermal ridge (AER). The AER consists of closely packed cells, 
connected by extensive gap junctions. This tight packing is thought to give the AER the mechanical strength to 
keep the limb ﬂattened along the D/V axis. The length of the AER determines the width (A/P) of the bud.
Beneath (more proximal) the AER there is the progress zone (PZ). The PZ contains rapidly proliferating cells 
and seems involved in the induction of positional information.
Proximal and posterior to the PZ there is the Zone of polarizing activity (ZPA). The ZPA has strong signaling 
proprieties and speciﬁes the position along the A/P axis.
Resolving the molecular basis of human malformation syndromes
30
embryo. The two major components of the early ﬁn/limb bud are a core of mesodermal 
undifferentiated cells and an ectodermal jacket that encloses them. Most of the limb 
will develop from the bud’s mesenchyme core. Limb muscle cells have another origin 
(different lineage), since they migrate into the bud from the somites. The limb bud growth 
centre (progress zone) lies underneath a specialised epithelial ridge located at the apex 
of the bud, the apical ectodermal ridge (AER). The AER, formed by a narrow band of 
tightly packed columnar cells connected by gap junctions, develops at the interface of the 
D/V ectodermal territories, and is a crucial organising region of the limb bud. Members 
of the FGF families are strong candidates as triggering factors for AER and ﬁn/limb 
bud formation53-56. Among the several genes expressed at the D/V border prior to AER 
formation, two appear particularly important for determining the AER location: Engrailed-
1 (En-1) and Radical fringe (r-Fng). En-1, a homeobox transcription factor, is expressed 
in the ventral ectoderm. r-Fng  encodes for a secreted factor related to Drosophila Fringe, 
a signal modulator working through the Notch pathway57, whose expression is restricted 
to the dorsal ectoderm by En-1. The AER is positioned exactly at the border between 
expressing r-Fng and non-expressing r-Fng cells49 and references therein. Two members 
of the Wnt family (highly conserved secreted signalling molecules that regulate cell-cell 
interactions during embryogenesis) are also involved. Wnt3a and Wnt7a are dorsalising 
factors, but it seems that only the former is also involved in AER regulation. The AER is 
essential for the growth of the ﬁn or limb. It produces FGF signalling molecules that are 
essential for maintaining the underlying progress zone in an undifferentiated proliferative 
state. The progress zone seems involved in inducing proximodistal identity. It has been 
suggested that there is a direct correlation between the time spent by a cell in the progress 
zone and its ﬁnal position along the proximodistal axis58  (see note a). FGFs from the 
AER also maintain another specialised region, the zone of polarising activity (ZPA). The 
ZPA, or polarising region, is the second crucial organising region in the ﬁn/limb bud and 
it is positioned at the posterior margin of the mesenchyme. Experiments on the chick 
wing60 indicated this region as the source of signals that confer a posterior identity to 
mesenchyme cells. The closer the cells are to the ZPA, the more posterior characteristics 
they acquire. The key signalling molecule in the ZPA is Shh that is activated by retinoic 
acid (RA). Since expression of Shh is restricted to the polarising region61, its long range 
effects are mediated by secondary signals relayed by the bone morphogenetic proteins 
(BMP). Maintenance of Shh expression in the ZPA requires Fgf4 that is provided by 
the AER. In turn, Shh feeds back to maintain Fgf4 expression in the AER. This positive 
(Footnotes)
a Although the progress zone model remains the most accredited, lately it has been questioned. Dudley and 
colleagues suggest a different model, where the various limb segments are ‘speciﬁed’ early in limb development 
as distinct domains, with subsequent development involving expansion of these progenitor populations before 
differentiation59
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feed back loop coordinates the proximodistal outgrowth promoted by the AER with the 
anteroposterior patterning induced by the ZPA. 
 I have brieﬂy introduced some of the key molecules involved in positional identity and 
in deﬁning differentiating regions involved in the ﬁn/limb generation. Key components to 
the interpretation of this positional information during development are the Hox genes62. 
Hox genes are the most studied genes in the comparison between limbs and ﬁns, and 
Hox expression patterns in ﬁns and limbs have shown striking similarities and also some 
differences46. Hox genes specify the anteroposterior body pattern (see above). They also 
have a major role in appendage localisation. Speciﬁc temporal/positional expression of 
Hoxa9, Hoxc9 and Hoxd9 is involved in limb positioning along the body axis and in 
fore-limb/hind-limb speciﬁcation. Probably, tissue speciﬁc Hox controlled secondary or 
tertiary signalling mediates the necessary co-ordination between tissue patterning in the 
limb and spinal cord, which is the necessity to develop specialised motor neurons at 
the same axial level of limbs. In addition, Hox genes expression may in turn inﬂuence 
Hox expression in neighbouring tissues52. Generally, three phases of Hox expression are 
recognised in limb development. During phase I the Hoxd genes domains are sequentially 
expressed across the distal limb. In phase II the expression is centred on the posterior 
distal limb, and phase III sees the spreading to the anterior part of the distal limb. The 
expression of Hoxa genes is similarly sequentially initiated in the progress zone, resulting 
in a nested expression pattern along the proximodistal axis, which sees the expression of 
Hoxa13 spreading to the anterior part of the distal limb in phase III. Phase III is related 
to the speciﬁcation of digits in tetrapod limbs and is the only phase that does not occur in 
teleosts49,63. 
 Speciﬁcation of forelimb versus hind limb or of pectoral versus pelvic ﬁns, is due 
to a different interpretation of the positional signals (timing of gene expression and A/P 
gradient) that control appendage patterning. This information is partially regulated by 
Hox genes during the pre-bud formation period. But Hox genes are not the only players 
in this speciﬁcation. For example experiments on chick wings have shown that, in spite 
of the great difference in skeletal pattern and in phase II Hox expression pattern, phase 
III pattern is very similar to that which occurs in the leg bud34. This calls for additional 
factors in ﬁn/limb speciﬁcation. Good candidates are the T-box (Tbx) genes. These are 
transcriptional regulators differentially expressed in fore- and hind- appendages of 
tetrapods and ﬁshes49,64. There is speciﬁc restriction of certain Tbx genes expression to 
fore- or hind- limbs (e.g. Tbx5 in the fore-limb and Tbx4 in the hind-limb). Moreover 
the Tbx genes interact with other candidate genes for limb speciﬁcation, like the already 
mentioned Hox9, or the homeobox gene Ptx1, also restricted to the hind-limb. Experiments 
of misexpression or knock out of these genes have strengthened their role as major players 
in ﬁn/limb identity49,65.
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1.1.4 Skin development
Molecular and developmental studies, especially on animal models, have recognised 
pathways that give rise, in different evolutionary steps, to several tissues that seem to 
have little in common. An example of this can be seen in development of ﬁsh scales, teeth 
and hair. The most apparent similarity between scale, teeth and hair is their deﬁnition as 
vertebrate appendages. If taken in pairs, we can say that hair and ﬁsh scales have an ordered 
distribution over the body, but their morphology and evolutionary history are different. 
Hair follicles derive from the ectoderm and contain keratin. They are thought to have 
evolved from reptile scales. Teleost elasmoid scales are dermally derived, mineralised 
structures, and like teeth do not contain keratin. They do possibly contain dentine- and 
enamel-derived proteins. Teeth and ﬁsh scales, in spite of their morphological difference, 
share the same membership to dermal skeleton derived tissues and a common ancestor66. 
Fish scales are derived from the dermal armour body of ancient vertebrates. A controversial 
theory sees teeth as derived from an internalisation of dentin-containing dermal armour 
scales into the oral cavity67,68. Although teeth and hair are morphologically and also 
evolutionarily very different, their origin due to epithelial-mesenchymal interactions, in 
early development, brings them to share common developmental pathways involving Shh, 
Bmps and Wnt signalling69. Although syndromes with absence of hair and teeth had long 
been reported70,71, no cause was found until 1994, when mutations in the EDA gene were 
found in hypohidrotic ectodermal dysplasia72. EDA or ectodysplasin, is a transmembrane 
TNF-like protein73. Animal models expressing phenotypes similar to the human disease are 
related to mutations in Eda and in its receptor (Edar), indicating that a cell-cell interaction 
mechanism is involved also in hair and teeth development74-76. Mutations of EDAR in 
human ectodermal dysplasia77 have conﬁrmed the key role of the TNF and TNF adaptor 
protein signalling pathway in vertebrate hair and teeth development. Common epithelial-
mesenchymal interactions during early development seem to be the basis for this pathway 
sharing68. The recent discovery that the failure of developing scales in the teleost Medaka 
rs-3 mutant is due to the ﬁsh’s Edar homologoue, shows that hair loss in mammals and 
failure of scale development in ﬁsh involve the same TNF pathway78. Moreover, these 
data show that a common pathway for the development of hair, teeth and ﬁsh scales 
has been identiﬁed. This suggests that a common developmental mechanism is used for 
vertebrate skin appendages formation involving epidermal-dermal interactions, in spite 
of the apparent lack of an evolutionary link between these skin appendages. The use of 
the EDA/EDAR TNF pathway for forming evolutionary unrelated skin appendages again 
conﬁrms that a limited number of developmental signals exist and that the differences are 
not made by the signal itself but are due to their interpretation.
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1.1.5 Use of natural mutations in human syndromes to identify new players 
in development
Many if not all of the genes involved in congenital anomalies are expected to play an 
important role in development79,80. Therefore the identiﬁcation of the genetic cause of 
human congenital syndromes can have the dual role of broadening our knowledge of 
embryological development, and of providing us with the means for explaining, perform 
pre- and/or post-natal diagnostic tests and in a future eventually preventing congenital 
abnormalities. Molecular analysis of human birth anomalies can be a powerful approach 
for understanding human development and provide greater insight in human evolution. The 
fact that limb development is probably the best known developmental process, together 
with the fact that the frequency of limb congenital anomalies is second only to heart 
defects, has made this one of the most studied ﬁelds81. Many genes in limb development 
have been found thanks to the studies of human syndromes and related animal models. At 
present there are more then 200 syndromes with limb defects in OMIM and for more than 
60 of these a causative gene has been found. Some examples are shown in Table 1.3. 
Table 1.3 Examples of syndromes with limbs defects and known causative gene. 
Syndrome Limb defects Gene Locus OMIM # Mouse
Acheiropody
Bilateral amputations of 
upper and lower extremities 
and aplasia of hands and feet
LMBR1 7q36 200500 Lmbr1
Achondroplasia
Rhizomelic shortening of 
limbs
FGFR3 4p16.3 100800 Fgfr3
Bardet-Biedl 2 Polydactyly BBS2 16q21 209900
Bardet-Biedl 6 Polydactyly MKKS 20p12 209900
Brachydactyly A1
Brachydactyly of middle 
phalanges
IHH 2q35-q36 112500 Ihh
Brachydactyly B
Brachydactyly of distal 
phalanges and nail aplasia
ROR2 9q21-q22.3 113000 Ror2
Brachydactyly C
Brachydactyly of the 
middle phalanx of the 
index and middle ﬁngers 
phalanx triangulation 
brachymetapody, 
hyperphalangy 
symphalangism
CDMP1 20q11.2 113100 Gdf5
EEC Ectrodactyly TP63 3q27 604292 P63
(Continued on next page)
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Table 1.3 Examples of syndromes with limbs defects and known causative gene. 
(continued)
Syndrome Limb defects Gene Locus OMIM # Mouse
Ellis-van Creveld
Short limbs, short ribs, 
postaxial polydactyly and 
dysplastic nails
EVC 4p16 225500 Evc
Grebe 
chondrodysplasia
Shortened and deformed 
limbs, with proximal-distal 
gradient of severity
CDMP1 20q11.2 200700 Gdf5
Greig-
cephalospolysynd-
actyly
Polysyndactyly GLI3 7p13 175700 Xt
Hand-foot-genital Brachydactyly HOXA13 7p15-p14.2 140000 Hoxa13
Holt-Oram
Upper limb deﬁciencies and 
duplications (anterior)
TBX5 12p24.1 142900 Tbx5
Klein-
Waardenburg
Oligodactyly PAX3 2q35 148820 Pax3
Oral-facial-digital
Syndactyly, clinodactyly, 
brachydactyly and 
occasionally postaxial 
polydactyly
CXORF5 Xp22.3-p22.2 311200 Ofd1
Pallister-Hall Postaxial polydactyly GLI3 7p13 146510 Xt
Robinow (AR)
Mesomelic shortening of 
limbs
ROR2 9q21-q22.3 268310 Ror2
Saethre-Chotzen Syndactyly of toes TWIST 7p21 101400 Twist
Saethre-Chotzen Syndactyly of toes FGFR3 4p16.3 101400 Fgfr3
Smith-Lemli-Opitz
Short or proximally 
placed thumbs. Postaxial 
polydactyly
DHCR7 11q12-q13 270400 Dhcr7
Synpolydactyly
Syndactyly, insertional 
polydactyly, brachydactyly
HOXD13 2q31-q32 186000 Hox4.9
Townes-Brocks Triphalangeal thumbs SALL1 16q12.1 107480 Sal1
1.1.6 Conclusions
The discoveries of signalling cascades and combinations of transcription factors that control 
cellular development and differentiation have implications that transcend developmental 
biology and integrate it with cell biology and the study of disease82. Although we still lack 
a lot of molecular information on the function of cells in tissues, we can start to make 
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reliable models of pathways, complexes, distinct protein functions and connect these to 
cellular properties of particular tissues. The more and more frequent connections between 
newly discovered genes and known phenotypes allow us to position such genes in speciﬁc 
pathways or processes. The fact that many of the discovered mechanisms, together with 
their critical regulatory genes, are conserved implies that the work on animal models 
systems is also relevant to human development and vice versa. This brings new powerful 
tools for the discovery of the molecular basis of human malformations.
1.2 Multiple Congenital Anomalies
1.2.1 History
Congenital anomalies are the most important cause of infant mortality in western society83. 
The event of a malformed child has always captured the attention of people. Records of 
abnormally formed children date back to prehistorical times. Statues from approximately 
6500 BC show ﬁgures of conjoined people, probably regarded as gods. Rock drawings 
discovered in the South Paciﬁc show dicephalic conjoined twins (5000-4000 BC), while 
pre-Columbian drawings in the U.S.A. depict a ﬁgure with sirenomelia. Representations 
of Egyptian gods showing achondroplasia and dwarﬁng dysplasia (circa 2000 BC) have 
been found. The ﬁrst written report of abnormalities is a clay tablet from the Royal Library 
of Nineveh (circa 2000 BC) where, in cuneiform characters, 62 human malformations are 
listed and interpreted. 
 Supernatural forces always have been a popular explanation for human anomalies. 
The will of god(s) was identiﬁed as the cause. The reasons could be manifold, but may 
be collected in two broad categories: “creativity” and  “message”. In the ﬁrst case, god(s) 
would create malformation for amusement, for show of power or just because it was 
possible. As Pliny the Elder (A.D. 23-24 – A.D. 79) writes in his “Naturalis historia” 
(natural history): “nature creates monsters for the purpose of astonishing us and amusing 
herself”. In case the purpose of a malformation was to convey a message, this could be either 
a warning or an admonition, or it could express displeasure or punishment. Sometimes 
malformations are associated to the doing of evil and therefore such malformations were 
to be destroyed, or worshipped, by worshippers of “evil gods”. 
 There is a reciprocal connection between malformations and god. Gods were 
created with the likeness of malformed humans, as for the conjoined goddesses or the 
Egyptian achondroplastic god Bes. Malformed babies were seen and the description of 
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their appearance was transmitted. The alteration, embellishment, exaggeration that the 
original description could undergo through the generations could eventually transform 
it into a god. Celestial bodies have also been indicated as a cause for human anomalies. 
Obviously astrology played a main role in this interpretation. Malformations were seen 
as one of the inﬁrmities caused by the unfavourable position of the stars, and as such they 
were inevitable and irreparable. Each speciﬁc malformation also carried messages for the 
future, as described in the clay tablet of the Royal Library of Nineveh.  
 Many theories have tried to explain the biological basis of reproduction. Aristotle, in 
“On the generation of animals”, writes that embryos were formed from material contained 
in menstrual blood that was somehow activated, controlled and moulded by semen: “the 
blood of the menses is the marble, the semen is the sculptor, and the foetus is the statue”. 
Others thought that egg or sperm contained a miniaturised but fully formed embryo. One 
subsequent theory that has long survived considered the embryos as formed by elements 
derived from all the body parts and transmitted by the reproductive ﬂuids71,84. Together 
with these reproductive theories grew the interpretations of malformations.
 A more “scientiﬁc” cause of anomalies was seen in the presence of abnormal 
reproductive components. A popular theory, that reckoned among its estimators the Greek 
philosopher Empedocles (495-435 BC) and the French surgeon Paré (1517-1590 AD), 
saw in the quantity of semen or in its faulty movement the cause of malformations. These 
theories saw the semen as all that is necessary for reproduction and the mother necessary 
only for the incubation, nourishment and safe haven of the embryo. Hybridisation with 
animals or maternal impressions and experiences during pregnancy were also thought to 
cause congenital abnormalities. 
 With the development of the microscope, fundamental changes in the concept of 
reproduction and malformations arose. The principle that embryos were already present 
and fully formed but miniaturised in the sperm or egg was substituted by the concept 
that embryogenesis proceeds from simple to complex. Although this was not a new 
idea, as Aristotle had already recognised it, there was now scientiﬁc proof. Arrest of the 
embryonic development was then proposed to be the cause of human malformation. The 
fact that some congenital defects as deformation of body parts, dislocations, fractures and 
amputations, can be seen as caused by mechanical forces, created the idea that mechanical 
forces cause infant abnormalities. The size and shape of the womb and the effects of 
violent external traumas to the abdomen were considered causative. The presence of 
internal forces was also taken into account. These could be due to pelvic contraction, to 
ﬁbroids, to tumours of the abdomen or pelvis, small uterus and so on. The force between 
co-twins was indicated to be causative of anomalies. Conjoined twins were thought to 
arise by elevated intrauterine pressure, forcing them to fuse. 
 The fact that disease of the embryo could cause human malformation became a 
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common thought only after the seventeenth century. 
 Studies on chicken eggs conﬁrmed that environmental factors could penetrate the 
“safe haven” surrounding the embryo. Beginning in the 19th century, systematic analysis 
of chicken eggs by tampering with temperature, position, chemicals, electricity, magnetic 
ﬁelds, gasses and more, was correlated with malformations85-89. Warkany and others 
continued and expanded such experiments in view of the possibility that environmental 
effects could also affect human embryo development90-93. In the late 1920’s it was 
recognised that pelvic irradiation of a pregnant woman caused malformations in the 
child94. The ﬁrst association of congenital malformation and infective disease (rubella 
virus) was made in 1941 by Gregg95. At the beginning of the sixties the ﬁrst association 
between a medicine taken by the mother and the presence of limb defects in the newborn 
was made96,97. The number of discovered teratogenic agents has increased greatly since 
then. The search for potential environmental agents that can cause malformations is now 
an important ﬁeld in teratology.
 That malformations, as well as normal features, could be inherited from parents was 
well known far before the mechanisms of heredity were established. There were two main 
theories: the pangenesis and the Aristotelian view.
 The pangenesis theory, whose roots precede Hippocrates, sustained that the anatomic 
characteristics, seen as units of inheritance, called “gemmules” by Darwin, came from 
all parts of the body of the parents and were collected in the semen or menses71,84,98. 
The “Aristotelian” view, as already mentioned, saw the menses as the repository of the 
material necessary for the embryo formation and the semen as activator and controller.
 In the 16th century Paré included heredity within the causes of malformations. 
Four centuries later heredity was a well accepted cause for several malformations. The 
rediscovery of Mendel’s work opened a new era in inheritance of traits. In 1902, the 
Sutton-Boveri theory was proposed. This theory suggests a parallel between Mendels’ 
law and chromosome behaviour. Although not unanimously accepted at the beginning, 
the correlation between chromosome and heritable traits was made. Shortly after, in 
1903, brachydactyly type A1 was the ﬁrst malformation to be attributed to single gene 
inheritance99. Its causal gene, IHH, was only recently identiﬁed100. Morgan, in his studies 
on drosophila mutants, provided the ﬁrst example of localisation of a single characteristic 
(gene) on a speciﬁc chromosome, utilising a particular natural mutation (white eyes) that 
was associated with sexual type101,102. He further established three fundamental concepts: 
(a) the concept of “linkage”, i.e. the propensity of some characteristics to remain associated 
instead of assorting independently; (b) the means for determining a positional order, i.e. 
mapping, of such characteristics/entities: (c) that these entities are placed in a linear order 
in the chromosome. In the early 1940’s George Beadle and Edward Tatum, through their 
experiments on Neurospora103, unveiled the biochemical mechanism of gene expression, 
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enunciating their “one gene-one enzyme” hypothesis that gained them the Nobel prize 
in 1958. Within the next 20 years several exciting breakthroughs were reported: in 1944, 
Avery and others recognised the DNA as the molecule responsible for the transmission of 
heritable traits104 the structure of the DNA was revealed105, the ﬁrst malformation caused 
by chromosomal abnormalities was discovered: Down syndrome caused by chromosome 
21 trisomy106, and, ﬁnally, cracking of the genetic code107.
1.2.2 Overview and clinical aspects
Congenital anomalies can be divided in major anomalies, those that are of obvious 
medical, surgical and cosmetic importance; and minor anomalies that, except for rare 
cases, are of no serious medical and surgical importance. Here we will mainly focus 
on the major anomalies. Based on the mechanism and time of occurrence, three basic 
categories of anomalies are recognised: malformations, deformations and disruptions. 
The clinical implications of each category are different, but it must also be clear that these 
categories may overlap and that it is not always possible to assign an anomaly to a speciﬁc 
category  (Figure 1.10).
 Malformations are morphologic defects of an organ, part of an organ, or a larger area 
of the body, resulting from an intrinsically abnormal developmental process (e.g. cleft lip, 
syndactyly)108, that arises during the initial formation of a structure. Malformations are 
caused by genetic or environmental factors or by a combination of the two109. About 3% 
of newborns have a malformation and 1% has multiple malformations110. Malformations 
can be divided in three classes: incomplete morphogenesis, redundant morphogenesis and 
aberrant morphogenesis. The ﬁrst class is most common and it can be further divided in 
three subtypes: hypoplasia (e. g. microcephaly), incomplete separation (e.g. syndactyly), 
incomplete closure (e.g. cleft lip). Redundant morphogenesis (e.g. polydactyly) is much 
less frequent. Cases of aberrant morphogenesis (e.g. paratesticular spleen) are rare. An 
inverse relationship can be found between the complexity of the malformation and the 
time of onset. The earlier the malformation is initiated the more serious its consequences. 
An early defect can start a “malformation sequence”, promoting a chain of secondary and 
tertiary events that cause multiple anomalies.
 Deformations are deﬁned as an abnormal form or position of a part of the body caused 
by non-disruptive mechanical forces108. Causes of deformation are mainly environmental 
but genetic causes are also possible109. Around 2 % of newborns show deformations. 
Postural scoliosis and hip dislocation are important deformations. Deformations are more 
likely to happen during late foetal life, in contrast with most malformations that tend to 
arise during the embryonic period, and therefore deformations tend to alter parts that were 
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previously normal. 
 The causes of deformations have been divided in two groups: extrinsic causes and 
intrinsic causes. Extrinsic causes are of mechanical origin, as for example unstretched 
uterine and abdominal muscles, unusual implantation site, amnionic tear, unicornuate 
or bicornuate uterus and twin foetuses. Intrinsic causes can be “malformational” or 
functional. About 7% of all malformations are associated with deformations111. In these 
cases malformations involving the CNS and urinary system, cause secondary deformations. 
The deﬁcient muscular innervation due to defects of the CNS limits the ability of kicking 
and position changing of the foetus. The amniotic ﬂuid gives protection to the foetus from 
extrinsic forces and, since the foetus urine produces most of the amniotic ﬂuid, it is evident 
Figure 1.10
Diagram of the mechanism and of the time of occurrence of malformations, deformations and disruptions 
(major anomalies).
The majority of malformations commonly arise within the embryonic period, although the cause of the 
malformation may have occurred earlier in time.
Deformations, instead, arise more commonly during the fetal period. Fetuses are prone to deformation because 
of their skeletal plasticity and rapid growth rate in a potentially constraining environment. Deformation may 
also arise postnatally, as in case of some progressive syndromes.
Disruptions tend to appear later in the intrauterine life compared to malformation and deformations. Disruptions 
tend to be more sporadic in contrast to malformation and deformations.
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how malformation of the urinary tract may produce deformities as a secondary event. 
Functional causes of deformations can be also due to neurologic or muscular disturbances, 
or to connective tissue defects110. After birth, free of the intrauterine constraining forces, 
the large majority of deformations correct spontaneously, whereas malformations do not. 
The degree of self correction is related to the time-length of the constraint and to the 
severity of the deformation. 
 Disruptions are morphological defects of an organ, or part of an organ, or a larger 
region of the body resulting from a breakdown of, or an interference with, an originally 
normal developmental process108. Typical disruptions are the abnormalities caused by 
aberrant tissue bands or by amniotic rupture. The outcome of such disruptions can be limb 
and digit amputation, bizarre facial clefts or asymmetric encephaloceles. Disruptions, 
in contrast to malformations and deformations, tend to be sporadic and show a higher 
variability. Some disruptions may be mistaken for malformations.
 Minor anomalies may also by divided in to three categories: malformational (e.g. down 
slanting palpebral ﬁssures), deformational (e.g. overlapping toes), and hamartomatous 
(e.g. pigmented nevi). These categories can be subdivided in internal and external. About 
2/3 of the external ones are found in the head, neck, and hand regions. 15% of newborns 
show a minor anomaly. Only 1% has two minor anomalies. What makes minor anomalies 
particularly important is that when 3 or more are present, in 90% of cases, there will also 
be major anomalies111 and references therein.
 Approximately 1% of all newborns carries multiple congenital anomalies (MCA)111. 
Sequence, syndrome and association are three terms frequently used for their classiﬁcation. 
They refer to the relationship that exists between the various anomalies. A sequence may be 
deﬁned as multiple defects derived from a single known or presumed structural defect108, 
i.e. a chain reaction where a primary event sets off a sequence of successive (secondary, 
tertiary, etc.) events resulting in apparently multiple anomalies. A syndrome can be 
deﬁned as multiple anomalies thought to be pathogenically related and not representing a 
sequence112 (e.g. EEC syndrome, Robinow syndrome). By the term association we deﬁne 
a non-random occurrence of several morphological defects not identiﬁed as a sequence or 
a syndrome112 (e.g. VATER, Vertebral anomalies, Anal atresia, TracheoEsophageal ﬁstula, 
Radial defects and renal anomalies).
1.2.3 Heredity 
Most congenital malformations are wholly or partly genetic in aetiology. They may be 
caused by a single gene (monogenic) mutation, polygenic inheritance, chromosomal 
abnormalities, or multifactorial. Identiﬁcation of monogenic malformation syndromes 
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is of particular importance since these syndromes may have a high recurrence risk113. 
Polygenically inherited syndromes are caused by mutations in two or more genes. These 
genes can be neighbouring genes, and in this case we talk of contiguous gene syndrome 
(e.g. Langer-Giedion syndrome114), or unattached genes, even located on different 
chromosomes, (e.g. Bardet-Biedl syndrome115). Multifactorial causation requires the 
combined inﬂuences of genetic and environmental factors (e.g. neural tube defects116). 
1.3 Gene Identiﬁcation: molecular genetic strategies
Since the identiﬁcation of the ﬁrst genes responsible for human diseases in the early 1970s, 
four main strategies for identifying human monogenic disease genes were developed: 
functional cloning, positional cloning, positional candidate and position-independent 
candidate gene strategies. The birth of these strategies followed the development of new 
molecular biology techniques. Recombinant DNA technology created the ﬁeld and then 
PCR-based procedures allowed the efﬁcient application of genome-wide linkage analysis 
and large scale mutation screening. 
1.3.1 Functional cloning
The ﬁrst inherited diseases were resolved by the position-independent strategy of 
functional cloning117. This was not a choice but the only method, since there was almost 
no mapping information at that time. Phenylalanine hydrolase deﬁciency which causes 
phenylketonuria, and the factor VIII blood clotting gene, the cause of hemophilia A, are 
examples of genes identiﬁed by this approach118,119. The functional cloning strategy is 
based on the knowledge of the normal cellular function of the protein, which guides its 
puriﬁcation and subsequently allows the partial deduction of the amino acid sequence. 
The polypeptide sequences can then be used in several ways: (1) to design degenerated 
oligonucleotides, corresponding to all possible codon permutations. Such gene speciﬁc 
oligonucleotides are used to screen cDNA libraries in order to isolate and characterise 
the corresponding gene. (2) alternatively, puriﬁed protein or a synthetic peptide analogue 
allows raising of speciﬁc antibodies that are suitable for screening expression libraries. 
 Another, fundamentally different, example of functional cloning is seen in approaches 
that use cellular or phenotypic complementation assays, as can be seen in the cases of 
carbohydrate-deﬁcient glycoprotein syndrome (CDGS)120, alkaptonuria121, or in the 
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identiﬁcation of the gene for Fanconi’s anemia C122. Mammalian cell lines, yeast and 
transgenic mice have been used in complementation assays. This approach also allowed the 
identiﬁcation or conﬁrmation of a number of tumour suppressor genes and oncogenes123-
125.
1.3.2 Position-independent candidate strategy
Position-independent candidate strategies rely on known characteristics of a gene, such as 
expression, function, homology to other genes, and existence of animal models, without 
making use of the chromosomal position of the gene. Good candidate genes are those 
that show an expression pattern and/or cellular function that ﬁts the phenotype under 
investigation. Homologies with known genes with expression pattern and/or function 
compatible with the disorder of interest or associated with a homologous disease in a 
model organism will increase the status of the candidate gene. For example tissue speciﬁc 
expression of a gene has led to the identiﬁcation of genes causing chondrodysplasias126, 
or inherited blindness127. 
1.3.3 Model organisms
Phenotypic homologies with model organisms have often provided precious information 
for human disease gene identiﬁcation. Human-murine homology is extensively used 
to identify disease genes. For example the online mouse locus catalog (MLC), now 
integrated in the mouse genomic database (MGD) at “The Jackson Laboratory” (www.
jax.org), contains exhaustive, yet concise phenotypic descriptions of mouse mutations. 
These mouse data, together with databases containing human clinical features (e.g. 
“London Dysmorphology Database or OMIM”), are used in particular web interfaces 
that allow the simultaneous search in these databases. Examples are “The Dysmorphic 
Human-Mouse Homology Database (DHMHD)” (www.hgmp.mrc.ac.uk/DHMHD/
dysmorph.html) or the “Combined Mouse/Human Phenotypes” (www.informatics.jax.
org/searches/noforms_mlc_omim.cgi). Natural occurring or induced gene mutations in 
the mouse may create a phenotype that bears resemblance to the human disorder caused 
by mutation of the orthologous gene. Such mouse models are particularly useful because: 
a) The presence of a detailed mouse genetic map and quick and accurate mapping through 
backcross mapping. b) The high degree of conservation of synteny. c) The considerable 
conservation of coding DNA, that allows easy recognition of human-mouse orthologous 
genes. Drosophila and recently zebraﬁsh models have been proven useful for identifying 
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some of the new players in development and in speciﬁc developmental cascades. For 
example, the “Drosophila Related Expressed Sequences” (DRES) database has been 
constructed to allow the identiﬁcation of genes and to study their function through the 
comparison of human ESTs and their putative orthologues in Drosophila128. Although 
similar to the mouse approach, DRES is not as powerful as DHMHD to recognize a 
phenotypic parallel with humans. This is mainly due to the greater evolutionary distance 
between man and Drosophila. Homologies with lower organisms are mostly used to 
study the function of the gene and genetic networks. Basic biological functions can show 
remarkable conservation in evolution, and such conserved pathways can guide to the 
discovery of human disease genes even by using yeast as a model. A striking example is 
provided by the identiﬁcation of two mismatch repair genes (MSH2 and MLH1) involved 
in colon cancer129,130. 
1.3.4 Positional cloning
By 1980, 90% of the new genes involved in human heritable disorders were discovered 
through functional cloning. At the beginning of the human genome project (1990) 
this percentage fell to 60%, and ﬁve years later only 25% of new genes derived from 
position independent methods. Within this time a new strategy to identify disease genes 
(based only on sub-chromosomal localisation of the gene) became increasingly more 
important; the positional cloning strategy. Positional cloning, initially and inappropriately 
referred to as reverse genetics, is the cloning of the gene responsible for a disease solely 
by knowing its chromosomal localisation. The most common methods to determine 
the initial localisation are linkage analysis, chromosomal aberrations and, for cancer 
genes, loss of heterozygosity screening. In the case of linkage analysis different methods 
can be used: “classical” linkage analysis through two point or multipoint mapping, 
homozygosity or identity by descent mapping, and association mapping. Homozygosity 
mapping is particularly useful for autosomal recessive disorders in inbred families and 
populations. It aims to identify regions of homozygosity that are shared only by affected 
individuals. Linkage analysis often yields a less accurate localisation of the disease 
gene, in other words if identiﬁes a wide critical region. Especially in the early days it 
was therefore a tedious task to ﬁnd the causative gene upon mapping of the disease. 
The Treacher Collins syndrome gene (TCOF1) is a good example of positional cloning 
through classical linkage analysis131. The CFTR gene involved in cystic ﬁbrosis (CF) 
was positionally cloned in 1989132 making use of strong linkage disequilibrium in the 
CF gene region (association studies). Chromosomal abnormalities that are associated 
with a certain disease are very useful in accurately localising the causative gene. An X-
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chromosome translocation breakpoint in a female with Duchenne muscular dystrophy 
(DMD) was instrumental in identifying the DMD gene133. Large deletions tend to give 
rise to complex non-speciﬁc phenotypes, but in some cases, where one or more distinct 
traits can be detected as in a contiguous gene syndrome, they can indicate a speciﬁc sub-
chromosomal localisation. The cloning of the choroideraemia and of the DFN3 deafness 
genes was based on systematic study of deletions in Xq21.2134,135. A special case of the 
use of deletions for the identiﬁcation of causative genes is the loss of heterozygosity 
(LOH) mapping, which is mostly restricted to the ﬁnding of tumour suppressor genes. 
The retinoblastoma gene (RB1) was identiﬁed through LOH mapping136,137. Duplications 
have had less utility for positional cloning. Nonetheless there are some cases where the 
dosage effect caused by complete gene duplication creates a phenotype. For example 
a duplication of the PLP gene may cause Pelizaeus-Merzbacher disease (PMD)138. The 
PMD situation is similar to that of Charcot-Marie-Tooth disease type 1a (CMT1a). In 
this last case there is duplication of the gene peripheral myelin protein 22 (PMP22)139,140. 
In recent years a number of methods have been developed for large scale screening for 
deletions/duplications. 
I. The comparative genomic hybridisation (CGH) technique allows the comparison of 
two different DNA populations and searches for differences between the two141-143. 
i. Matrix-CGH or array-CGH applies the CGH technique to an array of clones 
spotted on glass slides144,145. 
II. Representational difference analysis (RDA) is a powerful method to isolate 
differences between genomes. RDA relies on the combined implementation of three 
elements, i.e. subtractive hybridisation, representation and kinetic enrichment146. 
cDNA-RDA and MS-RDA are two recent variants. 
i. cDNA-RDA is based on differential gene expression and allows the comparison 
and separation of differentiated cells and stem cells, activated cells and resting 
cells, and of tumour cells from their normal counterpart147. 
ii. MS-RDA allows the detection of differences in methylation status148. 
III. Techniques employed to detect sub-microscopic deletions and insertions. 
i. The traditional method is based on Southern blot analysis of genomic DNA 
digested with restriction enzymes. Hybridization with probes from the region 
of interest will allow the detection of deviant restriction patterns as well as 
differences in dosage due to deletions or duplications. When rare-cutting 
enzymes are used to fragment the genomic DNA, the products have to be 
separated by pulsed-ﬁeld electrophoresis (PFGE). More recent application of 
these hybridisation protocols is the YAC representation hybrydization (YRH).
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ii. The YAC representation hybrydization (YHR) method is a technique inspired to 
the RDA and the YACadapt method149. The principle of YHR is the generation 
of small ampliﬁable restriction fragments derived from a YAC insert that span 
the genomic region of interest. After ligation of these fragments to appropriate 
linkers and subsequent PCR ampliﬁcation, the PCR products are used as 
hybridisation probes on Southern blots containing restriction enzyme digested 
genomic DNA150. 
IV. Quantitative-PCR techniques (that are rapidly replacing Southern blot techniques)
i. Multiple(x) ampliﬁable probe hybridisation (MAPH) is a recent technique that 
permits the measurement of locus copy number151. 
ii. The MAPH telomeric assay uses the MAPH technique with speciﬁcally designed 
hybridisation probes located at the end of human chromosomes152. 
iii. The newly developed multiplex ligation-dependent probe ampliﬁcation (MLPA) 
technique represents an improvement over MAPH153. 
Many factors may inﬂuence the amount of work that has to be done to identify a human 
disease gene by positional cloning. Most important is the size of the candidate region. 
Often the initial location identiﬁed by linkage corresponds to a sub-chromosomal region in 
excess of 10 Mb. At present, a comfortable size to work with is less than 1 Mb. Therefore 
much effort is put into reﬁning the critical region. The methods to reﬁne the critical region 
are usually extensions of the ones previously used to deﬁne it. 
 Once the critical area has been reﬁned, contigs of YACs, BACs and PACs used to 
be made for accurately mapping of all the elements (polymorphic markers, ESTs and 
genes) of the minimal critical region (physical mapping). Nowadays, this step can be 
skipped because such physical maps are already made and available through internet. 
It is within these ordered genes and/or ESTs that lies the gene causing the disorder. A 
purely positional approach may impose, to the less fortunate, much laborious and time 
consuming mutation screening before the actual gene is found. 
1.3.5 Positional candidate approach
As the knowledge on gene function, position and expression grows, classical positional 
cloning is gradually replaced by the positional candidate approach. Of the more than one 
hundred identiﬁed disease genes in 1997 about 80% used a positional candidate strategy77, 
(www.ncbi.nlm.nih.gov). This percentage has increased further over the past years and 
positional candidate gene analysis has contributed most to the current number of almost 
1500 human diseases linked to a gene (OMIM June 2003). In the positional candidate 
strategy the selection of candidate genes in a speciﬁc critical chromosomal region relies 
on the availability of information from previously isolated genes or ESTs. This strategy is 
Resolving the molecular basis of human malformation syndromes
46
based on their expression pattern during development, on gene function, on the presence 
of animal models and also on homology to other human or non-human genes. Ideally, 
the candidate gene is expressed at the place and at the time at which the disease arises, 
but restriction to speciﬁc tissues and times is not a prerequisite. Immunohistochemical 
analysis and RNA in situ hybridisation of tissue sections or in mouse embryos provides 
valuable information about the spatio-temporal expression of genes154. Also efﬁcient 
and less laborious are northern blotting and RT-PCR. An accurate diagnosis and good 
knowledge of the pathology can help to indicate the putative function of the candidate 
gene. This works both ways. If the biochemical pathway involved in the disease is 
known, then a candidate that might ﬁt in that pathway will be selected. As an example 
the Marfan syndrome (MFS, OMIM #154700) phenotype suggests abnormalities in the 
connective tissue. When the gene encoding the connective tissue protein ﬁbrillin (FBS1) 
was mapped at MFS locus in 15q21.1 it became an obvious positional candidate. Good 
candidate genes can also be genes that are part of the same biochemical pathway of a 
gene previously shown to be involved in a related disorder. The ﬁnding of an interactor 
or the ligand for a receptor that is involved in a particular disorder can be an example 
(e.g. GDNFα, NTN and RET in Hirschsprung disease). Likewise, paralogues of a speciﬁc 
disease gene are suitable candidates for related disorders (e.g. collagen II and XI, or 
FGFR1 - FGFR2 - FGFR3, or FBN1 and FBN2). The study of model organisms aids 
the selection of candidate genes. The homology may concern genes and/or phenotypes. 
Because there can be large homologies between human genes and orthologous genes 
of model organisms, in particular mouse, and due to the availability of many natural or 
induced mutants, selection of candidate genes can be made on such bases.
 The positional candidate gene approach can also work in the opposite direction: i.e. 
from gene to disease. It is then sometimes called positional candidate disease approach. 
An example can be found in RPGRIP1 and Leber congenital amaurosis (LCA). The 
RPGRIP1 gene encodes a protein that interacts with the RPGR protein involved in RP3. 
Subsequently null mutations in RPGRIP1 were found in patients with LCA155. This is 
actually a straightforward candidate gene approach. Another example can be seen in CRB1 
and Retinitis pigmentosa 12 (RP12). The similarity to CRB of Drosophila suggested a role 
for CRB1 in cell-cell interaction and possibly in the maintenance of cell polarity in the 
retina. The genomic position of CRB1 coincided with that of a recessive type of retinitis 
pigmentosa. When tested, RP12 patients showed to carry compound heterozygous, and 
homozygous mutations in the CRB1 gene156.
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1.3.6  “In silico” candidate analysis
With the claimed completion of the Human Genome Project the search for disease 
causing genes “in silico” has become an integral part of the positional candidate gene 
strategy. The current availability of various types of information in databases that are 
accessible via the Internet (an extensive list is shown in Appendix 6) has revolutionised 
the whole procedure of gene searching. The fact that almost the entire human and 
mouse genomes are available has drastically reduced the amount of work to be done 
at the laboratory bench. For example, physical mapping of a speciﬁc sub-chromosomal 
region can now be achieved at the computer desk. The problem that arises is how to 
efﬁciently handle all the information available. To overcome this, speciﬁc programs are 
created. For Example Swiss-Prot/trEMBL is an annotated protein database containing 
information also on function, domain structure, post-translational modiﬁcations and 
variants. Its recent integration with other databases available on the web permits, for a 
speciﬁc protein, to retrieve information on nucleic acid sequences, description of genetic 
disorders associated with such protein, 3D structure models and information related to 
the protein family157. In our department a pilot study was performed to identify candidate 
genes for multiple congenital anomalies using the expression data available from public 
databases (Appendix 1). This project has been expanded in collaboration with the Centre 
of Molecular and Biomolecular Informatics (CMBI, www.cmbi.nl) of our university. 
Presently a program for searching candidate genes for human inherited disorders in silico 
is available, named “GeneSeeker”. This program uses expression/phenotype as well as 
localisation information. The search for candidate genes for a speciﬁc syndrome requires 
the input of human phenotypic characteristics and eventual mapping data to generate a list 
of candidate genes158. Similar to other search engines, the efﬁcacy of GeneSeeker relies 
on the completeness and correctness of the linked databases, and this remains the major 
limitation of in silico search strategies.
1.3.7 Conﬁrmation of candidate genes
Regardless of the method used to select the candidate gene, proof of its involvement in 
the human disorder ultimately relies on mutation analysis. The identiﬁcation of mutations 
in several unrelated patients provides strong evidence that the tested gene is the disease 
gene. Additional evidence supporting the pathological effect of these mutations is often 
necessary. For testing small numbers of patients, direct sequencing may be applied for 
mutation analysis. When large patient groups need to be tested, a pre-screening protocol 
is more efﬁcient and less costly. The most common methods of mutation pre-screening 
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are Single Strand Conformational Polymorphism analysis (SSCP), Denaturing Gradient 
Gel Electrophoresis (DGGE), Denaturing high performance liquid chromatography 
(DHPLC), and Chemical or Enzymatic Cleavage of Mismatches (CCM and ECM). SSCP 
exploits the natural tendency of single stranded DNA to fold up in complex structures. 
The structure is determined by the nucleotide composition. The electrophoretic mobility 
of these structures is dependent on their conformation. Hence a change in the DNA 
sequence will cause a change in mobility. SSCP neither reveals the nature nor the position 
of the variant. The DGGE technique utilises the melting temperature of DNA fragments 
to detect mutations. The characteristic melting temperature of each fragment of double 
stranded DNA is due to its nucleotide sequence. A single base mutation will alter the 
denaturing temperature and consequently the migration pattern. Every single mutation 
shows a reproducible speciﬁc pattern and this can be quite easily recognised. Setting up 
conditions, for each fragment to be analysed, is very time consuming and this is the main 
drawback of this technique. A similar concept is used in the DHPLC159. This methodology 
uses an ion-pair reverse-phase liquid chromatography system to rapidly separate and 
visualise homo- and heteroduplex DNA molecules. The sensitivity of the analysis is 
maximised by maintaining the HPLC column at a temperature that favours partial strand 
denaturation in the presence of base-pair mismatching. CCM is one of the most sensitive 
methods. It utilises a series of chemical reactions to cleave DNA at the mutated site. DNA 
fragments of several Kb can be analysed. Toxicity of the chemicals used and procedural 
difﬁculty make this technique not very appealing. ECM is a new “clean” version of CCM, 
although the quality of the result is lower.  
 RT-PCR also can be used for scanning for unknown mutations. Testing RNA has 
advantages over DNA, in that intron mutations that affect splicing are more easily 
identiﬁed. But obtaining and handling it is more difﬁcult. In contrast to DNA techniques 
that normally involve ampliﬁcation and testing of each exon separately, gene scanning 
by RT-PCR requires a smaller number of reactions, and only RT-PCR allows the reliable 
detection of aberrant splicing. Drawback of using RNA is that mutated mRNA can be 
unstable. In these cases RT-PCR of heterozygous persons could show only the normal 
allele.
1.3.8 Differentiating causative mutations from harmless polymorphisms
Nucleotide changes identiﬁed by sequence analysis may reﬂect the sought causative 
mutation or may just be a harmless polymorphism. It is therefore important to distinguish 
between these two classes of nucleotide variations of the genome. The type of mutation 
can be indicative. A nonsense mutation is more likely to be a causative mutation than a 
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polymorphism. Conversely, a silent mutation is more likely to be a polymorphism than a 
causative mutation. However exceptions to these rules exist and one should be carefully 
not to make deﬁnitive conclusions from this. Additional evidence is generally required. 
There are different types of supporting evidence. a) Genetic evidence: this can be obtained 
through family studies, ascertaining the segregation of the mutation with the disorder or 
a de novo occurrence of the mutation. A de novo occurrence provides strong independent 
proof of being disease related for autosomal dominant mutations. The frequency of the 
sequence variation in a control population or, if it is present, in SNPs databases usually 
indicates that is a polymorphism. b) RNA-based support: gathered through RT-PCR 
and northern blot techniques, which can allow checking for nonsense-mediated RNA 
decay or (unexpected) splicing defects. Lately, as it has been found that at least 35% 
(and possibly 60%) of our genes undergo alternative splicing; special attention has been 
set on the splicing mechanisms and on their perturbations. The role of splicing in human 
genetic diseases has brought to light the necessity to check mutations not only at the DNA 
level but also at the mRNA level160 and references therein. The percentage of splicing 
mutations is likely to have been grossly underestimated in human genetic disease161. c) 
Sequence conservation: within gene families, protein domains, or in evolutionary terms, 
the conservation of a nucleotide sequence suggests its importance in maintaining the 
function/structure of the encoded protein, and strongly point to a causative role of a 
variation. d) Protein-based support: might be gained by analysing the protein structure. For 
this, 3D modelling can be very useful. The use of protein-speciﬁc antibodies, in immuno 
chemical studies (histological, cellular, western blots or through the developing arrays), 
can show the effect of the nucleic acid variation on the maintenance of the natural shape 
and functionality of the protein. e) Functional testing of mutations classiﬁes variations in 
two simple groups: functional and non functional. An assay may directly test enzymatic 
function, or another measurable functional characteristic. Complementation tests can 
be used to establish the functionality of a nucleic variation with various readouts at the 
protein, or cellular level. In some instances, the functional test involves a cell system from 
a model organism162,163 and references therein. 
1.4 Aim of this Study and Outline of the Thesis
Aim of this study is the identiﬁcation of genes that underlie multiple congenital anomalies 
(MCA) syndromes. Congenital anomalies are the most common cause of infant mortality. 
In this work we focussed on monogenic congenital disorders. This type of disorders is 
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particularly important because of their high risk of recurrence. The identiﬁcation of the 
genetic aetiology of MCA, besides broadening the knowledge of human development 
mechanisms (Chapter 1), is of relevance for a correct diagnosis and for genetic counselling, 
and it may be of aid for establishing therapeutic treatments. The present study aims also to 
compare different strategies for the search of genes underlying developmental disorders. 
In this work different genetic approaches have been employed to try to unveil MCA 
genes. 
 Chapter 2 introduces ectrodactyly ectodermal dysplasia and cleft lip/palate (EEC) 
syndrome and describes the identiﬁcation of the major gene involved in EEC. After an 
EEC-like disorder, limb mammary syndrome (LMS), was mapped in our laboratory to the 
long arm of chromosome 3, namely 3q27164, ﬁve EEC families were used to investigate 
a possible allelism. Traditional linkage analysis was performed and the EEC region was 
mapped between markers (D3S3530 and D3S1314) contained in the previously identiﬁed 
LMS region. After positioning of the markers, ESTs and genes present in the area, using 
a physical map, candidate genes were selected. The TP63 gene localisation in the critical 
region, together with its predicted function, expression pattern and the phenotype of the 
TP63 knockout mouse165,166, made it a likely candidate for EEC and LMS syndromes. 
Subsequential mutation analysis conﬁrmed TP63 involvement in EEC-like syndromes 
(Appendix 2). The molecular mechanisms underlying the involvement of TP63 in EEC 
are presented at the end of the chapter.
 Chapter 3 introduces the recessive form of Robinow syndrome (RRS) and describes 
the identiﬁcation of a gene in volved in RRS. Homozygosity mapping was used to identify 
the gene causing RRS. We ﬁrst used a panel of ﬁve consanguineous families and we 
looked for homozygous markers (microsatellite analysis). Homozygosity was detected 
for a set of 14 markers spanning about 14 cM in 9q21.3-q22. Fine mapping of the critical 
region was performed through the allele sharing analysis. In a panel of 10 families, all 
from the same country of origin, three shared the same set of alleles for seven consecutive 
markers. Besides suggesting the presence of a common ancestor in these families, this 
observation reduced the RRS critical region to 4.9 cM. Also in this case a YAC physical 
map was constructed so that the exact position of markers, ESTs and genes present in the 
area was deﬁned. Candidate genes were searched in the critical region. Within the genes in 
the area, ROR2 looked as the most appropriate candidate, due to the presence of an animal 
model that showed strikingly similarities with the human phenotype and an expression 
pattern during embryo development167-169 compatible with the predicted pattern for a gene 
causing RRS. Mutation analysis conﬁrmed the presence of homozygous mutations in our 
cohort of patients (Appendix 3). An overview of the molecular pathways of ROR2 and of 
the mechanisms underlying its role in RRS is presented at the end of the chapter.
 Chapter 4 describes the quest for a gene involved in oesophageal atresia (OA). In 
the search for the gene causing syndromic oesophageal atresia (ODED) we ﬁrst searched 
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for candidate genes upon querying gene-speciﬁc databases retrieved from the internet 
with search parameters that accurately described the prominent phenotypic features of 
the syndrome of interest. In such way, we identiﬁed 14 candidate genes, selected because 
of their pattern of expression during development (PAX9, WEE1, CLU and MEOX1), 
the effect of knockout mutations in mouse (HOXC4), and the physiological role of the 
corresponding proteins (genes encoding components of the retinoic acid metabolism). 
On the selected candidate genes we performed a limited linkage analysis, aimed at the 
chromosomal regions to which the candidate genes have been mapped. In addition, we 
analysed chromosome 2q24-q31 and 13q14-qter since patients with deletions of these 
chromosomal segments have several of the typical features of ODED. The linkage 
analysis was carried out on a three generations pedigree of a Dutch family with 11 affected 
members. No linkage was found and therefore twelve different regions of the genome 
and at least 14 candidate genes (about the 15% of the entire genome) were excluded for 
involvement in the ODED syndrome. Three additional small families were added and a 
genome wide scan of the remaining parts of the genome was performed. Presence of the 
ODED syndrome gene was clearly detected in the 2p23-p24 region. Further restricted 
linkage analysis on a panel of 20 families allowed us to reduce the critical region to 
about 1 cM (Appendix 4). Positional candidate genes were selected after constructing 
physical maps “in silico”, using the data available from the genome project drafts and 
the CELERA database. Up to now all candidate genes have been excluded by combined 
dosage and mutation analysis methods.
 Chapter 5 discusses the various ways in which we can deﬁne candidate genes for 
congenital malformation syndromes. Although we had mixed results in these studies 
(Chapters 2-4), the in silico candidate gene approach has clear potential, and should be 
the starting point for similar research project in the future.
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2.1 EEC Syndrome (OMIM #604292)
EEC is an acronym for Ectrodactyly Ectodermal dysplasia and Cleft lip/palate, this 
acronym was introduced in 1970 by Rudiger1. EEC is a syndromic form of ectrodactyly, 
which refers to a defect of the central rays of the limb. This malformation is also known as 
Split Hand Foot Malformation (SHFM), which is characterized by the absence of the three 
central rays. The main characteristics of EEC syndrome are foot and hand malformations 
(as also seen in isolated SHFM), abnormalities of ectodermal derivatives as nails, hair, 
skin and teeth, and clefting that can affect either both lip and palate together or only the 
lip. Other abnormalities can be present as well. Lachrymal duct anomalies, conductive 
hearing loss and urogenital defects are present in a subset of EEC patients2,3. Other facial 
dysmorphisms and respiratory infections are also associated with the syndrome, although 
less frequently4. Recurrent infections of eyes, respiratory tract, and urogenital system, 
may be secondary to the anatomic abnormalities, although an immunological component 
maybe involved as well5. The inheritance of EEC follows an autosomal dominant pattern. 
The penetrance is incomplete (between 93% and 98%), and variable expression is 
extensive. This variability of expression is more prominent between families than within 
the same family4. None of the three main symptoms is obligatory for the diagnosis6. As 
a matter of fact, EEC syndrome can be difﬁcult to separate from EEC-like disorders 
which include the ectrodactyly and cleft palate (ECP) syndrome. Patients affected by this 
syndrome have cleft palate but lack the cleft lip which is an otherwise highly common 
feature of EEC7. Ectrodactyly, Ectodermal dysplasia and Macular dystrophy (EEM) 
syndrome differs from EEC because of the macular dystrophy and an autosomal recessive 
mode of inheritance8. Ankyloblepharon, ectodermal dysplasia and clefting (AEC), also 
known as Hay-Wells syndrome, does not have ectrodactyly and ankyloblepharon (fused 
eyelids) is present in some patients9,10. Acro-dermato-ungual-lacrimal-tooth (ADULT) 
syndrome differs from EEC because of the absence of facial clefts and by the presence of 
excessive freckling and neurodermic signs11. Acro-renal syndrome or acro-renal polytopic 
ﬁeld defect, is a condition that combines ectodermal dysplasia and ectrodactyly or other 
limb/acral abnormalities with severe defects of the kidney12-16. Limb mammary syndrome 
(LMS) major abnormalities are ectrodactyly and other hand and/or foot malformations, 
nipple and mammary gland hypoplasia/aplasia17. Other defects, as lachrymal duct atresia, 
hypohydrosis, nail dysplasia, cleft palate/biﬁd uvula, hypodontia and ear pits may 
accompany this disorder18. 
 In 1994, following mapping studies for SHFM1, a ﬁrst locus for EEC (OMIM 
*129900) was proposed on 7q21.3-q22.119. However, successive linkage studies on other 
EEC families did not give the same result. Subsequently, O’Quinn and colleagues mapped 
EEC family in a broad area (about 33 cM) on chromosome 19 (OMIM *602077), namely 
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on 19p13.1-q13.120. Also in this study one EEC family clearly did not map to either of the 
proposed loci. These two studies demonstrated the genetic heterogeneity of this disorder, 
which must be added to its clinical heterogeneity. The TGF-β1 gene is located within 
the linkage region on chromosome 19q31.1. This gene is implicated in the development 
of most tissues that are affected in EEC patients, and made of it a candidate for EEC. 
However, no mutations of this gene were detected in EEC patients. In 1999, following 
studies on LMS, a third locus for EEC syndrome was proposed by our group on the 
long arm of chromosome 3 (see Appendix 2). Subsequently, we identiﬁed the p53-related 
transcription factor TP63 as the causative gene for EEC (Appendix 2). Further studies by 
our group demonstrated that this gene is the major EEC gene. 
 The family that showed linkage to chromosome 19 also mapped to the TP63 locus on 
chromosome 3q27. Indeed, we could identify a causative TP63 mutation in this family, 
which indicates that the linkage to chromosome 19 was fortuitous or that it represents a 
modiﬁer locus.
2.2 Discovery Strategy: a positional candidate approach
To identify the EEC gene a positional-candidate strategy was adopted. Because of the 
phenotype similarities between EEC syndrome and LMS18 a limited linkage analysis, 
in ﬁve EEC families, aimed to the region where LMS had been mapped was performed. 
Positive LOD scores were obtained with markers within the LMS region, with a maximum 
LOD score of 8.03 at marker D3S3530 at a θ = 0 (see Appendix 2). The colocalisation 
of EEC and LMS suggested the existence of a common causative gene present in this 
region. At this stage a positional candidate approach seemed the most logic strategy. The 
linkage studies allowed a reﬁnement of the EEC/LMS interval to 2.3 cM. Subsequently a 
physical map of the region was made, by using YAC clones. The YAC contig allowed the 
ﬁne-mapping of genes, ESTs and markers present in the region. Five known genes (LPP, 
Chordin, DVL3, SOX2 and TP63) were present in the wider EEC region. The physical 
mapping showed that 3 of them (Chordin, DVL3 and SOX2) did not map in the critical 
interval, one (LPP) mapped just outside the LMS region and TP63 mapped close to the 
top LOD score marker D3S3530. Although LPP was mapped immediately out of the 
critical interval it could not be excluded that part of the gene or its regulatory elements 
where within the LMS/EEC region. Therefore this gene was tested for mutations in LMS 
and EEC patients. LPP is a member of the LIM protein gene family and it has been found 
involved in lipomas as a fusion partner of the HMGIC gene21. TP63 appeared a good 
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candidate because of the expression data, and its candidate position was strengthened 
by recent reports of the TP63 knockout mice22,23. Although the information of the mouse 
was important, the high expression in epidermal cells, together with its chromosomal 
localisation, already made of TP63 a good candidate for EEC.
2.3 TP63
2.3.1 The TP63 gene
The TP63 gene (3q27) is the last discovered member of the prototype oncogene p53 
family24. Several groups have independently identiﬁed this gene and this accounts for 
the different names: TP63, p63, p51, KET, p53CP, NBP, and the ofﬁcial one, TP73L24-
30. To avoid confusion, especially with the other p53 family member p73 I will use the 
designation TP63 throughout this work. Until recently, the p53 tumour suppresser gene 
seemed to escape the rule that most of the oncogenes and tumour suppressor genes are 
grouped into families. Generally speaking, the relationship between genes of the same 
family is not restricted to sequence similarities, but often also to shared gene function. 
Family evolution is believed to be due to successive duplications and divergences of a 
single ancestral gene31. 
 The p53 family has three members. These are p7332 p53 and TP63. There are several 
common features among the p53 family members: a) The presence of large introns (1 
and 3 for TP63). b) An overall similar intron/exon structure. c) The sharing of conserved 
functional domains. d) The presence of common downstream targets. A number of 
differences can also be seen between the family members, such as: the gene size, the 
number of protein isoforms and the different roles in tumours and development. 
 Hallmark features of the p53 family are an acidic, NH
2
-terminal transactivation (TA) 
domain, a DNA binding domain (DBD) and a COOH-terminal oligomerisation domain 
(OD)  (Figure 2.1). Similarities between TP63 and p73 are higher than with p53.
2.3.2. Gene and protein structure
The genomic size of TP63 is similar to that of p73, larger than 60 Kb, and about three 
times the size of p53. TP63 contains 15 exons and encodes at least 6 different proteins 
(p53 has only two) that share a common open reading frame24,31,33,34. These 6 isoforms are 
Resolving the molecular basis of human malformation syndromes
68
the result of alternative splicing (α, β, and γ isoforms) and use of an alternative promoter 
(TA and ∆N variants)  (Figure 2.1). The ∆N variants (present also in p73 but not in p53) 
do not contain the TA domain. In addition to these six isoforms, the group of McKeon24 
has identiﬁed three additional TA forms (TA*). These new isoforms (not found in the 
other family members) are characterised by the presence of a NH
2
 –terminal extension 
of 39 additional amino acids. Other isoforms have been described by Bamberger and 
colleagues in the rat. They also suggest that expression of major variants may be more 
cell-type speciﬁc rather than differentiation speciﬁc35.
 The TA region is the least conserved of the hallmark domains of the p53 family (22% 
identity between TP63 and p53, 30% between TP63 and p73 and between p73 and p5336). 
The TA TP63 NH
2
–terminal region shows a strikingly high conservation (99% of amino 
acid identity) between the mouse and human amino acid sequence, not found in p53 and 
p7324. This could reﬂect the speciﬁc role that TP63 plays, within the p53 family, in both 
Figure 2.1
Isoforms of the TP63 gene:
On top: the TP63 gene structure, and the alternative splicing that produces the α (exons connected by solid 
lines), β andγ isoforms are indicated.
Below: the different isoforms induced by the use of an alternative promoter, the TA and ΔN variants.
Bottom: the schematic view of the p53 gene is shown for comparison.
The transactivating domain (TA), The DNA binding domain, the isomerisation domain (Iso) and the sterile-α-
motif domain (SAM) are indicated.
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human and murine development31. 
T he central core DBD is the most conserved domain among the family members (63% 
identical to p5337 and 87% to p7331). In particular, key residues involved in the direct 
contact with the DNA molecule as well as these that are essential for proper protein 
folding are conserved. Interestingly, most of the mutations we found in the TP63 DBD 
correspond to p53 hot spot mutations in human tumours (see Appendix 2). 
 The oligomerisation (OD) region of TP63 is located between residues 355 and 
404 and shows an identity of 38% with the corresponding region in p5337. In p53, the 
OD region is also involved in nuclear import (NLS), nuclear export (NES) and non-
speciﬁc DNA binding. The NLS and NES sequences are conserved within the family 
and therefore present in TP6338. TP63 as well as the other members of the family tend to 
form homotetramers. Studies by Davison and colleagues have shown that TP63 does not 
heterotetramerise with p53, while very weak binding between the OD regions of TP63 
and p73 has been detected39. A possible role of the COOH-terminal tails of TP63 and p73 
in the oligomerisation of these molecules has been hypothesised31. 
 Although not as well characterised as the domains just described, a proline-rich 
domain can be identiﬁed in all p53 family members. TP63 contains several PXXP and 
PPXY sequences (P = proline, X = any amino acid and Y = tyrosine). Such sequences can 
be target sites for proteins containing SH3 and WW domains (small amino acid sequences 
of about 40 amino acids characterised by the presence of two tryptophan residues 20 
amino acid apart). While binding of proteins containing SH3 domains has been reported 
only for p7336,40,41, Strano et al. reported the binding of the YAP (yes-associated protein) 
adaptor phosphoprotein to both p73 and TP63 (but not p53), via its WW domain. YAP can 
enhance the transcriptional activity of p7342.
 Due to their longer COOH-terminal tail, TP63 and p73 share two additional functional 
regions, a SAM (sterile α motif) domain and a TI (terminal inhibitory) domain, both 
present only in the α forms. SAM domains where initially identiﬁed as protein-protein 
interaction modules present in multiple signalling proteins and transcription factors 
involved in developmental regulation43,44. This domain generally consists of a compact 
globular domain containing ﬁve helices43,45,46. SAM domains participate in homo- or 
heterotypic interaction, but not in the case of TP63 (or p73). It is possible that the TP63 
(and p73) SAM domain may interact with other proteins, either SAM containing or not31. 
Recently, SAM domains have been implicated in protein-RNA interactions and, for the 
p73 SAM domain, binding to lipid membranes47,48.
 The last 70 amino acids of the α forms contain a region that is able to inhibit, in cis 
and trans, the transactivating capacity of the TAα isoform of TP63 (and of p73). The TI 
domain is located directly C-terminal to the SAM domain. This domain lacks a secondary 
structure, but it does not inﬂuence the subcellular localisation of TP63, as might have 
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been expected since unstructured sequences often harbour signals peptides that target 
proteins to speciﬁc cellular compartments. The group of Dötsch demonstrated that the TI 
domain controls the activity of TP63 through its binding with the TA domain. They also 
suggest that the TI binding site in the NH
2
-terminal region corresponds to the MDM2 
binding sequence that is conserved in all the p53 family members, and is important for 
the stability of the protein49. 
 Recently a new TA domain (TA2) in the TP63 gene has been discovered by Duijf 
et al.50. This TA2 domain is located in the 3’ exon, and therefore present only in the ∆N 
forms  (Figure 2.1). Independent conﬁrmation has been provided by the work of Dohn et 
al. on the effect of overexpression of ∆Np63α in relation with cell cycle and apoptosis51. 
 Differences in the protein domains, together with the emerging data on the various 
isoforms of the p53 family members, support the hypothesis of a divergence in signalling 
and function of the different transcripts. 
2.3.3 Expression in growth and differentiation
In the p53 family ubiquitous expression is characteristic of p53. In contrast, TP63 and p73 
seem to have a tissue-speciﬁc role in cell growth and differentiation. TP63 is abundantly 
expressed in proliferating basal cells of epithelial layers in the epidermis, mammary and 
salivary glands, prostate and epithelial lining of urogenital organs, and is essential for 
skin formation and in the generation of the AER, involved in the development of the 
extremities23,52. 
 The expression of the different TP63 isoforms varies in different tissues and different 
cell lines. For example, RT experiments on adult mice showed the presence of TA 
transcripts in heart, testis, kidney, thymus and brain. The ∆N form was present in kidney, 
thymus and spleen, but not in heart, liver, testis and brain. Immunohistochemistry on 
human epithelial tissues shows high expression of TP63 in basal cells, the ∆Np63α 
transcript being the most abundant24,53,54. 
 Recent reports have shown that levels of different isoforms may vary during different 
stages of growth and differentiation of keratinocytes and other squamous cells. The 
TP63 form levels increase during keratinocyte differentiation while, at the same time, 
levels of ∆Np63 decrease53,55-58. TP63 expression also varies within the different layers of 
the stratiﬁed epithelium, showing higher levels in the basal layer cells than in the more 
differentiated cells in the upper layer. 
 All these data support a major role for TP63 in ectodermal differentiation and 
development, which contrasts with the characteristic tumour suppressor role of p53. 
Corroboration of this major developmental role of TP63 came with the study of the 
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TP63 KO mice. These mice die shortly after birth and show signiﬁcant skin, limb and 
craniofacial defects, but do not develop tumours. The limbs are truncated or absent due 
to the failure in the initiation or maintenance of the AER22,23. There is absence of the 
squamous epithelia and their derivates as hair follicles, teeth, mammary, salivary and 
lachrymal glands. Other squamous epithelia derivates such as tongue, oesophagus, urinary 
bladder and cervix also show abnormalities22,23. 
 Further conﬁrmation of the developmental role of TP63 came with the identiﬁcation 
of germ line mutations in patients with EEC and other syndromes (see Appendix 2). Since 
our ﬁrst report of the involvement of TP63 in EEC (see Appendix 2) we and other groups 
reported the involvement of TP63 in EEC-like disorders  (Figure 2.2) including SHFM59, 
AEC60, ADULT syndrome50, LMS61 and Rapp-Hodgkin syndrome62,63.
2.3.4 Downstream targets
Little is known of the TP63 targets under physiological conditions. It seems that TP63 
can activate certain p53-responsive elements (p53 RE). Such activation will induce p53-
like responses like apoptosis. For example, TP63 can induce the p53-responsive genes 
p21 (a cyclin-dependent kinase inhibitor), GADD45 (p21 binding protein), MDM2 (a p53 
negative regulator), Bax (a proapoptotic protein)58,64 and references therein). Although 
Figure 2.2 
TP63 mutations in EEC syndrome and related phenotypes
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these studies may not be representative of the normal physiological situation due to the 
overproduction of TP63 (and/or p73) different activation potential of the same targets 
has been detected among the p53 family members. For example, TP63 can activate 
two proteins involved in epidermal differentiation, loricrin and involucrin, to a greater 
extent than p53 and p73. Expression of these two proteins is increased in epidermal 
cells following differentiation. This also conﬁrms the major role of TP63 in ectodermal 
development and differentiation53,64. The different COOH-terminal tails present in the 
various isoforms of TP63 (and p73) also play an important role in determining downstream 
targets. For example, TP63γ is able to transactivate the p21 promoter while the TP63α 
version cannot24. Moreover, TP63 β and γ forms are stronger apoptotic inducers than the 
α forms. This is probably due to the inhibitory function of the SAM and TI domains that 
are present exclusively in the α forms. 
2.3.5 TP63 role in oncogenesis
 
It was a great surprise that the p53 related genes p73 and TP63 did not reveal a similar 
tumour suppressor function. The two new family members could not account for 
those tumours lacking a p53 mutation. Somatic TP63 and p73 mutations are rarely 
found in tumours, and the functional signiﬁcance of the ones that have been found is 
questionable26. 
 Nevertheless, some oncogenic properties have now been attributed to the p53 
homologues58. Probably the variety of protein isoforms of these genes can account for 
these “contradictory” effects. Annie Yang and Frank McKeon58 talk of “two genes in 
one” referring to the fact that the TA forms can mimic p53-like functions while the ∆N 
forms show entirely opposite activities. TA forms can bind and transactivate traditional 
p53 targets. The TP63γ form is the most similar to p53 and both TP63γ and TP63β are 
able to transactivate p53-responsive reporter genes, while the TP63α form, due to the 
presence of the SAM and TI domains, cannot. Instead, the ∆N forms have proved to be 
powerful antagonists of p53 activity, blocking its transcriptional activity together with 
the transcriptional activity of their transactivating isotypes (see Appendix 2 and24,58). Two 
different mechanisms have been proposed to explain this inactivation: competition and 
sequestration. Simple competition for binding to the promoter of target genes may prevent 
the binding of the TA forms. Otherwise, the ∆N proteins may bind to p53, as well as to the 
TP63 and p73 TA molecules, forming completely or partially inactive hetero-oligomers. 
Binding can occur via the OD domain or through interactions independent from this 
region58. In light of this behaviour a dominant negative role has been assigned to the ∆N 
forms of TP63 and p73. Recent studies have shown that DNA stress signals inducing p53 
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expression, such as UV irradiation, also induce TP63. After UV-β irradiation there is a 
down-regulation of the “dominant negative” ∆N form, and an increase of TP63 levels. 
As a matter of fact, it has been shown that ∆Np63 decrease is associated with increased 
UV-dependent apoptosis in skin. Immature keratinocytes exposed to UV irradiation 
show a rapid loss of the ∆N forms of TP63 coincident with p53 stabilisation65. This 
competition between ∆Np63 and p53 may provide an explanation for the “keratinocyte 
paradox”. Studies on keratinocytes have shown a low p53-dependent transactivation in 
immature cells and a high p53-dependent transactivation in differentiating ones, while 
the protein levels showed an opposite distribution. Possibly the abundant ∆Np63 present 
in immature keratinocytes inactivates p53, and, as mentioned before, the decrease of 
∆Np63 that accompanies keratinocytes differentiation removes the ∆Np63 inhibition on 
p5324,55,66. Consistent with the TP63 implication in tumours is the fact that alterations 
in the 3q27 region are seen in a variety of squamous cell carcinomas and cancers from 
other sites including lung, cervix and ovary24,67,68. Moreover, levels of TP63 are often 
higher in malignant tissues. The highest levels of TP63 occur in the most undifferentiated 
cells69-71. Yet, it must be determined whether these high TP63 levels are causative or only 
associated with the tumour. Several authors have proposed that ∆Np63 may function as 
an oncoprotein through the mechanisms of sequestration and inactive hetero-oligomer 
formation or by competition for binding sites with wild-type p5368,72,73. Moreover, a direct 
attribute of ∆Np63 can not be excluded. If it is true that TP63 can somehow regulate the 
levels of p53, the opposite may also be true. Ratovitski and colleagues have shown that 
wild type, but not mutant, p53 can enhance ∆Np63 caspase dependent cleavage. A caspese 
recognition sequence (YVED) involved in TP63 regulation is located at the beginning of 
the TP63 DNA binding domain74. Thus including the down-regulation of the “oncogenic” 
form of TP63 in the p53 pathway. Still in line with the oncogenic function of TP63 and 
p53 is the discovery that certain mutated forms of p53 are able to bind and inactivate 
TP6375,76 and the fact that TP63 can bind WT-1 protein more strongly than p5377. 
 Finally, it is possible to hypothesise two opposite tumour inducing functions for the 
TP63 TA and ∆N transcripts: a tumour suppressor activity for the former, and an oncogenic 
activity for the latter. The fact that human tumours have shown rare TP63 mutations tends 
to largely rule out tumour suppressor function for TP63. As shown above, the oncogenic 
role of the ∆N forms is quite substantiated. 
 On the other hand, no tumours have been found in the TP63 knock out mouse model, 
as opposed to the p53 one. It is also true that these mice die very early and that they may 
not have sufﬁcient time to develop tumours. Moreover, patients affected by EEC or an 
EEC-like disorder caused by a TP63 mutation do not develop tumours. 
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2.3.6 A role in stem cell regeneration
Data obtained from the TP63 knockout mice suggest that TP63 may be involved in the 
maintenance of the stem cell population of the epithelium. The fact that many of the tissues 
affected in the TP63-/- mice are normally stratiﬁed epithelia, with stem cells in their basal 
layer and more differentiated cells in the upper layers, strengthens such a hypothesis. 
Anyhow, different groups give different explanations on the cause of the absence of 
epithelia in the affected sites. Some think that this absence is due to aborted epithelial 
differentiation22. Others, instead, say that TP63 does not have an essential role in the 
process of epithelial commitment23, and point out that the function of TP63 is to maintain 
the basal progenitor cell population58,78,79. Yang and McKeon, in their latest review, report 
data corroborating the role in stem cell maintenance of TP63. These include high levels 
of TP63 in the basal cell, and the involvement of TP63 in cell asymmetric division, that 
is characteristic of stem cells23,58. The mechanism through which TP63 preserves the stem 
cell population is still unknown. 
2.3.7 Family history
There are two main hypotheses on the evolution of the p53-family. According to the mouse 
knockout phenotypes, TP63 or p73 was the original gene. TP63 or p73 knockout mice 
show disruptions of their basic physiological processes leading to severe developmental 
and physiological consequences. Whereas p53 knockout mice, apart from their highly 
increased susceptibility to tumours, appear normal. Alternatively, considering the most 
ancient function, i.e. the protection against DNA damage, the original gene might have 
resembled more p53 than the others58. 
 Comparative studies with the single Drosophila p53-homologue Dmp53 have not shed 
a deﬁnite light on which is the original gene. DNA sequence homology and dominant-
negative experiments suggest a direct evolutionary connection between Dmp53 and 
human p5380-82. These results argue in favour of p53 being the original gene, and TP63 
and p73 the result of subsequent gene duplications. On the other hand, considering strictly 
the amino-acid sequence, Dmp53 appears much more similar to human TP63 and to other 
invertebrate homologues of TP63 and p73. The appearance of p53 orthologues coincides 
with the appearance of the vertebrate branch in the evolutionary tree. These data point out 
in the direction of a TP63-like gene as the archetype member of the family. 
 Comparative data from mouse and human proteins show a very high conservation 
between the TP63 and p73 proteins (99% identity for TP63 and more than 96% of identity 
for p73), in contrast with the divergence seen with p53 orthologues (86% identity). This 
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may reﬂect co-evolving interactions constraints between the ﬁrst two genes58. 
2.4 EEC Molecular Mechanisms
All TP63 mutations, except one, found in EEC patients are localised in the DNA binding 
domain (DBD) of TP63. All of these DBD mutations are predicted to affect amino acids 
implicated in DNA binding, either because they are in direct contact with the double 
helix or because they are essential for the correct functional folding of the binding site, 
as shown by the modelling of the DBD. Interestingly, all but one of these mutations 
fall in the highly conserved regions (see Appendix 2). Furthermore, several of these 
mutations affect amino acids that are very frequently mutated in p53-caused tumours. 
Taken together this suggests that the EEC mutations in the DBD affect important sites for 
the correct binding of the protein to the DNA or other molecules that recognise the same 
binding site. Transactivation assays have demonstrated that these mutations inhibit the 
binding of TP63 molecules to p53-responsive elements. However, the DBD mutations 
also disrupt the natural inhibitory effects of ΔNp63α, the major isoform of the epithelia 
that are affected in EEC syndrome. Therefore, the EEC syndrome phenotype may also be 
due to a loss of repressive activity. Indeed the only mutation found outside of the DBD 
(1572insA ) is a frame shift mutation that leads to a premature stop codon. This mutation 
affects the SAM domain, and therefore is only present in the α isoforms. Possibly the 
1572insA mutation, abolishes the TI domain, thereby causing a loss of the repression 
activity characteristic of these isoforms. 
 There are two hypothetical mechanisms through which TP63 mutations exert their 
effect: mutant alleles can either act as dominant negative or as gain of function. The 
possibility of haploinsufﬁciency has been ruled out because patients carrying a germline 
heterozygous deletion of the 3q27 region, encompassing the TP63 gene, do not show 
any EEC features. Moreover, no obvious phenotypic abnormalities are found in the 
heterozygous knockout (TP63wt/-) mice22,23. The divergent effects of the missense and 
frameshift mutations suggest that variation, increase or decrease, of the transactivation 
by TP63 leads to the developmental defects present in the EEC patients. The presence of 
different isotypes with different properties and their ability to form homo-oligomeric or 
hetero-oligomeric complexes may create even more variability and complicates the correct 
interpretation of the effect of mutations. It is worth to remind that the transactivation assays 
have been performed utilising target genes under the control of p53-responsive elements 
in cells that are devoid of p53, TP63 and p73. The in vivo effect might be different and 
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depend on many additional factors, which can be cell-speciﬁc, target gene speciﬁc, time-
dependent, prone to extra-cellular stimuli, etc. Also the genetic make-up of a cell is likely 
to have an effect on the biological consequences of a speciﬁc mutation, and hence on 
the phenotypic outcome. Such genetic modiﬁers may well explain the great phenotypic 
variability in families with a given TP63 mutation, as compared to unrelated individuals 
with the same mutation. The case of the EEC syndrome family ﬁrst linked to chromosome 
19 but later found to carry a TP63 mutation may point to such a modiﬁer gene. Patients 
in this family all present urogenital problems, i.e. atrophy of bladder epithelium, which is 
an occasional feature in other EEC syndrome patients.
2.5 TP63 Signaling Pathway
Studies on embryonic development have unveiled, BMPs, secreted factors of the TGFβ 
family as activators of TP63. ΔNp63 is a transcriptional target of Bmp signaling, in particular 
by bmp2b and bmp7, during gastrulation and in later proliferation and differentiation 
stages83-86. ΔNp63 regulates dorso/ventral patterning of the ectoderm, playing the role 
of neural repressor in the “neural default model”, according to which ectodermal cells 
will become neural cells unless instructed not to do so. Bmps have been identiﬁed as 
such instructive agents, suppressing neural and promoting epidermal speciﬁcation87. Bmp 
signaling is mediated by Smads, and this happens also with the regulation of ΔNp63. 
The identiﬁcation of Smad4 and Smad5 binding sites in the promoter region of ΔNp63, 
together with the knowledge that the interaction of these two Smads is required for 
mediating Bmp signals in early embryos, conﬁrms that this is how the transcriptional 
signaling of the Bmps is relayed to ΔNp6386,88. The regulatory role of Bmps on ΔNp63 
is not limited to the early development. In agreement with the notion that ΔNp63 has 
two subsequent and related activities, ΔNp63 has an early role in preventing ventral 
ectodermal cells from differentiating, and a later one in promoting proliferation of the 
epidermal stem cells86,89. There are some reports of a stimulating role of FGF10 on TP63 
during epidermal development, but if this is a direct interaction or acts through BMPs and 
other molecules is not clear yet90. 
 Although only a few TP63 regulators, bmp2b and bmp7, have been described, the 
downstream targets show greater numbers. TP63 has been shown to be involved in the 
Notch signal pathway that plays an important role in development by specifying cell 
fates91,92. JAG1 and JAG2, Notch receptor ligands, are transcriptional targets of TP63. 
The second intron of JAG1 contains the speciﬁc binding site for TP63, and through this 
interaction TP63 has been shown to modulate the Notch signaling in neighboring cells93. 
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Different TP63 isoforms show different regulatory properties of these proteins, ΔNp63α 
down-regulates JAG2 but not JAG1, while the TAp63 forms up-regulate them, TAp63γ 
more then TAp63α.94. Within TP63 regulation of multiple signaling pathways, there is also 
a role for the Wnt pathway; here ΔNp63α transcriptionally activates Dickkopf1 (DKK), 
which prevents the formation of active Wnt–Frizzled–LRP5/6 receptor complexes, thus 
blocking the canonical Wnt–β-catenin pathway94,95. Interestingly, also p53 can activate 
DKK96, and although ΔNp63 and p53 often show opposing functions, in this case they 
seem to up-regulate the same target. TP63 and p53 share other transcriptional targets. 
For example c-fos, a key gene in cell differentiation, proliferation and transformation, is 
activated by TAp63α and p53, but down regulated by ΔNp63α and ΔNp63γ. The suggestion 
that TAp63 and p53 may be involved in the same apoptotic pathway is strengthened by 
the fact that they can both up-regulate the PIG3 gene, a gene known to participate in 
p53-mediated cell death94,97. PIG3 gene encodes a quinone oxidoreductase homolog98 and 
p53 expression induces reactive oxygen species (ROS) production, which increases as 
apoptosis progresses under some conditions. Another link of TP63 to ROS regulation 
is the identiﬁcation of REDD1 (regulated in development and damage responses) as a 
transcriptional target. REDD1 is a mediator of redox regulation, although the mechanism 
by which it modulates intracellular ROS is still unknown99. The alteration of ROS levels 
by TP63 may also provide an alternative mechanism through which TP63 modulates 
functional interactions in differentiation and development. Moreover shifts in intracellular 
ROS levels have been shown to modulate cellular signaling through tyrosine kinase 
growth factors receptors, as the epidermal growth factor receptor (EGF-R)91,100,101. Wu and 
colleagues have uncovered many new transcriptional targets of TP63, and also pointed 
out differences of transcriptional regulatory effects between the two main isotypes of 
TP63, TAp63 and ΔNp63. From their study it emerges that there is no direct correlation 
between the two isotypes, consistent with the idea that TAp63 and ΔNp63 have different 
functional roles. In addition, in some cases the two isoforms showed opposing regulatory 
functions, as shown above with the Notch receptor ligand JAG194. Regulation of cell cycle 
genes PCTAIRE2 and PCTAIRE3 also show opposing regulatory action from ΔNp63α 
and TAp63α. In agreement with its potential oncogene status ΔNp63α up-regulates 
these cdc2-related serine/threonine speciﬁc protein kinases, since activation of cyclin-
dependent kinase 2 leads to cell proliferation. On the contrary TAp63α down-regulates 
these genes. The modulation of PCTAIRE2 and PCTAIRE3 expression shows that TP63 
plays a role in cell cycle control94. Among the genes exclusively regulated by ΔNp63α 
there is Hsp-7094. Hsps have a protective role to environmental, chemical and physical 
stresses. Several members of this family, including Hsp-70, have also an anti-apoptotic 
role. This direct activation gives to TP63 a role also in cellular stress response, together 
then supporting the oncogenic role for ΔNp63α. A possible role of TP63 in angiogenesis 
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has been suggested with the discovery that VEGF and IL-8, two genes involved in 
angiogenesis, are transcriptional targets for TAp63α (and arguably ΔNp63α) and ΔNp63α, 
respectively94,102. In accordance to the involvement of TP63 in skin differentiation, renewal 
and hair follicle morphogenesis, several downstream targets important for these features 
have been identiﬁed. Such as keratin-1 and keratin-6e, regulated by TAp63α, that play 
important roles in hair follicles94,103,104. Or BPAG1, that encodes a glycoprotein component 
of the skin membrane zone where it plays a role in epithelial mechanical integrity and 
cell migration, that is up-regulated by TAp63α94. FGFR2 and, to a lesser extent, other 
FGF signaling players (FGF1, FGF9, FGF18, FGFR1, and FGFR4), are up-regulated 
by TAp63α and down-regulated by ΔNp63α. Assuming that FGFR2 does not directly 
act upstream of the TP63 gene, two hypotheses have been made on the role of FGFR2 
and TP63 in skin initiation and development: one that the two genes might control two 
parallel pathways leading to skin initiation and development105; the other that FGFR2 is 
a downstream target of TP63. The most recent data indicate the latter may be the more 
correct one94. Suggestions that TP63 might be involved in limb development and/or skin 
formation via regulation of the FGF-signaling pathway94, must be taken in consideration 
although there is still much to understand of the FGF signaling cascade.
 Together with the up-stream transactivators and the down-stream targets, there are 
a series of interacting proteins affecting TP63 functions. Probably the ﬁrst discovered 
and the most studied of these interaction is the one with p53. Depending on which 
isoforms participate to the heterodimers, this protein complex might increase or decrease 
the transactivation capacity of p53. ΔNp63α can actively repress p53 transactivation of 
downstream targets24. Overall TP63 seems to be able to negatively affect p53-induced 
expression of speciﬁc genes, this either by the ΔNp63α-p53 interaction or by competing 
for the same promoter region. On the other hand p53 can promote or enhance proteosome 
degradation of ΔNp63α74. The emerging model is that TP63 functions as a negative 
regulator of speciﬁc p53 targets, while p53 has an important role in TP63 stability. We have 
seen above that TP63 can block the Wnt-β-catenin pathway by directly transactivating 
DKK. On the other hand association of ΔNp63α with the B56α regulatory subunit of PP2A 
and GSK3β hinder the correct functioning of the APC complex, disrupting the normal 
activity of the associated proteins, hence positively regulating β-catenin106. SSRP1, an 
HMG1-like protein107,108, can act as a TAp63 co-activator (and not of ΔNp63) by binding 
to the TP63 N-terminal domain109. SSRP1 enhances TAp63γ induced expression of 
several p53 target genes, as MDM2110, PIG3 (see above)98, and p21waf1/cip1(111,112). It seems 
that SSRP1 can act by stabilizing the TP63-DNA bond, this by simultaneously binding 
TP63 and DNA through its C-terminal HMG box domain. SSRP1 could also function 
as an anchor to recruit and initiate assembly of the chromatin-remodeling complex, or 
recruit other transcriptional regulators, or any combination of the three109 and references therein. 
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The sterile α-motif (SAM) present only in the TP63α forms interacts with regulatory 
proteins in pre-mRNA splicing such as ABBP1 and Scaf4. Both proteins are involved in 
RNA transcription, pre-RNA processing, RNA editing, and splicing113-115. ABBP1 is able 
to induce preferential splicing of FGFR2. FGFR2 alternative splicing produces tissue-
speciﬁc isoforms, epithelial variants (b isoforms, K-SAM) and mesenchymal variants 
(c isoforms, BEK)116 and references therein. ABBP1 induces the preferencial splicing of the BEK 
isoform, but physical association with TP63α leads to inhibition of ABBP1 activity, 
resulting in a shift of FGFR2 splicing towards the epithelial speciﬁc K-SAM isoform116. 
 An overview of TP63 molecular interactions and pathways is shown in Figure 2.3.
Figure 2.3
Diagram of TP63 molecular interactions and pathways:
On top: the TP63 inducers, BMPs and FGF10. FGF10 could have a direct or an indirect (via the BMPs) 
activatory role.
In the centre (green): the effectors 
At the bottom (red): the downstream targets and the pathways involved.
Resolving the molecular basis of human malformation syndromes
80
2.6 References
1. Rudiger RA, Haase W, Passarge E. Association of ectrodactyly, ectodermal dysplasia, and 
cleft lip-palate. Am J Dis Child 120:160 (1970).
2. Rollnick BR, Hoo JJ. Genitourinary Anomalies Are A Component Manifestation in the 
Ectodermal Dysplasia, Ectrodactyly, Cleft Lip/Palate (Eec) Syndrome. Am J Med Genet 
29:131 (1988).
3. Maas SM, Dejong TPVM, Buss P, Hennekam RCM. EEC syndrome and genitourinary 
anomalies: An update. Am J Med Genet 63:472 (1996).
4. Roelfsema NM, Cobben JM. The EEC syndrome: A literature study. Clin Dysmorphol 
5:115 (1996).
5. Obel N, Hansen B, Black FT. Normal Immunological Status in 4 Patients with Ectrodactyly-
Ectodermal Dysplasia-Clefting Syndrome (Eec-Syndrome). Clin Genet 43:146 (1993).
6. Fryns JP, Legius E, Dereymaeker AM, Vandenberghe H. Eec Syndrome Without 
Ectrodactyly - Report of 2 New Families. J Med Genet 27:165 (1990).
7. Opitz JM, Frias JL, Cohen MM. The Ecp Syndrome, Another Autosomal Dominant Cause 
of Monodactylous Ectrodactyly. Eur J Pediatr 133:217 (1980).
8. Ohdo S, Hirayama K, Terawaki T. Association of Ectodermal Dysplasia, Ectrodactyly, 
and Macular Dystrophy - the Eem Syndrome. J Med Genet 20:52 (1983).
9. Hay RJ, Wells RS. Syndrome of Ankyloblepharon, Ectodermal Defects and Cleft-Lip and 
Palate - Autosomal Dominant Condition. Br J Dermatol 94:277 (1976).
10. Seressantamaria A, Arimany JL, Muniz F. 2 Sibs with Cleft-Palate, Ankyloblepharon, 
Alveolar Synechiae, and Ectodermal Defects - A New Recessive Syndrome. J Med Genet 
30:793 (1993).
11. Propping P, Zerres K. Adult-Syndrome - An Autosomal-Dominant Disorder with Pigment 
Anomalies, Ectrodactyly, Nail Dysplasia, and Hypodontia. Am J Med Genet 45:642 
(1993).
12. Dieker H, Opitz JM. Associated acral and renal malformations. Birth Defects Orig Art 
Ser 3:68 (1996).
13. Pinheiro M, Freiremaia N, Chautardfreiremaia EA, Araujo LMB, Liberman B. Aredyld - 
A Syndrome Combining An Acrorenal Field Defect, Ectodermal Dysplasia, Lipoatrophic 
Diabetes, and Other Manifestations. Am J Med Genet 16:29 (1983).
14. Miltenyi M, Balogh L, Schmidt K, Detre Z, Hernady T, Czeizel A. A New Variant of the 
Acrorenal Syndrome Associated with Bilateral Oligomeganephronic Hypoplasia. Eur J 
Pediatr 142:40 (1984).
15. Miltenyi M, Czeizel AE, Balogh L, Detre Z. Autosomal Recessive Acrorenal Syndrome. 
Am J Med Genet 43:789 (1992).
16. Evans JA, Vitez M, Czeizel A. Patterns of Acrorenal Malformation Associations. Am J 
Med Genet 44:413 (1992).
17. Hamel B, Smits A, van Beersum S, Hoekstra H, Mariman E, Tuerlings J, van Buggenhout 
G, et al. A large family with limb-mammary syndrome: clinical and molecular ﬁndings. 
Eur J Hum Genet 148 (1996).
Chapter 2 - Ectrodactyly Ectodermal dysplasia and Cleft lip/palate syndrome
81
18. van Bokhoven H, Jung M, Smits APT, van Beersum S, Ruschendorf F, van Steensel M, 
Veenstra M, Tuerlings JHAM, Mariman ECM, Brunner HG, Wienker TF, Reis A, Ropers 
HH, Hamel BCJ. Limb mammary syndrome: A new genetic disorder with mammary 
hypoplasia, ectrodactyly, and other hand/foot anomalies maps to human chromosome 
3q27. Am J Hum Genet 64:538 (1999).
19. Scherer SW, Poorkaj P, Massa H, Soder S, Allen T, Nunes M, Geshuri D, Wong E, Belloni 
E, Little S, . Physical mapping of the split hand/split foot locus on chromosome 7 and 
implication in syndromic ectrodactyly. Hum Mol Genet 3:1345 (1994).
20. O’Quinn JR, Hennekam RC, Jorde LB, Bamshad M. Syndromic ectrodactyly with severe 
limb, ectodermal, urogenital, and palatal defects maps to chromosome 19. Am J Hum 
Genet 62:130 (1998).
21. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, VandeVen WJM. LPP, the 
preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM 
protein gene family. Genomics 36:118 (1996).
22. Mills AA, Zheng BH, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue 
required for limb and epidermal morphogenesis. Nature 398:708 (1999).
23. Yang A, Schweitzer R, Sun DQ, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe 
A, Caput D, Crum C, McKeon F. p63 is essential for regenerative proliferation in limb, 
craniofacial and epithelial development. Nature 398:714 (1999).
24. Yang AN, Kaghad M, Wang YM, Gillett E, Fleming MD, Dotsch V, Andrews NC, 
Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with 
transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305 
(1998).
25. Schmale H, Bamberger C. A novel protein with strong homology to the tumor suppressor 
p53. Oncogene 15:1363 (1997).
26. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura 
Y, Nakagawara A, Obinata M, Ikawa S. Cloning and functional analysis of human p51, 
which structurally and functionally resembles p53. Nat Med 4:839 (1998).
27. Senoo M, Seki N, Ohira M, Sugano S, Watanabe M, Tachibana M, Tanaka T, Shinkai 
Y, Kato H. A second p53-related protein, p73L, with high homology to p73. Biochem 
Biophys Res Comm 248:603 (1998).
28. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D. A new human p53 
homologue. Nat Med 4:747 (1998).
29. Tan M, Bian J, Guan K, Sun Y. p53CP is p51/p63, the third member of the p53 gene 
family: partial puriﬁcation and characterization. Carcinogenesis 22:295 (2001).
30. Zeng X, Zhu Y, Lu H. NBP is the p53 homolog p63. Carcinogenesis 22:215 (2001).
31. Marin MC, Kaelin WG. p63 and p73: Old members of a new family. Biochim Biophys 
Acta-Rev Cancer 1470:M93 (2000).
32. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, 
Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene 
related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human 
cancers. Cell 90:809 (1997).
33. Arai N, Nomura D, Yokota K, Wolf D, Brill E, Shohat O, Rotter V. Immunologically 
Distinct P53 Molecules Generated by Alternative Splicing. Mol Cell Biol 6:3232 (1986).
Resolving the molecular basis of human malformation syndromes
82
34. Will K, Warnecke G, Bergman S, Deppert W. Species-Speciﬁc and Tissue-Speciﬁc 
Expression of the C-Terminal Alternatively Spliced Form of the Tumor-Suppressor P53. 
Nucleic Acids Res 23:4023 (1995).
35. Bamberger C, Schmale H. Identiﬁcation and tissue distribution of novel KET/p63 splice 
variants. Febs Lett 501:121 (2001).
36. Yuan ZM, Shioya H, Ishiko T, Sun XG, Gu JJ, Huang YY, Lu H, Kharbanda S, 
Weichselbaum R, Kufe D. P73 is regulated by tyrosine kinase c-Abl in the apoptotic 
response to DNA damage. Nature 399:814 (1999).
37. Kaelin WG. The emerging p53 gene family. J Natl Cancer Inst 91:594 (1999).
38. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM. A leucine-
rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular 
localization and p53 activity by NES masking. Embo J 18:1660 (1999).
39. Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH. p73 and p63 are 
homotetramers capable of weak heterotypic interactions with each other but not with p53. 
J Biol Chem 274:18709 (1999).
40. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73 alpha and their 
collaboration to induce apoptosis. Nature 399:809 (1999).
41. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG, Levrero M, Wang JYJ. The 
tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA 
damage. Nature 399:806 (1999).
42. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, Oren M, Sudol M, 
Cesareni G, Blandino G. Physical interaction with Yes-associated protein enhances p73 
transcriptional activity. J Biol Chem 276:15164 (2001).
43. Chi SW, Ayed A, Arrowsmith CH. Solution structure of a conserved C-terminal domain of 
p73 with structural homology to the SAM domain. Embo J 18:4438 (1999).
44. Thanos CD, Bowie JU. p53 Family members p63 and p73 are SAM domain-containing 
proteins. Prot Sci 8:1708 (1999).
45. Schultz J, Ponting CP, Hofmann K, Bork P. SAM as a protein interaction domain involved 
in developmental regulation. Prot Sci 6:249 (1997).
46. Bork P, Koonin EV. Predicting functions from protein sequences - where are the 
bottlenecks? Nat Genet 18:313 (1998).
47. Barrera FN, Poveda JA, Gonzalez-Ros JM, Neira JL. Binding of the C-terminal sterile 
alpha motif (SAM) domain of human p73 to lipid membranes. J Biol Chem 278:46878 
(2003).
48. Green JB, Gardner CD, Wharton RP, Aggarwal AK. RNA recognition via the SAM 
domain of Smaug. Mol Cell 11:1537 (2003).
49. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, Darimont BD, Duijf PHG, van 
Bokhoven H, McKeon F, Dotsch V. A C-terminal inhibitory domain controls the activity 
of p63 by an intramolecular mechanism. Mol Cell Biol 22:8601 (2002).
50. Duijf PHG, Vanmolkot KRJ, Propping P, Friedl W, Krieger E, McKeon F, Dotsch V, 
Brunner HG, van Bokhoven H. Gain-of-function mutation in ADULT syndrome reveals 
the presence of a second transactivation domain in p63. Hum Mol Genet 11:799 (2002).
51. Dohn M, Zhang SZ, Chen XB. p63 alpha and Delta Np63 alpha can induce cell cycle arrest 
and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193 (2001).
Chapter 2 - Ectrodactyly Ectodermal dysplasia and Cleft lip/palate syndrome
83
52. Ikawa S, Nakagawara A, Ikawa Y. p53 family genes: structural comparison, expression 
and mutation. Cell Death Differ 6:1154 (1999).
53. De Laurenzi V, Melino G. Evolution of functions within the p53/p63/p73 family. Mech 
Cell Death 926:90 (2000).
54. Little NA, Jochemsen AG. p63. Int J Biochem Cell Biol 34:6 (2002).
55. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in 
normal and neoplastic human keratinocytes. J Invest Dermatol 113:1099 (1999).
56. Hall PA, Campbell SJ, O’neill M, Royston DJ, Nylander K, Carey FA, Kernohan NM. 
Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic 
cells. Carcinogenesis 21:153 (2000).
57. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha 
and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 87:368 
(2000).
58. Yang A, McKeon F. P63 and p73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 
1:199 (2000).
59. Ianakiev P, Kilpatrick MW, Toudjarska I, Basel D, Beighton P, Tsipouras P. Split-hand/
split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 
67:59 (2000).
60. McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit 
V, Kelly A, Atherton DJ, Grifﬁths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang 
A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H. Hay-Wells 
syndrome is caused by heterozygous missense mutations in the SAM domain of p63. 
Hum Mol Genet 10:221 (2001).
61. van Bokhoven H, Hamel BCJ, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PHG, 
Vanmolkot KRJ, van Beusekom E, van Beersum SEC, Celli J, Merkx GFM, Tenconi 
R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, 
Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JRW, Neri G, Brunner HG. p63 
gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split 
foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 69:481 
(2001).
62. Bougeard G, Hadj-Rabia S, Faivre L, Sarafan-Vasseur N, Frebourg T. The Rapp-Hodgkin 
syndrome results from mutations of the TP63 gene. Eur J Hum Genet 11:700 (2003).
63. Kantaputra PN, Hamada T, Kumchai T, McGrath JA. Heterozygous mutation in the 
SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia. J Dent Res 82:433 
(2003).
64. Irwin MS, Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell 
Growth  Differ 12:337 (2001).
65. Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR. Down-regulation of p63 
is required for epidermal UV-B-induced apoptosis. Cancer Res 60:4016 (2000).
66. Weinberg WC, Azzoli CG, Chapman K, Levine AJ, Yuspa SH. p53-mediated transcriptional 
activity increases in differentiating epidermal keratinocytes in association with decreased 
p53 protein. Oncogene 10:2271 (1995).
Resolving the molecular basis of human malformation syndromes
84
67. Heselmeyer K, Schrock E, Dumanoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. 
Gain of chromosome 3q deﬁnes the transition from severe dysplasia to invasive carcinoma 
of the uterine cervix. Proc Natl Acad SciUSA 93:479 (1996).
68. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, 
Sidransky D. AIS is an oncogene ampliﬁed in squamous cell carcinoma. Proc Natl Acad 
Sci USA 97:5462 (2000).
69. Park JJ, Sun D, Quade BJ, Flynn C, Sheets EE, Yang A, McKeon F, Crum CP. Stratiﬁed 
mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell 
neoplasia? Am J Surg Pathol 24:1414 (2000).
70. O’Connell JT, Mutter GL, Cviko A, Nucci M, Quade BJ, Kozakewich HP, Neffen E, Sun 
D, Yang A, McKeon FD, Crum CP. Identiﬁcation of a basal/reserve cell immunophenotype 
in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol 
Oncol 80:30 (2001).
71. Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, 
Peters R, McKeon FD, Crum CP. Expression of the p53 homologue p63 in early cervical 
neoplasia. Gynecol Oncol 80:24 (2001).
72. Crook T, Nicholls JM, Brooks L, O’Nions J, Allday MJ. High level expression of Delta 
N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal 
carcinoma (NPC)? Oncogene 19:3439 (2000).
73. Yamaguchi K, Wu L, Caballero OL, Hibi K, Trink B, Resto V, Cairns P, Okami K, Koch 
WM, Sidransky D, Jen J. Frequent gain of the p40/p51/p63 gene locus in primary head 
and neck squamous cell carcinoma. Int J Cancer 86:684 (2000).
74. Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D. p53 associates 
with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci USA 
98:1817 (2001).
75. Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A, Del Sal G, 
Levrero M, Sacchi A, Oren M, Blandino G. Physical interaction with human tumor-
derived p53 mutants inhibits p63 activities. J Biol Chem 277:18817 (2002).
76. Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C. A subset of tumor-derived mutant 
forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core 
domain. Mol Cell Biol 21:1874 (2001).
77. Scharnhorst V, Dekker P, van der Eb AJ, Jochemsen AG. Physical interaction between 
Wilms tumor 1 and p73 proteins modulates their functions. J Biol Chem 275:10202 
(2000).
78. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for 
multiplication. Proc Natl Acad Sci USA 84:2302 (1987).
79. Watt FM. Epidermal stem cells: markers, patterning and the control of stem cell fate. 
Philos Trans R Soc Lond B Biol Sci 353:831 (1998).
80. Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM, Abrams JM. Drosophila p53 
binds a damage response element at the reaper locus. Cell 101:103 (2000).
81. Jin S, Martinek S, Joo WS, Wortman JR, Mirkovic N, Sali A, Yandell MD, Pavletich 
NP, Young MW, Levine AJ. Identiﬁcation and characterization of a p53 homologue in 
Drosophila melanogaster. Proc Natl Acad Sci USA 97:7301 (2000).
Chapter 2 - Ectrodactyly Ectodermal dysplasia and Cleft lip/palate syndrome
85
82. Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, 
Demsky M, Fisher WW, Buchman A, Duyk G, Friedman L, Prives C, Kopczynski C. 
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 
101:91 (2000).
83. Blessing M, Schirmacher P, Kaiser S. Overexpression of bone morphogenetic protein-6 
(BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation 
depending on the pattern of transgene expression and formation of psoriatic lesions. J 
Cell Biol 135:227 (1996).
84. Dick A, Hild M, Bauer H, Imai Y, Maifeld H, Schier AF, Talbot WS, Bouwmeester T, 
Hammerschmidt M. Essential role of Bmp7 (snailhouse) and its prodomain in dorsoventral 
patterning of the zebraﬁsh embryo. Development 127:343 (2000).
85. McDonnell MA, Law BK, Serra R, Moses HL. Antagonistic effects of TGF beta 1 and 
BMP-6 on skin keratinocyte differentiation. Exp Cell Res 263:265 (2001).
86. Bakkers J, Hild M, Kramer C, Furutani-Seiki M, Hammerschmidt M. Zebraﬁsh Delta 
Np63 is a direct target of bmp signaling and encodes a transcriptional repressor blocking 
neural speciﬁcation in the ventral ectoderm. Dev Cell 2:617 (2002).
87. HemmatiBrivanlou A, Melton D. Vertebrate embryonic cells will become nerve cells 
unless told otherwise. Cell 88:13 (1997).
88. Hild M, Dick A, Rauch GJ, Meier A, Bouwmeester T, Haffter P, Hammerschmidt M. The 
smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning 
of the zebraﬁsh embryo. Development 126:2149 (1999).
89. Lee H, Kimelman D. A dominant-negative form of p63 is required for epidermal 
proliferation in zebraﬁsh. Dev Cell 2:607 (2002).
90. Tao H, Yoshimoto Y, Yoshioka H, Nohno T, Noji S, Ohuchi H. FGF10 is a mesenchymally 
derived stimulator for epidermal development in the chick embryonic skin. Mech Dev 
116:39 (2002).
91. Finkel T. Redox-dependent signal transduction. Febs Lett 476:52 (2000).
92. Artavanis-Tsakonas S. Notch signaling. Faseb J 12:A1292 (1998).
93. Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, 
Nakamura Y, Tokino T. The p53 family member genes are involved in the notch signal 
pathway. J Biol Chem 277:719 (2002).
94. Wu GJ, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CCR, Dong SM, Guo ZM, 
Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, 
Trink B. Delta Np63 alpha and TAp63 alpha regulate transcription of genes with distinct 
biological functions in cancer and development. Cancer Res 63:2351 (2003).
95. Zorn AM. Wnt signalling: Antagonistic Dickkopfs. Curr Biol 11:R592 (2001).
96. Wang J, Shou J, Chen XB. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is 
induced by p53. Oncogene 19:1843 (2000).
97. Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M. A polymorphic microsatellite 
that mediates induction of PIG3 by p53. Nat Genet 30:315 (2002).
98. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced 
apoptosis. Nature 389:300 (1997).
Resolving the molecular basis of human malformation syndromes
86
99. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, 
McKeon F, Haber DA. REDD1, a developmentally regulated transcriptional target of p63 
and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10:995 (2002).
100. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. Epidermal growth 
factor (EGF)-induced generation of hydrogen peroxide - Role in EGF receptor-mediated 
tyrosine phosphorylation. J Biol Chem 272:217 (1997).
101. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine 
phosphatases in vivo. Mol Cell 9:387 (2002).
102. Senoo M, Matsumura Y, Habu S. TAp63 gamma (p51A) and dNp63 alpha (p73L), two 
major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth 
factor (VEGF) gene expression. Oncogene 21:2455 (2002).
103. Takahashi K, Paladini RD, Coulombe PA. Cloning and Characterization of Multiple 
Human Genes and Cdnas Encoding Highly Related Type-Ii Keratin-6 Isoforms. J Biol 
Chem 270:18581 (1995).
104. Langbein L, Rogers MA, Winter H, Praetzel S, Beckhaus U, Rackwitz HR, Schweizer J. 
The catalog of human hair keratins I. Expression of the nine type I members in the hair 
follicle. J Biol Chem 274:19874 (1999).
105. Wilkie AOM, Morriss-Kay GM. Genetics of craniofacial development and malformation. 
Nat Rev Genet 2:458 (2001).
106. Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, Poliak N, 
Califano J, Trink B, Ratovitski E, Sidransky D. Delta Np63 induces beta-catenin nuclear 
accumulation and signaling. Cancer Cell 1:369 (2002).
107. Grosschedl R, Giese K, Pagel J. Hmg Domain Proteins - Architectural Elements in the 
Assembly of Nucleoprotein Structures. Trends Genet 10:94 (1994).
108. Baxevanis AD, Landsman D. The Hmg-1 Box Protein Family - Classiﬁcation and 
Functional-Relationships. Nucleic Acids Res 23:1604 (1995).
109. Zeng SX, Dai MS, Keller DM, Lu H. SSRP1 functions as a co-activator of the 
transcriptional activator p63. Embo J 21:5487 (2002).
110. Wu XW, Bayle JH, Olson D, Levine AJ. The P53 Mdm-2 Autoregulatory Feedback Loop. 
Genes  Dev 7:1126 (1993).
111. el Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer 
WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. 
Cell 75:817 (1993).
112. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein 
Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805 (1993).
113. Corden JL, Patturajan M. A CTD function linking transcription to splicing. Trends 
Biochem Sci 22:413 (1997).
114. Lau PP, Villanueva H, Kobayashi K, Nakamuta M, Chang BHJ, Chan L. A DnaJ protein, 
apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J Biol Chem 
276:46445 (2001).
115. Raitskin O, Cho DS, Sperling J, Nishikura K, Sperling R. RNA editing activity is 
associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing 
machinery. Proc Natl Acad Sci USA 98:6571 (2001).
Chapter 2 - Ectrodactyly Ectodermal dysplasia and Cleft lip/palate syndrome
87
116. Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, Yuriditsky 
E, Trink B, Sidransky D, Ratovitski E. p63 alpha mutations lead to aberrant splicing of 
keratinocyte growth factor receptor in the Hay-Wells syndrome. J Biol Chem 278:23906 
(2003).
Resolving the molecular basis of human malformation syndromes
88
Contents 
3.1 RRS
3.2 Discovery Strategy
3.3 ROR2 
3.4 Molecular Genetics of RRS
3.5 ROR2 Signaling Pathway
3.6 References 
Chapter 3
Robinow Recessive Syndrome (RRS)
Resolving the molecular basis of human malformation syndromes
90
Chapter 3 - Robinow Recessive Syndrome
91
3.1 RRS 
In 1969 Robinow and colleagues recognised a new dwarﬁng syndrome studying a 6 
generation pedigree that showed recurrent short stature, increased interorbital distance 
(hypertelorism), bulging forehead, depressed nasal bridge and malaligned teeth1. This 
new syndrome showed an autosomal dominant mode of inheritance. The main clinical 
hallmarks are: mesomelic dysplasia, small hands with clinodactyly and brachydactyly, a 
typical face showing hypertelorism, frontal bossing, short broad and upturned nose with 
anteverted nostrils, trapezoidal maxillary arch and irregular crowded teeth, hypoplastic 
genitalia and endocrine dysfunction2, OMIM and references therein.
 Shortly after the identiﬁcation of the autosomal dominant form of Robinow syndrome 
(RS; OMIM %180700) different authors suggested the presence of an autosomal recessive 
form of Robinow syndrome (RRS; OMIM #268310)3-7. The main discriminating features 
with the AD form are the occurrence of multiple rib and vertebral anomalies that are 
particularly severe in the RRS. Additional features reported in RRS patients is the 
occurrence of congenital heart defects, laxity of ligaments joints and skin, webbing of 
toes and epigastric hernia8,9. A study conducted by Soliman and colleagues observed 
dysfunction of sexual hormones (growth hormone, gonadotropin luteinizing hormone, 
follicle-stimulating hormone and testosterone in males) in a cohort of 14 children with 
RRS10.
 Quite interestingly, about 25% of all RS cases are of Turkish origin and a very high 
proportion (≈ 80%) of these cases is of the recessive form. Dr. Aksit suggested that the 
high rate of consanguineous marriages (21%) may be a responsible factor8. This is in 
agreement with our own results, that also exclude the hypothesis of a single founder 
mutation as the cause of the high incidence in the population of Turkish origin (see 
Appendix 3).
 In 2000 we, and independently Afzal and colleagues, identiﬁed the cause of the 
recessive form of the Robinow syndrome in homozygous mutations of the orphan receptor 
tyrosine kinase ROR2 gene (Appendix 3 and ref. 11).
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3.2 Discovery Strategy
3.2.1 Positional cloning
The availability of consanguineous families affected with RRS suggested the use of the 
homozygosity mapping approach for the search of a gene involved in this autosomal 
recessive disorder. A genome-wide scan was performed on the ﬁrst ﬁve consanguineous 
families for determining an initial localisation. After obtaining evidence for a common 
region of homozygosity on chromosome 9, a set of approximately 30 markers from this 
region was used to obtain convincing evidence for linkage. For further linkage conﬁrmation 
the entire panel of 11 families was checked for the same markers. Subsequently a set of 
10 markers in a 20 cM region were used to narrow down the linkage interval. As 10 of 
the families were of Turkish origin, and because the high incidence of RS in Turkish 
populations suggested the presence of a founder mutation, haplotypes were controlled 
for the regions of shared alleles between families. The sharing of 7 consecutive alleles 
between three unrelated families allowed an additional reduction of the critical interval. 
The construction of a YAC contig allowed the ﬁne mapping of genes, ESTs and markers 
in the RRS critical region. 
3.2.2 Positional candidate approach
Due to the still relative large size of the RRS critical region ≈ 4.9 cM and to the relatively 
high concentration of genes in this interval, a selection of candidate genes was needed. 
 Among the genes contained in the region there was ROR2. This gene appeared to be a 
good candidate gene because of its expression during mouse embryonic development, but 
mainly because the KO mouse shows a skeletal phenotype that strongly resembled that 
of the RRS patients12. In this case although the expression information in the mouse was 
ﬁtting with the pattern of a gene involved in RRS, it was also known that this gene was 
already involved in brachydactyly type B, an autosomal dominant congenital disorder 
that is quite different from RRS. Therefore it was the animal model that suggested this 
gene as a good candidate for causing RRS. 
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3.3 ROR2
ROR2 and ROR1 are the two structurally related proteins members of the ROR-family, a 
novel family of receptor tyrosine kinases (RTKs). RTKs play a crucial role in developmental 
mechanisms as morphogenesis, cell proliferation, differentiation, migration, survival and 
apoptosis13-16. In 1992, ROR1 and ROR2 were cloned as two new RTKs from the human 
neuroblastoma line SH-SY5Y, in a study aimed to identify TRK-related genes17. Members 
of the TRK-family of RTKs are involved in the regulation of the neurotrophic activity of 
the nerve growth factor (NGF) family of neurothrophins. 
 The cytoplasmatic region of ROR1 and ROR2 shows high homology with that of the 
TRK-family RTKs. Many conserved tyrosine residues involved in TRK kinase activity 
regulation are also found in ROR family members, including a tyrosine essential for 
transphosphorylation that is present in all ROR-family RTKs. However, ROR1 and ROR2 
also share some unique features, suggesting that they are members of a separate family of 
RTKs.  
 Unlike the TRK-family RTKs, the extracellular domain of the ROR-family RTKs 
contains a cystein-rich domain (frizzled-like) and a membrane-proximal Kringle domain18. 
The frizzled-like module was ﬁrst identiﬁed in G-coupled receptors of the frizzled (Frz) 
and smoothened families. The Frz modules are known to mediate signals of Wnt family 
members19. The Kringle domain is a highly folded structure, rich in cysteins, found in 
proteins involved in blood coagulation, apolipoprotein and in the hepatocyte growth 
factor18 and references therein. In the RTKs a Kringle domain is present only in the torpedo 
RTK, cloned from the torpedo californica electric organ (247,365}. Both the Frizzled-like 
and the Kringle domains seem to be involved in protein-protein interactions18. 
 Unlike the TRK-family RTKs, the ligands for the members of the ROR-family RTKs 
have not yet been found17,18,20,21 and references therein.  
 Studies on the drosophila nervous system have led to the discovery of Dror and 
Drsk, the drosophila members of the ROR-family RTKs, orthologs of ROR1 and ROR2 
respectively20,22. While only one member of the ROR-family RTKs, cam-1, has been 
identiﬁed in c. elegans. cam-1 is involved in the regulation of migration, asymmetric cell 
division, and neuronal development23. An additional N-terminal Ig-like domain is present 
in mammalian Ror1 and Ror2 homologues17,22. These data show that the ROR-family 
RTKs are evolutionarily conserved. On the other hand, very little is known about the 
functional and developmental roles of the mammalian ROR-family RTKs.  
 Localisation of ROR2 to 9q21.3-q22 was achieved by radiation hybrid mapping24, 
FISH analysis25 and also conﬁrmed by our own results (see Appendix 3). The mouse Ror2 
orthologue is on chromosome 13 in a region of high synteny with the human 9q18.
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 Comparison between the sequences of the two members of the mammalian ROR-
family RTK, Ror1 and Ror2, shows differences in the highly conserved cytoplasmatic 
domain that could indicate possible functional differences. For example, the proline-reach 
domain, present only in the mammalian orthologues, of mouse and human ROR1 contains 
a WW consensus site (see Chapter 2) that is absent in Ror2 and ROR2. On the other 
hand, Ror2, ROR2 and Dnrk contain a YALM motif that can bind to the SH2 domains of 
proteins such as SHC, CSK, and p85 of PI3K. These data indicate that different RORs 
interact with distinct functional sets of molecules18. 
 Expression studies on cells and mouse embryos have shown spatio/temporal overlaps 
and differences between the expression of Ror1 and Ror2. For instance Ror2 shows 
transient expression after induction with retinoic acid (RA) in P19EC cells, while Ror1 
expression increases steadily. Another example is the developmental expression of Ror1 
and Ror2 in neuronal tissue and in other tissues18,26 (see Table 3.1). 
Table 3.1 Developmental expression of Ror1 and Ror2 (data from refs. 12,18,26)
Day Ror2 expression Ror1 expression 
E   7.5 Entire primitive streak Anterior part of the embryo
E   8.5
As at E 7.5 + Neural and non-neural tissues, 
prosencephalon and mesencephalon, neural 
tube (dorsal part of trunk), cephalic neural 
crest cells 
Cephalic mesenchyme (high in neural crest 
cells migrating to pharyngeal arches)
Mesodermal and neural crest-derived 
mesenchyme
E   9.5
Facial primordia
Dermomyotome (dorsomedial) and 
sclerotome
Forebrain, midbrain and presomitic 
mesoderm  
Limb: Strong expression
Facial primordia
Dermomyotome (dorsomedial) and 
sclerotome
Diencephalon (dorsal), mid-hind brain
Limb: Strong expression
E 10.5 Limb: entire limb Limb: proximal region of limb bud
E 12.5
Limb: perichondrium of digits and marginal 
regions of limbs
Limb: anterior and posterior region of limbs 
and prospective necrotic zones
E 13.5
Heart: myocardium, interventricular septum, 
aortic valve and atrium (not epicardium)
Lung: alveoli
Brain: limbic neocortex, hippocampal 
neuroepithelium and caudate puntamen
Limb: perichondrium of digits and marginal 
regions of limbs
Heart: myocardium, interventricular septum, 
aortic valve and atrium (not epicardium) 
Lung: alveoli
Brain: not reported 
Eye: lens epithelium
Limb: interdigital regions
E 18
Eye (not speciﬁed), rhinencephalon, 
cerebellum and spinal cord
 Eye (not speciﬁed), rhinencephalon, 
cerebellum and spinal cord
P   0 similar to E 18 similar to E 18
P   8 increased expression in medulla oblongata  increased expression in medulla oblongata
≥ P 23 Hardly detectable in any tissues 
Brain, heart, lung, kidney and thymus
Limbs = Mesenchyme not Ectoderm
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 The partial overlap of expression of mRor1 and mRor2 in the developing face, limbs, 
heart and lungs may suggest functional redundancy12,21,26.  
 In 2000, DeChiara and colleagues showed that mRor2 has an essential regulatory role 
in cartilage and bone growth plate patterning and development12. Ror2 is expressed in the 
chondrocytes of the developing primordium of all bones formed through endochondrial 
ossiﬁcation (e.g. limb bones). No expression was found in the precursor regions of 
bones that form without a cartilaginous precursor (e.g. frontal bones of the skull), and no 
expression was detected in bone itself. Interestingly, postnatal expression was detected in 
adult proliferative and resting chondrocytes of older growth plates12.
 Ror2-/- mice show variable shortening of different bones, the distal long ones being the 
most severely affected. Such abnormalities are in agreement with the phenotype shown 
by patients affected by RRS. In contrast Ror1-/- newborns are similar in size to wild-type 
mice and show no apparent gross malformation or abnormality. Both knock-outs show 
forced respiration and cyanosis and die within 24 hours (Ror2-/- within 6 hours) after 
birth. The heterozygous mRor1+/- mice are viable and fertile and appear normal (for a 
comparison of the different knockouts phenotypes see Table 3.2). 
Table 3.2 Ror knockouts defects (adapted from ref. 27)
Phenotypes mRor1-/- mRor2-/- mRor1-/- /mRor2-/-
Neonatal lethality + + +
Forced respiration and 
cyanosis
+ + +
Respiratory dysfunction + + +
Dysplasia of distal long 
bones
- + +
Ventricular septal 
defects
- + +
Dwarﬁsm - + ++
Short limbs and tail - + ++
Facial anomalies - + ++
Dysplasia of proximal 
long bones
- + ++
Hypoplasia of maxilla 
and mandible
- + ++
Sternal defect - - +
Dysplasia of pubic bone 
symphysis 
- - +
Transposition of great 
arteries
- - +
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 The fact that mRor1 and mRor2 interact genetically in the development of the skeleton21, 
may explain why double knock out mRor1-/- mRor2-/- mice show a skeletal phenotype 
that is more severe than that seen in either of the single mutants. For example mRor1-/- 
mRor2-/- mice exhibit dysplasia of the proximal long bones in addition to shortening of 
the distal long bones (mesomelic) present in the mRor2-/- mouse. Redundancy of function 
of mRor2 is seen in the mRor1-/- mice, where Ror2 compensates for the lack of Ror1 in 
the development of the skeletal system21. Functional redundancy of Ror2, with respect to 
Ror1, has also been shown in heart development. 
 The important role played by the ROR proteins in the migration and function of 
neural crest cells which are required for the correct formation and development of the 
cardiovascular system might suggest a possible mechanism through which ROR may 
control cardiovascular system development21 and references therein. 
3.4 Molecular Genetics of RRS
In 1999 we were the ﬁrst to map RRS to the long arm of chromosome 9, namely in 
9q2228. In the same year we and Afzal and colleagues found homozygous mutations in the 
ROR2 gene in RRS patients11 and Appendix 3. Both missense mutations and stop codon 
mutations were found. While stop mutations are found along the whole gene, missense 
mutations are clustered in the extracellular region and in the protein-protein or protein-
ligand interaction domains  (Figure 3.1). 
Figure  3.1
ROR2 mutations in patients with RRS 
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 These mutations will result in non-functional alleles. Either because, in the case of the 
truncating mutations, the resulting protein will lack the essential phosphorylation site, or 
because the binding properties of the receptor to its ligand(s) or its dimerising capacity are 
impaired by the missense mutations  (Figure 3.2). This last situation can occur because 
the missense mutations may affect a speciﬁc binding or dimerisation site or because the 
mutation affects an amino acid essential for maintaining the functional conformation of the 
receptor. The loss of function model proposed for the RRS mutations is in agreement with 
the fact that patients carrying heterozygous deletions of the 9q22 region encompassing 
the ROR2 gene show no symptoms of RRS. Nor do the heterozygous Ror+/-  mice show 
any skeletal phenotype. By contrast, ROR2 mutations causing BDB are heterozygous 
dominant mutations and these are thought to cause the disease through a gain of function 
mechanism that will lead to illegitimate signalling. Therefore we are confronted by a gene 
that is involved in two unrelated MCAs, that are inherited with different modes, through 
two opposite mechanisms. 
 We have excluded, at least in our cohort of Robinow syndrome patients, that the 
Figure 3.2
Functional model of RRS mutations
On the left the wild type receptor in the centre the resulting non-functional receptors due to the RRS 
mutations.
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recessive and autosomal dominant forms of Robinow syndrome are allelic through 
mutation of ROR2. Lately, the group of Morgante showed an autosomal dominant RS 
patient with a direct duplication of the region containing ROR1, 1p31. Southern blot 
analysis suggests that in this patient ROR1 is disrupted. This suggests that ROR1 could be 
a causative gene for AD RS29. However, direct sequencing of ROR1 in 10 patients with 
autosomal dominant Robinow syndrome failed to detect any causative mutations of this 
gene (Mazzeu personal communication, 2004).
3.5 Ror2 Signaling Pathway
Recent works have begun to shed light on the molecular role played by Ror2 and the 
pathways in which Ror2 is involved  (Figure 3.3). Through the discovery of the Xenopus 
ortholog, Xror2, Hikasa and colleagues have identiﬁed ligands for the receptor30. Xror2 is 
involved in the non-canonical Wnt signaling for the planar cell polarity (PCP) pathway. 
This pathway regulates the convergent extension movements of the axial mesoderm and 
neuroectoderm during early embryogenesis. Xror2 is located downstream of the organizer 
speciﬁc transcription factor, the homeobox gene Xlim-1. The Frizzled-like domain allows 
Xror2 to bind to several Wnt proteins, for example Xwnt5a and Xwnt11, with which it 
shows synergistic effects in the inhibition of convergent extension in embryos. Further 
demonstration of the regulatory roles of Xror2 in convergent extension during gastrulation 
and neurulation in amphibians can be seen in:
a) The effects of complexes formed by Xror2 and other PCP mediating or 
odifying proteins as Xfz7, Stbm and the already mentioned Xwnt11, on the 
PCP pathway. 
b) The possibility of rescuing the elongation inhibitory effects caused by Xror2 
by a dominant-negative mutant of Cdc45, whose wild type form is involved 
in the PCP pathway.
Although Xror2 has roles in morphogenetic movements in early developmental stages it 
does not inﬂuence the cell fates. Moreover these roles of Xror2 in inhibiting convergent 
extension seem to be independent from the kinase domain, raising the possibility that 
the ectodomain may have a signiﬁcant function independently from the tyrosine kinase 
domain. This is in agreement with what has been found in C. elegans where cam-1, the C. 
elegans ror, is required for asymmetric cell division, cell migration and axon outgrowth 
of a speciﬁc type of neuronal cell, and tyrosine kinase activity is required only for some of 
these functions but not for cellular migration23,30. This interesting feature of the Ror-family 
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RTKs, to function in kinase activity-dependent and -independent manners, has been also 
reported in human embryonic kidney cells31. Oishi and colleagues have conﬁrmed these 
data in mouse32. They have demonstrated the association of Ror2 with Wnt5a via the 
Frizzled-like domain. Moreover Ror2 is able also to form complexes with Wnt5a putative 
receptors, as rFz2 or hFz5. These results once again suggest that Ror2 acts as a receptor 
for Wnt proteins to activate the non-canonical Wnt5a/JNK pathway during developmental 
morphogenesis in mammals32. Unpublished data by Yoda conﬁrms the involvement of 
mouse Ror2 in the PCP pathway of Wnt signaling. Interestingly the Drosophila Drl, a 
receptor for the ﬂy ortholog of Wnt5a, is a member of the receptor-like tyrosine kinase 
(RYK). The RYK family is an atypical receptor tyrosine kinase that appears to lack the 
Figure 3.3
Diagram of ROR2 pathways:
On top the identiﬁed ligands of the receptor (involvement of the receptor–like tyrosine kineses is hypothesised, 
see text).
Down stream target of the ROR2 receptor is Dlxin1 protein, Dlxin1 can interfere directly or indirectly with the 
transcriptional functions of The Dlx/Msx homeodomain protein family, in particular of Dlx5 and Msx2.
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catalytic activity33,34. Moreover the phenotype of Ror2-/- mice, Wnt5a-/- mice and RYK-
/- mice, are quite similar including shortened limbs and craniofacial abnormalities35. 
Members of the RYK family may transduce signals together with catalytically active 
tyrosine kinase33.   
 Dlxin-1 has been identiﬁed as a downstream target of Ror231. The Ror2 C-term proline-
rich domain is required for the association of the two proteins. The association with 
Dlxin-1 is kinase independent. Dlxin-1 is a member of the necdin/melanoma associated 
antigen gene (MAGE) family. Necdin mediates growth arrest of postmitotic neurons, 
presumably by interacting with E2F1 and p5336-38. The rat ortholog of Dlxin-1, NRAGE or 
MAGE-D, has been associated with apoptotic pathways involving p75NTR in developing 
neuronal cells, inhibitor apoptosis protein (IAP) and c-Jun dependent apotosis cascade in 
mitochondria39-41. 
 Dlxin-1 is capable to bind and regulate the transcriptional functions of most of the 
Dlx/Msx family of homeodomain proteins, and in particular Dlx5 and Msx242. Msx2 
is localized in the nucleus. It is involved in bone development and formation acting 
as an osteocalcin repressor43,44. Dlx5 has several roles from development of GABA-
ergic neurons, to limb development and bone and cartilage formation. Dlx5 potentiates 
osteocalcin transcription by interfering with Msx245 and references therein. 
 Dlxin-1 binds more strongly Msx2 than Dlx5, and is thought not to be directly involved 
in the transcriptional activation of Dlx5 but in bridging or stabilizing a complex of Dlx5 
and coactivators42. The sequestration of Dlxin-1 to the membranous compartments by 
Ror2 therefore indirectly affects the transcriptional functions of Msx2 and Dlx5. 
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4.1 Oesophageal Atresia and ODED Syndrome
Oesophageal atresia (OA) is a common life-threatening congenital anomaly with an 
incidence of 1 in 3000 newborns. OA can be non-syndromic or associated with other 
congenital anomalies. The non-syndromic form is considered to be multifactorial and 
both its pathogenesis and causation are poorly deﬁned. Recurrence of OA in families 
has occasionally been noted1 and a multifactorial genetic cause was suggested. Several 
families have been reported where a syndromic form of OA showed an autosomal 
dominant pattern of inheritance. Association of OA with other congenital anomalies is 
most frequently seen in the sporadic “VATER association” (MIM 192350) where OA is 
associated with other gastrointestinal atresias or stenoses, anomalies of the urinary tract 
and heart defects2. Autosomal dominant inheritance occurs in the Oculodigitoesophagodu
odenal syndrome (ODED; MIM 164280), or Feingold syndrome, a rare disorder reported 
as a combination of multiple congenital anomalies comprising digital abnormalities 
(present in all affected), among which are brachydactyly of the ﬁngers and syndactyly 
of the feet (typically of the 4th and 5th toes), microcephaly, short palpebral ﬁssures, 
learning disabilities, and oesophageal/duodenal atresia (in more than 30% of the cases). 
Recently also vertebral anomalies have been reported in a family with this syndrome3. 
The oesophageal/duodenal abnormalities are the most severe clinical manifestation in 
ODED syndrome. Since the ﬁrst description in 1975 by Feingold several families have 
been reported in literature presenting ODED syndrome or similar phenotypes3-11. Some 
cases of association of OA with chromosomal abnormalities have been reported. OA has 
been found in patients with deletion of 22q11, 12q24.3-qter, 17q22-q23.3, trisomy 18 and 
trisomy 2112-15 (see Appendices 4 and 5). However, compilations of data on chromosomal 
abnormalities failed to identify a region for OA16. 
 In an attempt to identify an OA gene, we studied several ODED families. A linkage 
study was ﬁrst performed on a large three generation pedigree (see Appendices 4 and 
5). First, several chromosomal regions containing candidate genes were excluded. These 
candidates were selected employing a novel method for probing candidate genes (see 
Appendix 1). Candidate genes were selected according to their pattern of expression 
during development, the effect of knock-out mutations in mouse, and the physiological 
role of the corresponding proteins, as in the case of genes encoding components of 
the retinoic acid (RA) metabolism (Table 4.1). In fact, the distribution of the ODED 
syndrome phenotype matches that of a gene involved in RA metabolism and regulation. 
Moreover, the role of retinoic acid proteins during the morphogenesis of the gut, limbs 
and craniofacial region is well documented17-19. 
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Table 4.1 First selection of candidate genes for ODED syndrome (non-positional in silico 
approach)
Genes Candidate category Function
CRABP1 Physiological role May regulate access of RA to nuclear receptors
CRABP2 Physiological role May regulate access of RA to nuclear receptors
RARα Physiological role RA nuclear receptor
RARβ Physiological role RA nuclear receptor
RARγ Physiological role RA nuclear receptor
RORα Physiological role Steroid hormone nuclear receptor RAR related
RXRα Physiological role Involved in RA response pathway
RXRβ Physiological role Involved in RA response pathway
RXRγ Physiological role Involved in RA response pathway
PAX9
Expression during 
development
Endodermal epithelium lining the prospective 
oesophagus and oral cavity. Restricted regions of 
mesenchyme of face and limbs (mouse & chick)
MEOX1
Expression during 
development
Mesoderm induction and earliest regional speciﬁcation, 
somatogenesis and myogenic and sclerotomal 
differentiation
CLU
Expression during 
development
Associated with apoptosis
WEE1
Expression during 
development
Could act as a negative regulator of entry into mitosis
HOXC4 Animal model Cell polarity. Mouse KO has OA
ITGα6 Phenotypic similarities Congenital duodenal atresia + epidermolysis bullosa
 Finally, regions deleted in patients showing several of the typical features of the 
ODED syndrome were included in the study  (Figure 4.1).
 After exclusion of all such regions, a genome wide scan was started on the remaining 
parts of the genome that were not covered by the candidate gene approach. Linkage 
between markers D2S131 and D2S170 in the 2p23-p24 region was found  (Figure 4.2 
and Appendices 4 and 5). The ﬁnding of a family with non-syndromic OA linking to the 
same area supports the idea that this is the region of a gene involved in OA and raised 
the possibility of ODED being a contiguous gene syndrome, or that certain alleles of the 
ODED gene are a risk factor for non-syndromic OA. 
 Because of its expression pattern during mouse development and its localisation in 
a mouse region syntenic to that of the human ODED locus was mapped, the positional 
candidate gene SIX2 was tested for mutations and excluded (see Appendices 4 and 5). 
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Figure 4.1
First candidate regions for the for OA and ODED 
Figure 4.2
Two point linkage analysis for the ODED region 
The Max LOD score region (in red) is between markers D2S149 and D2S144. D2S144 show the highest LOD 
score peek 
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4.2 Discovery Strategy
Given the fact that syndromic OA can be monogenic, while isolated OA is considered 
multifactorial, we decided to study the autosomal dominant inherited ODED syndrome in 
attempt to discover a causative gene for OA. 
 Following the identiﬁcation of a single locus on Chromosome 2p23-p24 a YAC contig 
of the critical area was made for ﬁne-mapping additional markers, genes and ESTs. The 
addition of a new family allowed us to restrict the linkage interval to a region between 
markers D2S1829 and D2S320  (Figure 4.3). This mapping reﬁnement permitted us to 
exclude several candidate genes, for example SYND1 (see Appendices 4 and 5) considered 
for its function (receptor of extracellular-matrix components and growth factors 
expressed during development) and expression (strongly expressed in oesophageal, facial 
and digital mesenchyme in mouse embryos), because these were now mapping outside 
the critical interval. Next, a search on the internet databases for genes present in the 
region was carried out. ESTs and genes located in the interval were tested for presence 
of microdeletions with dosage Southern blot technique. In addition, direct sequencing 
for point mutation search was used when only a few exons were present. An extra band 
appeared in the dosage Southern blot of one patient with the probe corresponding to the 
VSNL1 gene. Subsequent sequencing of this gene did not show any abnormality in either 
Figure 4.3
Yac contig for the ODED candidate region
The minimum interval region, between markers D2S1829 and D2S320, is shown in red. This is completely 
covered by four overlapping YACs (322, 320, 323 and 324) from the YAC contig.
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ODED or sporadic OA patients. 
 The release, in July 2000 of the genome draft public database (http://genome.ucsc.
edu/) allowed us to gain more speciﬁc information on the ODED region. Based on 
the new information, gene prediction programs and in silico 5’ PCR, the intron-exon 
structure of some genes, such as FLJ22116, were completed. Additional information 
was retrievable from the “Celera Discovery System”. This allowed us to conﬁrm the 
correct localisation of tested candidate genes and to restrict the linkage interval to about 
1 cM. Sixteen additional predicted genes were indicated in the ODED candidate region. 
Among these, four candidate genes were selected because of the presence of homologous 
predicted genes in the mouse syntenic region and of their predicted function: a Mesogenin 
like gene, a twist related gene of the basic helix-loop-helix transcription factor family; 
a RAD2-related gene; a Smad anchor for receptor activation (SARA) like gene and a 
gene spanning over a sequence gap, present both in the public and commercial databases. 
Sequence analysis was performed on the predicted exons of all these genes. At the end 
of February 2002 an updated release of the Celera discovery systems indicated as true or 
predicted genes in the ODED interval only the genes already tested. Unfortunately the 
information available on this region, still incomplete and or contradictory, has delayed the 
identiﬁcation of the ODED causing gene. 
 Currently information on genes from the critical region is still not sufﬁcient to detect 
an ODED/OA gene. This situation is likely to improve in the coming time. Therefore a 
positional cloning approach can be performed with reasonable hope of success. A search 
for homologous fragments within the ODED critical region and the mouse syntenic region 
has been undertaken with the aid of the molecular bioinformatics department of our 
university. In this way the genes present in the region will be deﬁned and then tested.
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5.1 Discussion
The aim of this research was the identiﬁcation of the genetic basis underlying several 
syndromes of multiple congenital anomalies. In each case we attempted to use a candidate 
gene analysis as the preferred method. Our hypothesis was that by combining systematic 
phenotype analysis and gene-speciﬁc information available through the Internet, the 
causative genes underlying such syndromes could be identiﬁed rapidly and effectively. 
As a ﬁrst test, we searched the gene expression database (GXD) using syndrome-speciﬁc 
patterns of organ involvement (see Appendix 1) in syndromes for which the genes were 
already known. The majority (4 of 7) of disease genes could be identiﬁed in this way 
(see Appendix 1).  While demonstrating the utility of a candidate-only approach, several 
reasons remained for proceeding cautiously with this strategy.
 First, the number of genes in the gene expression database at that time was clearly still 
very small (only 2467 genes described). Second, for most genes, only a few tissues had 
been examined for expression patterns, so that the overall expression pattern of a speciﬁc 
gene would often be incomplete. Third, the result could be biased by selective inclusion 
of gene speciﬁc information data, due to the fact that demonstration of the involvement of 
a gene in human disease will trigger more extensive analysis of developmental expression 
patterns of the corresponding gene in mice. As the project progressed, we mostly chose a 
positional candidate gene approach in this work to search for the causative genes for four 
separate syndromes of unknown genesis. In the case of three of these syndromes a mutated 
gene was identiﬁed. In EEC syndrome and Robinow syndrome, a positional candidate 
gene was identiﬁed partly based on speciﬁc expression in human and mouse (EEC), or on 
the phenotype of knockout mice (EEC and Robinow syndrome). Mutation analysis then 
rapidly allowed the veriﬁcation of the TP63 and ROR2 genes as the causative genes for 
these syndromes (see Appendices 2 and 3). In the third case, a gene underlying Walker 
Warburg syndrome was identiﬁed because of an overlapping phenotype with two other 
human conditions that have abnormalities of muscle, eye and brain, and the realization 
that both of these involved defective O-linked glycosylation1. 
 The fourth syndrome studied by the candidate gene approach did not yield any useful 
clues and in this case the approach was unsuccessful. 
 We searched for a gene involved in ODED syndrome (see Chapter 4) in a large 
three generation pedigree together with other smaller families already available in the 
department. ODED syndrome has a fully penetrant autosomal dominant pattern of 
inheritance2,3. Finding the gene underlying this syndrome would be especially interesting 
since this would constitute the ﬁrst gene involved in human Oesophageal Atresia. 
Oesophageal atresia is a frequent (1/3000 newborns) life threatening anomaly of unknown 
causation. It is present in about a third of the ODED syndrome patients. 
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 The web search indicated 15 ODED candidate genes. These genes were selected on 
the basis of their prominent expression in developing oesophagus and limb, the effect of 
knock-out mutations in mouse, the involvement in other forms of intestinal atresias, and 
the physiological role of the corresponding proteins. A restricted linkage analysis of these 
loci was performed (see Chapter 4). None of the candidate regions showed linkage with 
ODED syndrome. Only by using a genome-wide approach we were then able to deﬁne 
the critical region on the short arm of chromosome 2 (see Appendix 4). 
 At that time we believed that the major ﬂaw of our internet-assisted candidate gene 
selection approach was in the quality of the information contained in the gene expression 
and knock-out databases. Insufﬁcient expression data and inconsistency of search terms 
between the different databases were a big handicap of the system (see Appendix 1). 
However, our latest investigations have excluded mutations in all genes that are within 
the critical interval in the (Celera and Santa Cruz Dec 2001 freezes) human genome draft 
freezes  (Figure 5.1). This suggests that the ODED gene sequence has not been identiﬁed 
and up to today is still not present in these databases. Therefore the ODED gene was 
not traceable through this method, since a “conditio sine qua non” of our method is the 
presence of the searched gene in the databases.
 Today, with the information on TP63 and ror2 knockout mice4-6 in the databases, it 
should be possible to pick up these genes through the candidate gene approach. However, 
neither gene had been cloned at the time we began our research, therefore they could not 
have been represented in the databases. In retrospect then, our choice to adopt a positional 
candidate gene approach rather than a straightforward candidate gene approach for the 
genes involved in EEC and RRS was a fortuitous one. 
 Interestingly, once TP63 had been identiﬁed as the causative gene for EEC syndrome, 
phenotypic overlap allowed ﬁve other human malformation syndromes to be identiﬁed 
that have TP63 gene mutations with a clear genotype-phenotype correlation7-13. 
So how good is the candidate gene approach really? Clearly, the prospects can only get 
better for this type of in silico research. With the completion of the human genome project 
all human genes will become available for this type of research. At the same time, we are 
seeing great progress in gene annotation in many species for function, gene expression 
studies and mutant phenotypes (see e.g. in refs. 14-17).
 Thus, the impact of the candidate gene method should continue to improve, especially 
when more advanced bio-informatics tools become available to exploit this wealth of 
data.
A Pubmed search for 2001 and 2002 in three major human genetics journals shows several 
examples where a candidate gene was selected as part of the disease gene identiﬁcation 
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process (Table 5.1).
The analysis of these examples is only a snapshot of the use of the candidate gene approach 
and its achievements. Still, it points out its current power as well as the forthcoming 
potential of this method. 
 Most of the examples demonstrate the importance of an animal model in the discovery 
of a causative gene for human disorders. For instance Arikawa-Harisawa and colleagues 
noted the similarities between the phenotype of perlecan knock-out mice and patients 
with the Silverman-Handmaker type of human skeletal dysplasia18. Similarly, Loeys and 
colleagues19 noted that the phenotype in inbred kindred with multiple affected individuals 
with cutis laxa was similar to that of the ﬁbulin 5 knockout mouse. A homozygous missense 
mutation was duly identiﬁed. Jumlongras and colleagues20 studied the Witkop tooth and 
nail dysplasia. They performed a targeted linkage analysis for the region containing the 
MSX1 gene on chromosome 4. This choice was based on a previous report of a mutation 
in this gene associated with isolated hypodontia, and on expression of the Msx1 gene in 
tooth buds as well as nail beds. Linkage and a nonsense mutation in the homeodomain of 
Msx1 were identiﬁed. Suzuki and colleagues21  reasoned that the light ear mouse mutant
Figure 5.1
Comparison of two different “Freezes” of the UCSC human genome draft of the Region between D3S3628 and 
D3S1314:
On top the 17 July 2000 Freeze, below the 22 December 2002 Freeze. A decrease in the number of sequence 
gaps is accompanied by a more complete and correct information of known genes, as well as for the computer 
predicted ones. 
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Table 5.1 Examples of causative gene identiﬁcation through a candidate gene approach
Author Journal Disorder Gene
De Sandre-Giovannoli 
A et al.
Am J Hum Genet 70 : 726-
36, 2002
Charcot-Marie-Tooth disorder type 2 LMNA
Gorlov IP et al.
Hum Mol Genet 11: 2309-
18, 2002
Cryptorchidism GREAT
Ibanez-Tallon I et al.
Hum Mol Genet 11 : 715-21, 
2002
Primary ciliary dyskinesia and 
hydrocephalus
Mdnah5
Jamieson RV et al.
Hum Mol Genet 11: 33-42, 
2002
Cataract, ocular anterior segment 
dysgenesis and coloboma
MAF
Kitamura K et al. Nat Genet 32: 359-69, 2002
X-linked lissencephaly with 
abnormal genitalia
ARX
Loeys B et al. 
Hum Mol Genet 11: 2113-8, 
2002
Cutis laxa FBLN5
Pendleton A et al.
Am J Hum Genet  71: 933-
40, 2002
Chondrocalcinosis ANKH
Suzuki T et al. Nat Genet 30: 321-4, 2002 Hermansky-Pudlak syndrome HPS4
Ahmed ZM et al
Am J Hum Genet  69: 25-34, 
2001
Usher syndrome type 1F PCDH15
Arikawa-Hirasawa E 
et al.
Nat Genet 27: 431-4, 2001
Dyssegmental dysplasia Silverman-
Handmaker type
Perlecan
Guilbot A et al.
Hum Mol Genet 10 : 415-21, 
2001
Charcot-Marie-Tooth disorder type 4 Periaxin
Jumlongras D et al.
Am J Hum Genet 69 : 67-74, 
2001
Witkop syndrome MSX1
Wildin RS et al. Nat Genet 27: 18-20, 2001
X-linked neonatal diabetes mellitus, 
enteropathy and endocrinopathy 
syndrom
FOXP3
was phenotypically similar to Hermansky Pudlak disease in humans. Mutations were 
subsequently identiﬁed in a human gene homologous to light ear in several individuals 
from a cohort of Hermansky Pudlak patients. Each of these studies testiﬁes to the 
remarkable conservation of phenotypes between humans and mice for mutations in the 
same gene.
The choice of a candidate gene utilising an animal model does not mean complete overlap 
of phenotypes or function. The difference between species takes its toll. In some cases a 
difference in phenotype seen between the animal model and the human phenotype can be 
explained by the severity of the mutation. This was suggested by Ibanez-Tallon22. These 
authors observed disturbed left-right asymmetry (situs inversus) as well as hydrocephalus 
in MdnaH5 knockout mice, while only situs inversus had been observed in humans with 
mutations of the same gene. Similarly, the difference in severity between the severe 
phenotype of the perlecan knockout mouse and lethal Silverman Handmaker dysplasia on 
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the one hand and the much milder human Schwartz Jampel syndrome indicate a genotype-
phenotype correlation according to the severity, type or localisation of the mutations18,23. 
It has been our experience as well as that of others that non-overlapping phenotypes 
may occur with the same gene through mutations that have different functional effects. 
A striking example is provided by the brachydactyly type B phenotype that is seen with 
gain of function mutations of ROR2 as opposed to the recessive Robinow syndrome that 
results from homozygous loss of ROR2 function (see Chapter 3, Appendix 3 and24,25. 
Similarly, phenotypes induced by mutations in Indian hedgehog (IHH) where heterozygous 
missense mutations induce brachydactyly type A1 and homozygous mutations lead to 
acrocapitofemoral dysplasia26,27.
 The other studies in table 1 employed a positional candidate gene approach. The 
functional annotation of the genes in the critical interval allowed a much more efﬁcient 
identiﬁcation of the causative genes28-33. Several authors used the human genome draft 
information as part of their candidate gene approach searching for causative genes21,30,34. 
To be completely successful the candidate gene approach needs:
1) A complete inventory of all the genes in the human genome. 
2) Good and reliable gene expression data, especially in mammals. 
3) A good inventory of all human mutations and their phenotypic consequence
4) A comprehensive overview of biological and metabolic pathways.
5) Integration of all the above data
These requirements are discussed in more detail below.
1) A complete inventory of all the genes in the human genome. 
 This has not been accomplished yet. The public data (Santa Cruz freeze April 
2003 at UCSC, http://genome.cse.ucsc.edu/) show that about 99 percent of the human 
genome’s gene-containing regions have been sequenced to an accuracy of 99.99%. Yet, 
there are missing portions, essentially contained in DNA regions with unusual structures 
that can not be reliably sequenced using current technology. Moreover the sequence is 
still not fully annotated. New genes are still being discovered in this sequence using 
more reﬁned gene prediction software35. Also, comparison between human and mouse 
genomes, demonstrates that many RNA-encoding genes still need to be discovered36. 
The role of non-translated RNAs in human congenital malformations remains largely to 
be deﬁned. Mutations in a non-translated gene have been found to underlie cartilage hair 
hypoplasia37.
 The mouse genome, has been sequenced almost completely (≈ 96%-100% [Santa Cruz 
freeze at UCSC, http://genome.cse.ucsc.edu/ and Nature 5/12/2002]) but the annotation is 
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still largely incomplete. Estimates by the mouse sequencing consortium indicate that 99% 
of the mouse genes have a sequence match in the human genome and that the 96% of these 
genes are located within syntenic regions of mouse and human chromosomes38. In-silico 
comparison of the human and mouse sequences has already allowed the identiﬁcation 
of more than 6000 potential novel genes39. Even in relatively well-studied regions of 
the genome new genes were uncovered40. In spite of this overwhelming tendency to 
homology, a few examples have been identiﬁed of genes that have emerged in the primate 
lineage of evolution only, and therefore are not present in the mouse genome, such as two 
novel genes involved in Down syndrome (DSCR9 and DSCR10)41 or the RHD gene42.  
2) Good and reliable gene expression data, especially in mammals. 
 For mice, the most complete source is the emap database (http://genex.hgu.mrc.
ac.uk/intro.html) that contains a 3D mouse development atlas integrated with expression 
information. Unfortunately the database of graphical gene-expression data is not 
completely updated and most information is limited in the time window between Theiler 
stages 14 and 15 (9-9.5 dpc). Therefore, at the present stage, it is a beautiful but extremely 
limited tool for a gene search. In the future it will be possible to use it to ﬁnd genes 
that have user-deﬁned expression patterns and the complete integration with databases as 
GXD will make it a very powerful tool for gene function studies43.
 The Human Gene Expression Index (HuGeIndex - http://www.hugeindex.org) is 
a database that contains expression information of genes in about 20 different normal 
human adult tissues. It is possible to search within these tissues for the expression of a 
speciﬁc gene, or to ﬁnd groups of genes that show similar expression patterns, or generate 
scatterplots to compare two different expression patterns. Either pattern may be the pattern 
from a single experiment or the average pattern from all experiments done with a given 
tissue. Naturally the search can be performed only within the tissues and with the genes 
present in the HuGeIndex database. This database is still in its early stages, and therefore 
is currently of little use in a gene hunt.  
 GeneCards (http://bioinformatics.weizmann.ac.il/cards/) is an integrated database 
containing human genes and proteins information. It is biomedically oriented and contains 
some expression information. GeneCards can be a useful starting point, since it contains 
a fair amount of information, plus links to all major databases. About the gene speciﬁc 
information contained in each “gene card” it must be remembered that the content is 
selectively extracted by other databases and that such selection is subjectively done by 
the curator. 
 There are also a number of tissue speciﬁc databases, such as the Tooth Gene 
Expression Database - http://bite-it.helsinki.ﬁ/ or the Craniofacial and Oral Gene 
Expression Network, COGENE-http://hg.wustl.edu/COGENE/index.html that contain 
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information on expression changes that occur during early stages of development with 
particular emphasis on craniofacial development. Databases are available that provide 
gene expression information in cancerous and selected non-cancerous human tissues 
(SAGE Genie - http://cgap.nci.nih.gov/SAGE). Databases of this kind can provide also 
some useful information in selecting a candidate gene. For example: a speciﬁc expression 
of a particular cDNA in a determined region at a certain developmental stage. However it 
must be taken in to account also that most of these have limited information and are not 
continuously updated.
 There are also databases that contain gene expression information in different species 
and allow searches according to expression proﬁles. For example Bodymap - http://
bodymap.ims.u-tokyo.ac.jp/, a human and mouse gene expression database using ESTs. 
Handling this expression database requires considerable expertise. Again the number of 
tissues is limited. For searching candidate genes, most of the time general expression 
information (e.g. expressed in mouse developing chondrocytes) cannot be processed. 
Several brain regions are included.
3) A good inventory of all human mutations and their phenotypic consequence. 
 This type of information is already partially available through databases such as OMIM 
(http://www.ncbi.nlm.nih.gov/omim/) and the Human Gene Mutation Database (HGMD- 
http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html). Moreover attempts to relate mutations 
to speciﬁc phenotypes via animal models are presented in the Dysmorphic Human-Mouse 
Homology Database (DHMHD - http://www.hgmp.mrc.ac.uk/DHMHD/dysmorph.html) 
and the Drosophila Related Expressed Sequences Homepage (DRES - http://www.tigem.
it/LOCAL/drosophila/dros.html), although the latter has not been recently updated.
A database containing a complete set of phenotypes for perturbation of each gene could 
be extremely useful in a candidate gene approach search. Unfortunately this is not to be 
expected in the near future. Furthermore, its fulﬁlment will be challenged by the fact 
that one gene can have multiple phenotypes depending on the type and location of the 
mutation (see chapter TP63 and ROR2). A more realistic alternative can be the phenotypic 
classiﬁcation of mutagenized mice. This information can be found in the ENU-Mouse 
Mutagenesis Screen Project - http://www.gsf.de/ieg/groups/enu-mouse.html and in 
TBASE - http://tbase.jax.org/.  
 Although the ENU approach has already generated large numbers of mouse models 
for human diseases, covering disorders from deafness to development, the ENU-mouse 
resource contains only a few thousand mutants (against more than 10000 established 
genes or phenotype loci in humans [OMIM 06/2003]). Therefore such approach at best 
provides functional information on only 10% of the human and mouse genomes. Moreover 
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not much has been done on the study of multiple allelic variants for every single locus44.
 However, it is possible to selectively breed mice with a mutation from these ENU 
mutagenesis programs. As well as from the new ENU-mutagenesis complementary 
approach devised to generate germline chimaeric mice from embryonic stem (ES) cells 
mutagenized with ethylmethanesulphonate (EMS)45,46. These methods allow for the 
generation of a mouse mutant for any selected gene. 
 TBASE is a database of transgenes and knockouts in mice. One may encounter two 
types of difﬁculties in using it. The ﬁrst one is due to a nomenclature inconsistency 
between this database and major human genes databases as OMIM and GDB. The second 
one is due to the limited amount of information contained in this database47.
4) A comprehensive overview of biological and metabolic pathways.
 The Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.
genome.ad.jp/kegg/) provides an integrated computerized effort to sum the current 
knowledge in cellular and molecular biology to reconstruct the biological and metabolic 
pathways. Also commercial companies have proteomic pathways projects and several 
detailed pathways can be found at their websites (e.g. biocarta – www.biocarta.com). 
 Metabolite speciﬁc databases may contain information on mutations and associated 
phenotypes (e.g. Globin gene server - http://globin.cse.psu.edu/globin/html/). 
 Metabolism is still best studied in yeast. The knowledge obtained from this simple 
eukaryote may be exploited to elucidate molecular pathways involved in a group of related 
or similar disorders. This strategy has been successfully applied for the identiﬁcation of 
the POMT1 gene in WWS1 and the elucidation of a number of gene defects in congenital 
disorders of the glycosylation (CDGs)48.
 Mutations in different genes in a single pathway can cause a range of related 
phenotypes, or may underlie the genetic heterogeneity seen in many syndromes. For 
example, the congenital muscular dystrophy syndromes as MEBD, Fukuyama and Walker 
Warburg syndrome are caused by mutations in genes that encode members of the same 
glycosylation pathway (see ref. 1 and Table 5.2). 
 Other examples include the Marshal and Stickler syndromes involving components 
of type XI and Type II collagen49-51 and the hypohidrotic ectodermal dysplasias involving 
the same TNF-related signalling pathway. 
5) Integration of all the above data
 Already today the amount of information available is so large that retrieving 
speciﬁc information can be time-consuming. Moreover the unordered accumulation of 
massive amounts of information may hide possible gaps and lead to misunderstanding 
and misinterpretation. In addition, comparing and integrating data dispersed in several 
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different databases can be a tremendous task due to the differences in annotation and 
available options to perform searches. On the other hand, such a comparison of data from 
Table 5.2 Comparison of CMD syndromes. Different mutations in the same metabolic 
pathway give rise to different phenotypes.
WAWAS MEBD Fukuyama
Brain
Cobblestone lissencephaly +++ +++ +++
Pachygyria ++ Frontal ++
Polymicrogyria + Posterior ++
White matter abnormalities +++ Mild and patchy Improving with age
Occipital cele ++ ± 0
Muscle
Congenital muscular 
dystrophy
+++ +++ +++
Calf pseudohypertrophy 0 0 +
Merosin reduced 0 Unknown ++
Eye
Eye abnormalities +++ +++ ±
Retinal dysplasia ++ 0 0
Optic nerve pallor +++ ++ ±
microphtalmia ++ 0 0
Others
Ventricular dilatation +++ ++ Mild
Macrocephaly ++ + 0
Microcephaly ± ± ++
Defect O-mannosylation O-mannosylation Glycosylation
different sources may be essential for a candidate gene search. Bioinformatics tools that 
can integrate information from several web databases through uniﬁed search techniques 
can be extremely useful for a successful candidate gene search. At our university, 
through a collaboration with the Centre for Molecular and Biomolecular Informatics 
(CMBI - http://www.cmbi.nl/), such a tool has been developed, the “GeneSeeker” (http://
www.cmbi.kun.nl/GeeneSeeker/). In the current version the “GeneSeeker” collects 
and integrates, automatically, from 9 different web-based database positional data and 
expression/phenotypic data47.
 Other similar attempts are:
a) A data-mining system based on score relationship between terms, combining Medline 
and genome draft data searches52. This approach combined the information from 
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MEDLINE and a protein sequence database to derive relationships between pathological 
conditions and terms describing protein function. Next, for each of the 455 diseases with 
chromosomal mapping information, protein-function terms were associated by combining 
the medical terms found in the literature regarding the disease with the set of previously 
computed relationships. 
 To test the performance of this system, the authors analyzed 100 genes for which 
disease-causing mutations had already been reported. The disease-related gene was 
identiﬁed in 55 cases (being on average among the best-scoring 3% of genes). 
b) Pubgene
Jenssen and colleagues53 carried out automated extraction of explicit and implicit 
biomedical knowledge from publicly available gene and text databases to create a gene-
to-gene co-citation network for 13,712 named human genes by automated analysis of 
titles and abstracts in over 10 million MEDLINE records. The associations between 
genes were then annotated by linking genes to terms from the medical subject heading 
(MeSH) index and terms from the gene ontology (GO) database. The extracted database 
and accompanying web tools for gene-expression analysis were collectively named 
‘PubGene’. 
 The authors validated the extracted networks by three large-scale experiments showing 
that co-occurrences reﬂected biologically meaningful relationships, thus providing an 
approach to extract and structure known biology. The applicability of the tools was further 
validated by analyzing two publicly available microarray data sets.
 There is a public, limited, version of Pubgene and a more complete version for 
subscribers. See http://www.pubgene.uio.no/cgi-bin/hs/index.cgi.
In conclusion, the in silico candidate gene approach has given positive results in some 
instances and failed to identify candidate genes in others. Not surprisingly, the failures 
are mainly due to incomplete information in the databases at the time of the research. 
Undoubtedly the in silico candidate gene approach will become more and more important 
for disease gene discovery. In fact the potential of a candidate gene approach is very large 
and, we would advocate this approach as an optimal starting point for the search of a gene 
causing multiple congenital abnormalities. This is especially true when it is possible to 
integrate the position-independent candidate strategy with positional information.  
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Summary
We report on a strategy for the identiﬁcation of candidate genes for multiple malformation 
syndromes using expression data available in public databases. The basis for this pilot 
study was the assumption that, for a multiple malformation syndrome, the expression 
pattern of the causative gene should at least cover the organs or tissues affected by the 
syndrome. Twenty malformation syndromes were selected from the OMIM and deﬁned by 
three to ﬁve main symptoms. These key symptoms were translated into anatomical terms 
that were used to query the Gene eXpression Database (GXD). The searches covered 65% 
of the database and yielded an average of 16 candidate genes per syndrome. Of these, 23% 
were ubiquitously expressed or housekeeping genes. Further database evaluation of these 
potential candidate genes was based on positional information and on information from 
mouse knockouts. In a ﬁrst experiment, the correct gene was identiﬁed as a candidate 
in four of seven syndromes for which the causative gene is already known. In addition, 
this strategy identiﬁed new candidate genes for disorders for which the genetic basis is 
unknown. We identiﬁed candidate genes for the Walker-Warburg, DOOR, C, scalp–ear–
nipple and oculocerebral hypopigmentation syndromes. Our results suggest that it may 
ultimately be feasible to identify disease genes by probing gene expression databases 
with simple syndrome descriptions. 
Introduction 
Four main strategies for identifying human disease genes are often distinguished, namely 
functional cloning, positional cloning, positional candidate, and position- independent 
candidate strategies. In functional cloning, information about the presumed cellular 
function is used to identify the unknown disease gene. The gene product is already 
known and the gene coding for it can quickly be identiﬁed. This approach has been useful 
for those diseases in which well-known metabolic pathways or structural proteins are 
affected, such as phenylketonuria, alkaptonuria and haemophilia.1–3 
 In positional cloning, the gene is isolated on the basis of its chromosomal localisation, 
without prior information about its function. To achieve this, ﬁrst the localisation of the 
disease gene must become known. This is done by means of linkage analysis using extended 
families. Next, genetic and physical maps of the chromosome area are constructed and 
potential genes in the region identiﬁed. Finding a disease-associated mutation is required 
to prove which of the genes in the region is the disease gene. Positional cloning is gradually 
being superseded by the positional candidate approach. Thanks to the increasing volume 
of gene sequences, either partial or  complete, deposited in public databases, candidate 
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genes can often be found by database searches, targeting the area where a disease gene 
has been localised. In this way, the efforts involved in cloning and analysing large pieces 
of chromosomal DNA can often be avoided. When a disease gene is mapped to a speciﬁc 
chromosomal segment, additional criteria are useful to prioritise the different positional 
candidates. Among these criteria is the expression pattern of the positional candidate 
genes.4 A different approach from the positional cloning and positional candidate 
strategies is that of the position-independent candidate. For example, genes that are 
expressed in a single tissue can be considered as candidate genes for those inherited 
disorders in which only that tissue is affected. Examples are the collagen genes in the 
chondrodysplasias,5 retinaspeciﬁc genes in inherited blindness6 and cochleaspeciﬁc genes 
in deafness.7 Natural or induced mutations in model organisms such as the mouse or similar 
syndromes in humans for which the gene is already known8,9 may further suggest a gene 
for a particular disorder. Human multiple malformation syndromes are deﬁned by speciﬁc 
recurring patterns of abnormalities in tissues of different embryonic origin. In analogy to 
the candidate approach for single-tissue disorders, genes that have an expression pattern 
matching the syndromal pattern of abnormalities can be considered as candidates. To our 
knowledge, a generalised approach that compares gene expression data with syndrome-
speciﬁc patterns of organ or tissue involvement has not been attempted. Here we report 
on our experience with such a strategy for gene identiﬁcation based on matching gene-
expression patterns with syndrome- speciﬁc patterns of organ involvement. 
Methods
Syndrome Deﬁnition
In order to search databases for candidate genes, a syndrome must ﬁrst be translated 
into an expression pattern. To deﬁne those areas in which gene expression is critical for 
the development of the syndrome, its deﬁning features should be separated from rare or 
nonspeciﬁc signs. This is a central problem in syndromology for which many solutions 
have been proposed.10 These solutions, however, have not been incorporated into clinical 
syndromology practice nor in the available syndrome databases. Ideally, one would use 
a database that attaches weights to signs and symptoms based on their sensitivity and 
speciﬁcity relative to other syndromes. The London Dysmorphology Database11 (LDDB) 
does deﬁne a syndrome as a pattern, but does not distinguish essential from non-essential 
symptoms. The (P)OSSUM databases12,13 can allocate a weight to symptoms, but as this 
must be done by the user, this does not obviate the problem. We chose to circumvent this 
problem by asking two experienced clinical geneticists to deﬁne a set of 20 syndromes by 
three to ﬁve main symptoms. The symptoms were chosen from the listings in the LDDB, 
Appendix 1 - Probing the gene expression database for candidate genes
135
as this is the most comprehensive database to date. A third clinical geneticist decided 
where the ﬁrst two disagreed on a particular core symptom. 
Deﬁnition of Search Terms 
To search gene expression databases, the phenotypic abnormalities of the syndrome must 
be translated into search terms. At the time this work was undertaken, the expression 
databases that were available (such as the Genome Database (GDB) and the Gene 
eXpression Database (GXD)) were based entirely on literature abstracts. Therefore we 
deﬁned the most commonly used developmental terms in the literature and used these 
in our searches. It should be noted that the newer GXD versions do have standardised 
expression terms. 
 To deﬁne the most commonly used terms, the 1997 issues of three major developmental 
biology journals (Genes and Development, Mechanisms of Development, Development) 
were examined for possible search terms. Both abstracts and the body of text of 
approximately 540 papers were evaluated. This resulted in a list of 1775 terms. Several 
of these were synonymous terms (for example, genito-urinary and urogenital). The 1775 
terms were checked for occurrence in 3000 MedLine abstracts which had been selected 
using ‘embryo’ and ‘development’ as keywords. A simple shell script was written to count 
the terms and run on a PC running RedHat Linux 5.0–5.2, kernel versions 2.0.34–2.0.36. 
Terms that occurred at a frequency greater than 15 per 1000 articles were selected for 
use as search terms. A total of 153 terms was thus selected, less than 1% of the original 
list. These terms were arranged in a hierarchical look-up table which closely follows the 
branching structure of the LDDB feature list. Most of the headings of the LDDB feature 
list are matched by at least one term in the thesaurus. The search terms are grouped under 
organ systems headings as syndrome features in the LDDB. Syndrome features selected 
by the expert panel could thus be translated into developmental search terms by selecting 
the appropriate organ system heading and choosing the terms describing the affected 
tissue. 
Selection of a Suitable Database 
The starting point for the candidate gene selection procedure described here is the 
hypothesis that the gene which causes a multiple congenital malformation syndrome is 
expressed in the tissues affected in that particular syndrome. To ﬁnd candidate genes 
based on this assumption, a database must contain searchable expression information for 
human genes. No such databases are at present available. We therefore used mouse data 
as a second-best approach. There are many databases available on the mouse as a model 
organism,14 but only the Gene eXpression Database (GXD), maintained by the Jackson 
Laboratories (www.informatics.jax.org), contains systematically ordered expression data 
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that can be searched using anatomical or functional terms. This database was selected to 
examine the feasibility of candidate identiﬁcation based on expression patterns. 
Candidate Gene Selection 
To ﬁnd candidate genes for a speciﬁc syndrome, between two and four search terms 
were used to query the Gene eXpression Database. Compound searches, wildcarding 
and the use of regular expressions (a pattern that is matched against a string) are not 
allowed in this database. Each new search term requires a new query. The result of a 
query is a list of hyperlinked genes and their associated literature references, encoded 
in HTML (HyperText Markup Language). The genes in the listings are expressed in the 
tissue described by the search term. Candidate genes for the syndrome are those that are 
expressed in all tissues affected in the syndrome, ie are present in all listings. A shell-script 
was written to compare the downloaded ﬁles and select those genes that were present in 
each of the listings downloaded for that syndrome.15
The Pilot Study
 In order to evaluate the strategy outlined above, a pilot study was conducted. Twenty 
malformation syndromes were selected from the OMIM (Online Mendelian Inheritance 
in Man) database16 by querying it with ‘syndrome’ and picking OMIM numbers from 
the list at random. Syndromes for which the gene is already known, chromosome 
abnormalities and metabolic diseases were excluded. Syndromes were selected if the 
component abnormalities involved two or more anatomically distinct organ systems. The 
selected syndrome features were translated into search terms by use of the look-up table. 
A potential problem is that genes may be indexed under synonymous terms. Using only 
one term from the list of possible synonyms would give rise to many potential candidate 
genes being missed. To evaluate the magnitude of this problem, searches were made 
either using ‘blanket terms’, ie terms describing the organ system in the broadest sense, 
or by a list of synonyms, for example, ‘limb’ vs ‘hand + digit + ulna + radius’. Separate 
sets were compiled either of ‘blanket terms’ or of sets of synonyms. These terms were 
then entered in the GXD. The resulting HTML-encoded listings were downloaded and 
saved for later evaluation. Candidate gene listings were prepared by using the shell script 
that identiﬁes genes which arise in all searches. In order to evaluate the potential for this 
approach to uncover disease genes, a set of seven syndromes for which the molecular 
basis is already known was also examined.
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Results 
Characteristics of the Search Terms 
The 29 blanket search terms (Table 1) used to describe the total of 20 syndromes in the 
initial pilot study together recovered 1596 (65%) of 2467 genes in the GXD (number as 
determined on 15 June 1998). One third of the database, 886 genes, was not accessed by 
this set of terms. This could be due to our limited selection of terms, but other causes such 
as missing expression data also seem possible. 
Table 1 Syndromes selected at random from OMIM and their description in expression 
patterns.
Syndrome (No. of genes returned) MIM number Translation/search terms 
 C-syndrome (20) 211750 Cranium, digit, brain 
 Cerebro-costo-mandibular syndrome (13) 117650 Rib, palate 
 FG syndrome (3) 305450 Cranium, ear, brain, hindgut 
 Wolcott-Rallison syndrome (1) 226980 Vertebra, limb, pancreas 
 Weill-Marchesani syndrome (8) 277600 Eye, tooth, digit 
 Branchio-oculo-facial syndrome (15) 113620 Branchial, eye, skeleton 
 Cerebro-oculo-facial-skeletal syndrome (5) 214150 Brain, skull, eye, digit 
 Costello syndrome (61) 218040 Heart, brain, skin 
 Oculocerebral-hypopigmentation syndrome (12) 257800 Brain, eye, pigment 
 DOOR syndrome (5) 220500 Ear, kidney, digit 
 Johnson-McMillin neuro-ectodermal syndrome (32) 147770 Brain, skin, tooth 
 Walker-Warburg syndrome (56) 236670 Muscle, eye, brain 
 Megalocornea-mental retardation syndrome (18) 249310 Cornea, brain 
 Nance-Horan syndrome (50) 302350 Eye, tooth 
 OFD type 1 (1) 311200 Brain, palate, tongue, digit 
 OFD type 3 (1) 258850 Tongue, digit, brain 
 Opitz-Frias syndrome (7) 145410 (O)esophagusa, genital 
 Scalp–ear–nipple syndrome (4) 181270 Skin, ear, mammary 
 Senior-Loken syndrome (35) 266900 Retina, kidney 
 Varadi-Papp syndrome (4) 277170 Cerebellum, oral, digit 
aboth ‘oesophagus’ and ‘esophagus’ were used as search terms and the results concatenated since both terms 
return different sets of genes. 
 
 To clarify this, the abstracts of 40 genes not among those retrieved by the 29 blanket 
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terms were evaluated (genes listed in Table 2).
Table 2 Properties of genes not found using 29 blanket search terms
Gene Abstract Gene Abstract 
 Hp1a no terms Canp3 no abstract 
 Hsd17b4 terms in list Cd3e terms in list 
 Iap1 terms in list Cea10 terms in list 
 Lamp1 terms in list Cebpa-rsl no terms 
 Uty no terms Cmkbrll2 terms in list 
 Abl terms in list Dabl no terms 
 Ar terms in list Dmahp no terms 
 Cebpdl terms in list Epsl5-rs no terms 
 Fgdl no terms Err2 about other gene 
 Lbxl terms in list Gnal2 no terms 
 Mif terms in list Gnao terms in list 
 Rnu6 no terms Gnaz terms in list 
 Clk4 no terms H2-Tl7 no terms 
 Rab6kiﬂ no terms Has3 no terms 
 Tbxl4 none Hbb-y about other gene 
 Scal terms in list Il3rb2 terms in list 
 Etv6 terms in list Mage-rsl no terms 
 Etv5 no terms Semak removed from db 
 Fgfr3-ps no terms Tcra-C terms in list 
 Finl3 no terms Zfx terms in list 
‘Terms in list’: terms found in abstracts can also be found in extended list of 153 search terms.
  
 It turned out that 18 out of 40 genes either had no abstract or an abstract without 
anatomical search terms. Of another 18 genes, the abstracts contained terms which are 
not among the 29 terms selected in the initial study, but are in the main list of 153 terms. 
Of the remaining four genes, one had a term not present in either list and one entry had 
been removed from the database.  A small number (two out of 40) genes was associated 
with abstracts which described a different gene from the one indexed. Assuming that our 
sample of 40 genes analysed is representative of the 886 genes that were not retrieved, the 
following calculations can be made. Of all the genes currently in the GXD database, some 
65% are accessible by a set of 29 simple blanket-type search terms and this increases 
to 81% if an extensive list of 153 (including several synonymous terms) is used. Of the 
remaining 19%, 17% are not accessible by anatomical search terms. Approximately 2% 
of the searches will retrieve false positives, that is genes which are not expressed in the 
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tissue being queried. Based on these results, the core set of 29 terms was used in a pilot 
study to evaluate further the feasibility of the candidate gene selection procedure. 
Database Search by Syndrome 
Patterns In order to test the feasibility of using expression patterns for the selection of 
candidate genes, we ﬁrst examined seven syndromes for which the causative gene is 
known. In four of these, the disease gene was identiﬁed as one of 19 to 45 candidate genes 
(Table 3). 
Table 3 Result of search with syndromes of known genesis
Disorder/MIM number Search terms Causative gene identiﬁed? Selectivity 
 
Tricho-Dento-Osseous 
Ectoderm Skeleton Tooth yes; DLX3 1/19 
 
Ulnar Mammary 
Limb Mammary yes; TBX3 1/22 
 
Townes-Brocks 
Limb Ear no; HASL1 NA 
 
Holt-Oram 
Limb Heart no; TBX5 NA 
 
Hand–Foot–genital 
Limb Genital yes; HOXA13 1/45 
 
Renal-Coloboma 
Renal Eye yes; PAX2 1/22 
 
Alagille 
Liver Eye Heart no; Jag2 NA 
NA = no applicable.
 In the other three cases, the gene was not found by using the selected combination 
of search terms. The TBX5 gene for Holt-Oram syndrome was retrieved by using ‘limb’ 
as a search term, but not by ‘heart’. Alternative search terms were used. Queries using 
‘cardiac’, ‘ventricle’ and ‘atrium’ were raised, all with negative results. Similarly, the 
Jag2 gene was not identiﬁed for Alagille syndrome, since only the ‘heart’ query was 
positive, but not ‘eye’ or ‘liver’. The gene for Townes-Brocks syndrome (HSAL1 or 
SSAL) did not feature at all in the GXD, presumably because the mouse homologue has 
not been identiﬁed. Thus, our analysis of seven multiple congenital anomaly syndromes 
identiﬁed the causative gene in the majority, but also showed up some of the weaknesses 
of this system using current databases such as GXD. We examined a larger series of 
syndromes for which the genes were not yet known in order to gain a better view of 
whether candidate gene lists are speciﬁc for each syndrome description, and whether 
candidates on these lists are in fact biologically plausible, ie real candidates. Since only 29 
terms from the list were used to describe 20 syndromes, the possibility of overlap between 
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syndrome descriptions exists, perhaps causing different syndromes to be described by 
an identical set of terms. As can be seen in Table 1, this was not the case in the pilot. 
Thus, a relatively limited number of terms still conferred a unique syndrome ‘pattern’ in 
this pilot experiment. The syndrome signatures were used to query the Gene eXpression 
Database. The gene listings resulting from each query were downloaded and combined 
to generate a list of candidate genes speciﬁc to each syndrome. As expected, different 
numbers of terms yielded different numbers of candidate genes. For four syndromes, two 
terms were used to deﬁne the characteristic pattern of organ involvement. These searches 
yielded on average 25 genes per syndrome. For twelve syndromes, three terms were used. 
The average yield of these searches was 16 genes per syndrome. Four syndromes were 
described with four terms each. The yield in these searches was four genes per syndrome. 
Based on these results the pilot was continued with the 12 syndromes that were described 
using a combination of three blanket terms. A total of 20 different terms was used to 
describe these 12 syndromes. The total number of candidate genes retrieved from the 
GXD for the 12 syndromes combined was 115. This is 7.4% of the total number of 1552 
genes that could have been retrieved by the 20 search terms separately. The number of 
genes picked up by the searches varied from one (OFD type 3; terms ‘tongue’, ‘digit’, 
‘brain’) to 61 (Costello syndrome; terms ‘heart’, ‘brain’, ‘skin’). For the 115 genes that 
were retrieved for the 12 syndromes, 57 genes (49.6%) were picked up only once and 
58 genes (50.4%) between two and eight times. An example of a syndrome query is 
given in Table 4. Here 56 genes were retrieved for the Walker-Warburg syndrome (WWS) 
and evaluated for their potential as candidate genes. Gene function was assessed using 
the Mouse Genome Database.17 Mouse knockout models were searched in TBase.18 The 
search terms used in individual searches were ‘muscle’, ‘eye’ and ‘brain’. As shown in 
Table 3, 15 genes were not considered further as syndrome-speciﬁc candidate genes on 
the basis of their known role as housekeepers or their ubiquitous expression. Another 20 
genes are associated with human or mouse phenotypes which do not resemble WWS. 
Therefore the likelihood of these genes causing WWS is reduced. Among these were 10 
mouse knockout models, illustrating the value of knockouts for the evaluation of candidate 
genes. This proportion can be expected to increase in future, as more developmentally 
important genes are targeted in the mouse. Another 11 genes were not likely candidates 
because their products are known to function in single biochemical pathways that are 
not likely to explain the syndromic pattern of organ involvement. For example, Isl1 is 
a LIM-homeodomain gene required for the development of pancreatic islet cells and 
motor neurons.19 The ﬁrst analysis left 10 genes which merit further evaluation. Of these, 
eight are associated with human or mouse phenotypes featuring brain, eye and/or muscle 
abnormalities. The combination of data on expression patterns and function suggested 
that the remaining two genes may be candidates for the disorder (Table 3). 
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Table 4 Evaluation of WWS candidate genes
Strong candidates
Similar mouse / human phenotypes
 Hnf3beta –/– mouse has head and brain abnormalities
 Lama2 dystrophia muscularis mouse mutant
 Ncam –/– mouse has mild brain phenotype/lethal
 Otx2 –/– mouse has no rostral structures, +/– NTD
 Pax3 Human:WS1, –/– mouse has exencephaly
 Pax7 –/– mouse has head and brain abnormalities
 Pdgfra Patch mouse, may have NTD
Shh
Human: HPE, –/– mouse has severe defects of brain, limb, 
midline structures, foregut
Six3 Human: HPE, –/– mouse has eye/brain phenotype40
Expression and/or function
 Cdh4 expression in retina, brain, muscle; cell adhesion
Utrn part of dystrophin complex, expressed in neural progenitors
Less likely candidates
Dissimilar human/mouse phenotype
Bmp2 –/– mouse post-implantation lethal
Bmpr –/– mouse lacks mesoderm
Cd44 –/– mouse has immune disturbance
 Cdh2 –/– mouse has inﬂammatory bowel disease
 Col10a1 Human: Schmidt metaphyseal dysplasia
 Col2a1 Human: SED type skeletal dysplasias
 Col1a1 Human: osteogenesis imperfecta
Dlx1 –/– mouse has abnormal 1st/2nd branchial arch
Dmd Human: m. Duchenne
Egfr waved-2 mouse mutant
Fgf4 –/– mouse failure of embryogenesis
Flk1 –/– mouse failure of vascular development
Gja1 Human: Implicated in situs inversus
Lamb1-1 neonatal cutis laxa mouse mutant
Msx-1 Human: missing molars
Nﬂ –/– mouse has ALS-like phenotype
Pax1 undulated mouse mutant
Tgfb1 –/– mouse has severe inﬂammatory disease
Tnc  –/– mouse is normal
Vim  –/– mouse is normal
                      (continued on next page)
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Table 4 Evaluation of WWS candidate genes (continued)
Less likely candidates
Known housekeepers/ubiquitously expressed
Actb actin beta, cystoskeletal element
Crya2 lens protein
Ccnd2 cyclin D2
Cdkn1c p57 tumor suppressor
Dag1 part of Ca2+ signalling pathways
Ecm2 extracellular matrix protein
Pkca protein kinase c, ‘a’ subunit
Pkcb Protein kinase c, ‘b’ subunit
Slc2a1 glucose transporter
Slc2a2 idem
Slc2a4 idem
Sparc extraembryonic matrix glycoprotein
Tubb component of microtubules
Tubb3 idem
Vwf Von Willebrand factor
Functional data negative/equivocal
Cdh1 required for compaction of embryos
Col16a1 connective tissue component
Col19a1 connective tissue component
Gfap glial cytoskeleton
Isl1 LIM homeodomain protein
Lama1 mainly expressed in genitals
Lamb1-2 pseudogene
Nfm neuroﬁlament medium chain
Sim2 may be involved in Down’s syndrome
Syp component of synaptic vesicles
NTD: neural tube defect; HPE: holoprosencephaly; WS1: Waardenburg syndrome type 1; SED: 
spondyloepiphyseal dysplasia;ALS: amyotrophic lateral sclerosis.
To prioritise  between these 11 candidate genes, positional information was sought. 
Recently, the muscle–eye–brain disease (MEBD) gene was mapped to human chromosome 
1p32.20 Whether MEBD is allelic to WWS is not known, but the syndromes have a 
similar pattern of organ involvement. No positional candidate genes could be identiﬁed 
in this region, so it was of interest to check whether any of the candidate genes identiﬁed 
above maps near this region or is in a syntenic mouse chromosomal region. None of 
the genes in our list has been localised to the 1p32 region in humans. However, Cdh4, 
which has not yet been mapped in humans, may be in the relevant area, as it is in a 
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region on mouse chromosome 2 which shows synteny with human 1p32–33 and therefore 
is an interesting candidate. Cdh4 belongs to the cadherin family of cellular adhesion 
molecules. It is expressed in muscle, retina and brain; inhibition of cadherin action in the 
brain leads to neuronal migration defects.21,22 In view of its expression pattern, Cdh4 is an 
attractive candidate gene for this disorder. Thus, the search for Walker-Warburg syndrome 
uncovered 11 candidate genes, one of which is also a positional candidate for MEBD. 
Similar results were obtained for the other 11 syndromes in this limited pilot experiment. 
On average, 23% of the genes were ubiquitously expressed or housekeeping genes. Of the 
remainder, six genes (or their associated pathways) were considered potential candidates 
for one of the syndromes in the pilot study, namely Bmp4, Fgf4, Dct, Mitf, Pdgfra and 
Lef-1. For these genes, mouse mutants either occur naturally or have been generated, 
which facilitates their evaluation (Table 5). 
Table 5 Potential candidate genes found for some of the syndromes described by three 
terms
Syndrome Candidate genes Arguments for gene 
C-syndrome 
terms: cranium, digit, brain 
Fgf4 Overexpression in mouse gives cranial 
and limb abnormalities 
Oculocerebral hypopigmentation syndrome 
terms: brain, eye, pigment  
  
Dct Slaty mouse has similar pigment 
disturbances; Dct expressed in brain. 
Involved in pigmentation and eye 
development,
 Mtf Waardenburg syndrome type II in 
humans. 
Pdgfra Patched mouse has CNS and pigment 
anomalies 
DOOR syndrome 
terms: ear, kidney, digit 
Bmp4  –/+ mouse has polydactyly, cystic 
kidneys and inner ear defects 
Scalp–ear–nipple syndrome 
terms: skin, ear, mammary 
Lef1  –/– mouse lacks mammary tissue, hair 
and teeth 
These are discussed below. A search for DOOR syndrome using ‘ear’, ‘kidney’ and 
‘digit’ asterms uncovered ﬁve candidate genes, of which BMP4 may be especially 
convincing. The heterozygous Bmp4 knockout mouse has pre-axial polydactyly, cystic 
kidney malformations and in a number of cases shows circling behaviour consistent with 
an inner ear defect. Shortening of the nasal and frontal bones, giving the appearance 
of a boxer’s nose, were also noted.23 DOOR syndrome is a disorder characterised by 
onychodystrophy, triphalangeal thumbs, mental retardation, seizures and sensorineural 
deafness. Cystic malformations of kidneys and urinary tract have also been described.24 
The face is characterised by a short, broad nose. There is no mention of dystrophic claws 
or seizures in the knockout mice, but the mouse phenotype seems to resemble the human 
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DOOR phenotype sufﬁciently to warrant consideration of Bmp4 as a serious candidate 
gene for this disorder. One search also resulted in Fgf4 as a candidate gene for C syndrome 
(trigonocephaly and polydactyly). An insertional mutation in the mouse upregulating the 
expression of Fgf3 and Fgf4 in the mouse causes craniofacial malformations.25 The mutant 
is called Bulgy eye (Bey). Bey mice are viable and fertile but show facial shortening 
with increased interorbital distance and craniosynostosis. According to Carlton et al, who 
described the mutant, the Bey mutation resembles Crouzon syndrome.25 Although two 
Fgfs are upregulated here, this study suggests that Fgf4 may be involved in the regulation 
of suture closure. Fgf4 is involved in limb patterning as well. In the Strong’s luxoid 
mouse mutant, ectopic expression of Fgf4 causes polydactyly.26 Fgf4 is normally secreted 
by the ZPA and is one of the regulators of antero-posterior polarity in the limb.27 These 
data suggest that either Fgf4 or a gene regulating its expression in the developing skull 
and limbs may be involved in C syndrome, which is characterised by trigonocephaly and 
polydactyly.28 For three other syndromes in the list, potential candidate genes were also 
obtained. Various mutations in dopachrome tautomerase, Dct, have been found in the Slaty 
mouse mutant, which has patchy to diffuse hypopigmentation.29 This phenotype models 
the pigmentation phenotype of oculocerebral hypopigmentation syndrome. Moreover, Dct 
is also expressed in the brain although its role in that organ is as yet unclear.29 Mutations in 
the Mitf gene cause microphthalmia in the mouse and are responsible in humans for about 
15% of Waardenburg syndrome type II cases.30 In the mouse, a number of Mitf alleles 
exist, all associating disturbances of pigmentation with various other abnormalities.31 This 
suggests that Mitf may be relevant for a number of different pigmentation phenotypes in 
humans. As such this gene is a candidate for oculocerebral hypopigmentation syndrome in 
which microphthalmia has been reported to occur.32 Pdgfra is mutated in the Patch mouse, 
that shows patchy depigmentation33 and, depending on its genetic background, other 
anomalies varying from cardiovascular malformations to neural tube defects.34 Although 
neural tube defects are not a feature of oculocerebral hypopigmentation syndrome, the 
mouse appears to be more prone to developing neural tube defects upon perturbation of 
developmental genes and it is conceivable that a similar mutation in humans could give 
rise to a more subtle neural tube phenotype. Finally, the search for the scalp–ear–nipple 
syndrome produced Lef-1 as a candidate. Scalp–ear– nipple syndrome is characterised by 
hairless nodules on the scalp, malformed external ears, hypo- to aplasia of nipples and 
breast tissue and widely spaced or missing secondary teeth.35 Lymphoid enhancer factor-1 
is an HMG-domain DNA-binding protein expressed in the neural crest, mesencephalon, 
tooth germs and other sites during embryogenesis.36 It is a component of the Wnt pathway, 
and probably modulates the actions of β-catenin.37 Homozygous deﬁciency of this gene 
causes postnatal lethality in mice. Mutant mice lack teeth, mammary glands, whiskers 
and hair. All anlagen of these tissues are reduced in number and are arrested in their 
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development. Although the phenotype is lethal in mice and nodules of the skin were not 
described, the lack of hair, missing teeth and aplasia of breast tissue suggest that Lef-1 
may be a candidate gene for scalp– ear–nipple syndrome.
Discussion 
If it is to be used for the purpose of generating positionindependent candidate genes, a 
gene expression database should ideally have the following features: 
•  include all human genes; 
 • be updated regularly;
• all genes in the database should be examined for expression in a large number of 
tissues, so that both presence and absence of expression are listed;
 • contain data in the form of gene expression patterns for deﬁned embryonal 
stages, deter-mined by comparable, standardised methods;
• the database should allow searching with uniform search terms for genes, 
tissues, and stages of development. 
 
It appears that the GXD at present fails to fulﬁl several of these requirements. 
 At the time our study was undertaken, the GXD contained less than 3% of the total 
number of genes expected to be present in the mouse. Often, only a few tissues have been 
examined for gene expression patterns, so there is no way of knowing whether the data 
presented accurately reﬂect the expression pattern of a gene. At the time of our study no 
standard terminology had been implemented in the GXD to describe expression patterns, 
which often necessitates multiple searches with synonyms for a single tissue. In addition, 
a limited number of errors are probably inevitable in the construction of this and similar 
large databases. On average, 2% of all query results will not be associated with veriﬁable 
expression data and hence constitute a false positive result. 
 Although it is possible to search for stage-speciﬁc gene expression patterns, stage 
grouping in the GXD database was not very precise. Embryonic stages are described 
as days post coitum (dpc) instead of embryonic Theiler stages. Since dpc sometimes 
cover several Theiler stages and embryonic tissues sometimes appear over the course 
of one Theiler stage, this is a source of potential error. Lastly, gene expression patterns 
listed in the GXD had been determined by a number of different methods. Comparing 
expression data for various candidate genes and assessing the reliability of these data is 
not yet optimal. It may be argued that there are examples of mutations in genes that are 
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ubiquitously expressed, but cause a very speciﬁc pattern of organ involvement. Examples 
are eye diseases such as RP3 and gyrate atrophy which are due to mutations in ubiquitously 
expressed genes. This does not in itself invalidate the approach outlined here. In fact, a 
general feature of all candidate gene strategies is that they represent educated guesses and 
hence should be regarded as hypothesis-generating rather than as problem-solving. 
 It is of interest to note that out of seven syndromes for which the gene is known, a 
search based on organ involvement returned a list of genes which included the real disease 
gene in four of seven cases (trichodentoosseous, hand–foot–genital, unlar–mammary, 
and renal-coloboma syndromes, Table 3). In addition, our limited pilot experiment of 
20 syndromes of unknown genesis yielded credible candidate genes for several of these 
(Table 5). Therefore, even though many problems still have to be solved, it would appear 
to be possible to use simple search terms that describe organs or anatomical regions, 
by which one can convert human malformation syndromes into a syndrome-speciﬁc 
developmental gene expression pattern. Using only 29 simple terms at present covers 
65% of the GXD and a manageable list of 153 terms covers 84%. Thus, the number of 
terms that is required to translate a syndrome to an expression pattern is not large. 
 As the number of genes in expression databases increases, so will the numbers retrieved 
in this type of search. Therefore, secondary criteria for the ranking of candidates will have 
to be developed. For this purpose, genetic localisation would be a useful possibility. Also, 
the number of genes retrieved will be smaller if more search terms, or speciﬁc periods for 
embryonic gene expression are used to deﬁne the syndromes. 
 In conclusion, our data suggest that it may ultimately be possible to probe gene 
expression databases for candidate genes for multiple congenital malformation syndromes 
using simple syndrome descriptions. The potential value of this is illustrated by recent 
data.38 For instance, the genes for Townes-Brocks syndrome (SAL1) was initially identiﬁed 
on the basis of positional information. Upon examination of the expression pattern of 
its mouse homolog (Msal1) it became clear that it matched the pattern of abnormalities 
observed in the syndrome. This established the SAL1 gene as an excellent candidate for 
Townes-Brocks syndrome, a hypothesis which was borne out by subsequent mutation 
analysis. It is also encouraging that in our analysis of seven syndromes due to known gene 
mutations, we could identify the gene for four of these using expression data as the only 
clues. If this method is to be used on a larger scale, the expression databases will need 
to meet as many of the requirements listed above as possible. Projects such as GENEX, 
an internet-accessible database that integrates mouse anatomy data with gene expression 
data,39 may ameliorate the situation in the near future. In the GENEX database, expression 
patterns are listed according to Theiler stages. The terms used to describe various tissues 
and organs were standardised from the beginning. As the authors of the database are 
also responsible for the expression studies, uniform methodology is assured. When this 
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and other similar databases for human developmental data are fully operational, most 
of the above requirements will be met. With the expected accumulation of genomics/ 
proteomics data, these and other databases can be used to identify position-independent 
candidate genes for human congenital malformation syndromes. Such candidate genes 
can be the starting point for further investigations. In most cases these will be in the form 
of targeted linkage analyses in small families. In cases where such family material is 
unavailable, direct mutation analysis may be the strategy of choice.
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Summary
EEC syndrome is an autosomal dominant disorder characterized by ectrodactyly, 
ectodermal dysplasia, and facial clefts. We have mapped the genetic defect in several 
EEC syndrome families to a region of chromosome 3q27 previously implicated in the 
EEC-like disorder, limb mammary syndrome (LMS). Analysis of the p63 gene, a homolog 
of p53 located in the critical LMS/EEC interval, revealed heterozygous mutations in 
nine unrelated EEC families. Eight mutations result in amino acid substitutions that are 
predicted to abolish the DNA binding capacity of p63. The ninth is a frameshift mutation 
that affects the p63, but not p63 and p63 isotypes. Transactivation studies with these 
mutant p63 isotypes provide a molecular explanation for the dominant character of p63 
mutations in EEC syndrome. 
Introduction
The central reduction defect of the hands and feet known as ectrodactyly, split hand/
split foot malformation (SHFM), or lobster-claw, occurs in approximately 1 in 18,000 
newborns (Czeizel et al., 1993; Evans et al., 1994). The etiology of this condition is 
unknown, but several genetic factors may be involved. Based on linkage studies and 
the analysis of chromosomal abnormalities, three loci have been identiﬁed in humans: 
SHFM1 on 7q21.3-q22.1 (Scherer et al., 1994; Crackower et al., 1996), SHFM2 on Xq26 
(Ahmad et al., 1987), and SHFM3 on 10q24-q25 (Nunes et al., 1995; Raas-Rothschild 
et al., 1996). In almost 40% of the cases, ectrodactyly is associated with other anomalies 
(Czeizel et al., 1993; Evans et al., 1994). A well-known example is the EEC syndrome, 
which comprises Ectrodactyly, Ectodermal dysplasia, and Cleft lip with or without cleft 
palate. EEC syndrome has an autosomal dominant mode of inheritance with highly 
variable expression and reduced penetrance. Ectodermal dysplasia in the EEC syndrome 
affects the skin, hair, nails, and teeth (Roelfsema and Cobben, 1996). Other symptoms 
are lacrimal duct abnormalities, urogenital problems, conductive hearing loss, facial 
dysmorphism, chronic/recurrent respiratory infections, and developmental delay (Gorlin 
et al., 1990). A locus for EEC syndrome on chromosome 19 was identiﬁed in a family 
from the Netherlands with EEC syndrome and urogenital defects (O’Quinn et al., 1998). 
We recently mapped the genetic defect in another large Dutch family with an EEC-like 
phenotype to chromosome 3q27 (van Bokhoven et al., 1999). The condition in this family 
could be distinguished clinically from EEC syndrome and was denoted Limb Mammary 
Syndrome (LMS).
 Here we report the construction of a physical map from a 3 cM region containing 
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the causative gene for LMS. Linkage analysis revealed that the genetic defect in several 
EEC syndrome families colocalizes with the LMS locus. This observation suggested that 
these disorders are allelic. YAC clones covering the EEC/LMS critical region were used 
to map ESTs and the positional candidate genes SOX2, DVL-3, LPP, Chordin, and p63. 
In addition to several ESTs, only p63 was found to exactly map within this region. The 
p63 gene (Osada et al., 1998; Senoo et al., 1998; Trink et al., 1998; Yang et al., 1998), 
a homolog of the archetypal tumor suppressor gene p53, is abundantly expressed in 
proliferating basal cells of epithelial layers in the epidermis (Yang et al., 1998). In keeping 
with this expression pattern are the phenotypes of the recently reported p63 knockout 
mice (Yang et al., 1999; Mills et al., 1999). P63-deﬁcient mice lack all squamous epithelia 
and their derivatives, including hair, whiskers, teeth, as well as the mammary, lacrimal, 
and salivary glands. Particularly striking are severe limb truncations with forelimbs 
showing a complete absence of the phalanges and carpals, and variable defects of ulnae 
and radiae and hindlimbs that are lacking altogether. Subsequent analysis of the p63 gene 
revealed heterozygous mutations in nine unrelated patients with EEC syndrome. The p63 
mutations act in a dominant fashion in humans, giving rise to a phenotype that resembles 
that of p63 knockout mice.
Results
Linkage Analysis in EEC Families
To investigate the possibility of allelism with LMS, polymorphic markers from the 3q27 
region were used for a linkage analysis in ﬁve families with EEC syndrome. Positive 
LOD scores were obtained with markers from within the LMS interval for each of these 
families (Table 1). The added Z
max 
across these families is 8.03 at marker D3S3530 at a 
recombination fraction θ = 0. Recombination events were observed between markers 
that deﬁne the LMS interval, D3S1580 and D3S1314, and the disease locus, indicating 
that these ﬁve EEC syndrome families map to the same 3 cM region of 3q27 that was 
previously found for the LMS family (van Bokhoven et al., 1999). This colocalization 
and the overlapping clinical features of these disorders strongly suggest that the same 
gene is involved in both EEC and LMS. If so, the critical region for EEC/LMS was 
reduced to a 2.3 cM interval by a recombination event between marker D3S3530 and the 
genetic defect in EEC family  Bri-1 (64:1 odds). 
Physical Mapping of the LMS Critical Region
By using the Whitehead STS-based map of the human genome, YAC clones were selected 
that each should contain several STSs from the region around D3S1580 and D3S1314. 
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The size and integrity of the YACs was determined by pulsed ﬁeld gel electrophoresis and 
Southern blots probed with total human DNA (data not shown). PCR was then performed 
to map STSs on the YACs. This approach allowed us to place the YACs into a contig 
covering the critical region for LMS/EEC syndrome (Figure 1). Five STSs within this 
region were derived from expressed sequences (ESTs): A004N18, WI-6145, WI-19957,
 
Table 1 Linkage analysis in families with EEC Syndrome   
Family Locus Z
max
 at θ = 0 Flanking Markers (Proximal–Distal) 
 LMS D3S3530 12.01 D3S1580–D3S1314 
 Ams-1 D3S3530 4.53 NDa–D3S1314 
 D19S49 4.06 D19S894–D19S416 
SLC-1  D3S3530 0.86 NDa 
SLC-2  D3S3530 1.76 NDa 
Bri-1  D3S1294 1.81 D3S3530–3qter 
Leu-1  D3S3530 0.88 NDa 
Linkage analysis in the EEC syndrome families was performed with markers from the critical region that was 
deﬁned previously for LMS38. Reconstructing haplotypes identiﬁed ﬂanking markers for the EEC syndrome 
families. Note that family Ams-1 shows signiﬁcant LOD scores for two loci. The chromosome 19 locus was 
found previously by O’Quinn et al. (1998).
a  For these families no recombinations were detected in the region around 3q27.
STSG1588, and SGC33716. According to the Unigene database, each of these ﬁve ESTs 
represents a cluster of 2 to 65 cDNA clones derived from a variety of cDNA libraries.  
 We checked by PCR the localization of 5 known genes (LPP, Chordin, DVL3, SOX2, 
and p63) on our YAC panel. Chordin, SOX2, and DVL3 were negative for all YACs, 
whereas PCR fragments of expected sizes were obtained in the reaction with total human 
DNA. LPP was positive only for YAC 949G9, indicating that this gene is just outside 
the LMS/EEC critical region. However, it cannot be excluded that part of the LPP gene 
or of its regulatory elements is within the LMS/EEC region. We therefore sequenced all 
coding exons and ﬂanking intron sequences of the LPP gene in one LMS patient. Except 
for one intron polymorphism, no deviations from the reported sequences were detected. 
Finally, PCR ampliﬁcation of part of exon 14 of the p63 gene revealed that this gene maps 
precisely within the LMS critical region. This localization, in combination with the high 
expression level of p63 in epidermal cells and the phenotype of the recently reported p63 
knockout mice (Yang et al., 1999; Mills et al., 1999), make this gene a likely candidate 
for LMS and EEC syndrome.
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P63 mutation analysis
The p63 gene encodes multiple isotypes by two transcription initiation sites and extensive 
alternative splicing (Yang et al., 1998; Figure 2A). Since only the cDNA sequences of the 
human p63 gene were known, we set out to resolve the genomic structure via an exon 
bridging technique. Exon-speciﬁc primers were designed based on the proposed p63 gene 
structure (Yang et al., 1998). By long-range PCR with YAC DNA as template, we were 
able to amplify most of the introns of this gene (Figure 2A). The splice sites and ﬂanking 
intron sequences of the PCR fragments were determined. These data allowed us to design 
intron-speciﬁc primers suitable for ampliﬁcation of exons 5 to 14. The resulting PCR 
fragments obtained from 25 unrelated EEC syndrome patients and a patient from the LMS 
family were analyzed for mutations by direct sequencing. A total of nine heterozygous 
nucleotide changes were detected in EEC syndrome patients (Figure 2). The arginine 
at position 204 (numbering based on the TA-p63α isotype) was found to be mutated in 
four unrelated patients, with three of these showing a substitution by tryptophan and 
one by glutamine. In patient Nij-1 a change of C to T at nucleotide position 910 (with 
respect to the A of the start codon) results in a missense mutation Arg304Trp. Another 
missense mutation Cys306Arg was found in patient Nij-2. Both mutations are located in 
exon 8 of the p63 gene, which encodes a core element of the DNA-binding domain. Two 
Figure 1. 
Physical map of the region containing the gene for EEC/LMS syndrome.
Genetic intervals for LMS and EEC syndrome are shown at top. The physical map underneath shows the 
approximate positions of genetic markers, ESTs (indicated by asterisks), and the LPP and p63 genes. The order 
of genetic markers was deduced from genetic maps (Dib et al., 1996), and conﬁrmed by mapping of these 
markers to partially overlapping YAC clones from the 3q27 region. The vertical lines at the YAC clones indicate 
the presence of a STS/EST as determined by PCR. YAC clones are from the CEPH megabase YAC library. Five 
ESTs map to the LMS region and three map to the combined EEC/LMS region. The p63 gene is the only full-
length cDNA that maps to the LMS/EEC critical region.
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Figure 2 
Schematic representation of the human p63 gene and position of mutations found in EEC syndrome patients.
(A) Intron-exon structure of the p63 gene showing the two transcriptional start sites and the various splicing 
events leading to the 6 known isotypes of p63 (Yang et al., 1998). Initiation of transcription in exon 1 produces 
the TA-isotypes, containing the transactivation (TA) domain, while initiation in exon 3’ gives rise to the ΔN-
isotypes without the TA domain. The splicing events that produce the α isotypes are indicated with solid lines; 
splicing events that produce the β and γ isotypes are indicated with dotted lines. Protein domains are shown for 
the TA-p63α and ΔN-p63γ isotypes. The open reading frame is indicated in gray; conserved protein domains are 
highlighted with colors: red, transactivation domain; blue, DNA-binding domain; green, isomerization domain. 
All missense mutations are located in the DNA-binding domain, which is contained in all 6 p63 isotypes. The 
frameshift mutation [INS(A)] located in exon 13 is predicted to produce truncated α isotypes, whereas the β and 
γ isotypes are left unaffected.
(B) Amino acid sequence comparison of the DNA-binding domain of human p53, p63, and p73. The highly 
conserved domains II to IV that were identiﬁed by Cho et al. (1994) are underlined. Blue shading depicts amino 
acids that directly contact the DNA, and the red colors indicate the Zn-binding amino acids. The black bars 
indicate the relative frequency of mutations that are found at a particular amino acid of p53 from human tumor 
material (Hollstein et al., 1991; Hainaut et al., 1998). All amino acid substitutions that are found in the p63 gene 
of EEC syndrome patients are located in the conserved domains, and often affect residues that bind to DNA or 
residues that are frequently mutated in p53.
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Figure 2: Celli et al.
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other missense mutations, Ser272Asn and Arg279His, are located in exon 7. Finally, an 
insertion of one nucleotide (1572insA) was detected in exon 13 of patient Nij-4, resulting 
in a frameshift at codon 525 (tyrosine) and a premature stop codon in the same exon 
(Figure 3A).
 In at least ﬁve families, the mutation is de novo: family Nij-1 (Arg304Trp), Nij-2 
(Cys306Arg), Nij-3 and Lei-1 (both Arg204Trp), and Nij-4 (frameshift) (Figure 3 and 
data not shown). In two of the families that map to chromosome 3q27, Leu-1 and SLC-
1, cosegregation of the mutation and the disease was observed (Figure 3B and data not 
shown). For all mutations the mutant allele was not present in 100 investigated control 
chromosomes. A comparison between the DNA-binding domains of p53, p63, and p73 
demonstrated that all mutated amino acids are strictly conserved (Figure 2B). These data 
Figure 3 
Segregation of p63 mutations in families with EEC syndrome.
(A) Frameshift mutation in family Nij-4. Partial sequence of a PCR amplicon containing exon 13 derived from 
patient Nij-1 (bottom) and her healthy mother (top). The extra adenosine in one of the alleles of the patient is 
not present in her father’s (not shown) and mother’s DNA.
(B) ASO hybridization of the Arg279His mutation in family SLC-1. PCR fragments derived from exon 7 were 
electrophoresed in a 2% agarose and transferred to two separate nylon ﬁlters by Southern blotting. Each ﬁlter 
was hybridized with a 32P-labelled oligonucleotide, with either a complete match to the wild-type allele (5’-
ATG AAC CGC CGT CCA ATT-3’) or to the mutant allele (5’-ATG AAC CAC CGT CCA ATT-3’).
(C) Segregation of the Arg304Trp mutation in family Nij-1. The 260 bp PCR fragment containing exon 8 was 
digested with HpaII. The wild-type product is cleaved into fragments of 157 and 103 bp. Due to the mutation 
the HpaII site is lost, resulting in partial digestion of PCR fragments derived from affected individuals. Note that 
the mutation has occurred de novo in the germ line of one of the grandparents.
(D) Segregation of the Cys306Arg mutation in family Nij-2. The 260 bp PCR fragment containing exon 8 was 
digested with BamHI, which gives rise to products of 154 and 106 bp for the mutant allele, while the wild-type 
allele is not digested. Note that the mutation has occurred de novo in the germ line of one of the parents.
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conﬁrm that the p63 sequence changes are causative mutations for EEC syndrome.
 We have not yet identiﬁed mutations in the LMS family nor in several EEC syndrome 
families mapping to 3q27. Most likely, these mutations reside in other parts of the p63 
gene not analyzed here, including exons 1 to 4 or 15.  
Protein modeling predicts an impairment of DNA binding due to p63 mutations
To obtain a structural context for the mutations described here, we built a model of the 
p63 DNA binding domain based on the known structure of its homolog, p53  (Chothia and 
Lesk, 1986; Sander and Schneider, 1991; Cho et al., 1994; Chinea et al., 1995). According 
to this model, the p53 and p63 DNA-binding domains assume a similar loop-sheet-helix 
motif and two large loops that make up the DNA-binding surface of the protein (Figure 
4). This model is supported by the fact that p53 and p63 bind to the same DNA motifs 
(Yang et al., 1998). All amino acids of p53 that directly contact the DNA are conserved 
in p63, and therefore are predicted to have similar functions (Figure 4). Three of the 
Figure 4
Modeling of the DNA-binding domain of p63.
In all panels DNA is represented as a purple stick model. Protein is shown as a ribbon model with red strands, 
blue helices, and green turns and loops. The side chains of interesting residues are shown as ball-and-stick 
models (C = green; N = blue; O = red; S = yellow; Zn = purple).
(A) The protein-DNA complex viewed along the carboxy-terminal helix of the DNA-binding domain (Helix H2 
in p53; Cho et al., 1994). From left to right are shown Arg279 (248 in p53), Ser272 (241) and Arg304 (273).
(B) As in panel (A). Top to bottom are shown Arg311 (280), Asp312 (281), Cys306 (275) and Arg304 (273).
(C) Arg204 (175) is shown just below the Zn-binding site consisting of Cys205 (176), Cys269 (238), Cys273 
(242) and His208 (179).
A B
C
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ﬁve positions where amino acid changes cause EEC syndrome are directly implicated 
in DNA binding. The serine at position 272 (241 in p53) makes a hydrogen bond with 
a phosphate in the DNA backbone, which is lost upon replacement of this residue by 
asparagine. The arginine at position 304 (273 in p53) contacts a backbone phosphate. 
This contact is abrogated by the mutation to tryptophan, which in addition can impose 
steric hindrance on the DNA binding. Arginine 279 (248 in p53) reaches into the minor 
groove of the DNA where it contacts nucleotides of adjacent pentamers of the consensus 
sequence PuPuPuC(A/T) that is required for p53-speciﬁc DNA recognition. The amino 
acid substitutions at the two other positions, arginine 204 and cysteine 306, are predicted 
to diminish the DNA binding capacity of p63 through structural deformation of the 
protein. Cys306 (275 in p53) reaches inside the protein where it is located underneath the 
aspartate at position 312. Asp312 plays an important role in the positioning of the p63 
DNA-binding surface by forming salt bridges with Arg304 and Arg311. The Cys306Arg 
mutation will disrupt the proper contacts between these two arginines and the DNA by 
destabilizing the Asp312. In p53, the arginine (175) that corresponds to Arg204 in p63 
has a critical role in stabilizing two loops (L2 and L3; Cho et al., 1994). Cho et al. (1994) 
cite several lines of evidence that suggest that mutations of this arginine lead to (partly) 
unfolded protein. The high degree of local similarity between p53 and p63 in this area 
of the molecule strongly suggests a similar role for Arg204 in p63, and that mutation of 
this Arg to Trp or Gln will create extensive structural rearrangements. Thus, all missense 
mutations are predicted to disrupt DNA binding either directly by replacing amino acids 
that bind to DNA, or indirectly by creating marked changes in the structural conformation 
of the DNA binding domain.
P63 mutations affect transactivation and dominant-negative properties
To assess consequences of p63 mutations found in EEC patients on p63 function, we 
performed transactivation assays with mutant p63 proteins, containing either an amino 
acid substitution (Cys306Arg) or the frameshift mutation. Individual p63 mutant and 
control isotypes were assayed in a cell transfection model for their ability to transactivate 
p53 reporter genes and to suppress p53- and p63-mediated transactivation, respectively. 
Whereas wildtype TA-p63γ, like p53, is a potent transactivator of the p53-responsive 
reporter gene, the TA-p63γCys306Arg mutant fails to drive expression from this reporter gene 
(Figure 5A). The absence of transactivation of the TA-p63γCys306Arg mutant might have 
been due to trivial explanations such as destabilization or inability to access the nucleus. 
However, TA-p63γCys306Arg had a similar nuclear localization as wild-type protein (data not 
shown), suggesting the more likely possibility that the Cys306Arg mutation affects p63 
binding to DNA target sites. ΔN-p63α, the major p63 isotype in basal cells of epithelial 
tissues (Yang et al., 1998), lacks transactivation capabilities against p53 reporter genes 
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but rather shows remarkable dominant-negative activities towards transactivation of these 
genes by both p53 and TA-p63γ (Yang et al., 1998). We asked whether the Cys306Arg 
substitution in ΔN-p63α would affect these dominant-negative activities towards p53 and 
Figure 5
 Transactivation of a p53 reporter gene by wild-type and mutant p53 and p63 isotypes.
(A) Human Saos-2 cells were transfected as indicated, lysed in detergent lysis buffer 24-36 h after transfection, 
and assayed for transactivation using a β-galactosidase reporter gene containing p53-binding sites (PG13-β-
gal). The transactivation activity of TA-p63γ is lost due to the Cys306Arg mutation. 
(B) Transactivation analysis in Saos-2 cells transfected with wild-type p53 expression vector, minimal p53 
reporter construct, and either wild-type (WT) or mutant (M) expression vectors at a 1:1 ratio with respect to 
p53, as indicated.
(C) As in panel (B) except that TA-p63γ instead of p53 expression vector was used.
(D) Assessment of the consequences of the frameshift mutation (TA-p63αFS and ΔN-p63αFS) for transactivation. 
Assays were conducted with the indicated combination of constructs as in the above panels.
A constitutive luciferase expression vector (PGL3; Promega) was used in all samples to normalize for 
transfection efﬁciency and sample preparation. Error bars indicate standard deviation in triplicate experiments. 
The relative transactivation at the vertical axis is the degree of stimulation with respect to assays with vector 
without p53/p63 sequences.
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TA-p63γ in the transfected cell model. As expected, wildtype ΔN-p63α strongly repressed 
p53-induced transactivation of the p53 reporter gene (Figure 5B), which is likely 
attributed to effective competition for p53 DNA target sequences (Yang et al., 1998). In 
contrast, co-expression of the ΔN-p63αCys306Arg mutant showed no signiﬁcant effect on the 
transactivation activity of p53 (Figure 5B), which indicates that the mutation disrupts 
the DNA-binding ability of this p63 isotype. Similar effects towards p53 transactivation 
were observed for wildtype and mutant ΔN-p63γ isotype (Figure 5B). The effects of ΔN-
p63αCys306Arg expression on the transactivation functions of TA-p63γ in this cell model were 
more complex than towards p53. ΔN-p63αCys306Arg was as effective as wildtype ΔN-p63α in 
blocking transactivation by TA-p63γ (Figure 5C). Since ΔN-p63αCys306Arg does not seem to 
have DNA binding capacity, the observed suppression is likely the result of the formation 
of defective heterooligomers between TA-p63γ and ΔN-p63αCys306Arg. The formation of 
defective heterooligomeric complexes is also suggested by the effect of mutant ΔN-p63γ 
towards TA-p63γ transactivation. Whereas wildtype ΔN-p63γ slightly stimulates rather 
than suppresses transactivation by TA-p63α repression of transactivation is brought 
about by ΔN-p63γCys306Arg. It is likely that the ability of heterooligomer formation between 
mutant and wildtype p63 isotypes underlies the dominant nature of the p63 missense 
mutations in EEC syndrome.
 We next investigated whether the frameshift mutation had similar trans-dominant 
effects on transactivation. While TA-p63α normally lacks transactivation activity, its 
truncated derivative, TA-p63αFS, is a strong activator of reporter gene expression (Figure 
5D). Thus, the TA-p63αFS mutant has not only maintained its DNA binding capacity but 
has also acquired transactivation activity compared to TA-p63α. TA-p63αFS lacks almost 
half of the carboxy-terminal α tail of TA-p63α, which is completely absent in TA-p63γ 
Apparently, the α tail, or more speciﬁcally the domain that is encoded downstream of the 
nucleotide insertion, confers an auto-inhibitory effect on p63 transactivation. We then 
asked how the truncation of the α tail would affect the suppressive activities towards p53 
and TA-p63γ transactivation. In the cotransfection assays, ΔN-p63αFS suppressed p53-
mediated transactivation, which reﬂects the retained DNA binding capacity of this mutant 
isotype. Cotransfection of ΔN-p63αFS with either TA-p63γ or TA-p63αFS, however, 
yielded a signiﬁcantly higher reporter gene expression than in the absence of ΔN-p63αFS 
(Figure 5D). Apparently, ΔN-p63αFS is able to form potent transactivation complexes 
with the TA-p63 isoforms. A similar, but less pronounced activity was observed for wild-
typeΔN-p63γ in such cotransfection assays (Figure 5B and C).
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Discussion
P63 mutations cause EEC syndrome
We have demonstrated that mutations in p63 are an important cause of the EEC syndrome. 
P63 mutations were found in nine unrelated families. Eight of these mutations cause 
amino acid substitutions. The ninth mutation introduces a frameshift in exon 13 of the 
p63 gene, and causes a premature termination codon in the same exon. Unequivocal 
evidence that the mutations are causative for EEC syndrome was provided by the 
observation that the changes are de novo in ﬁve of the families. In addition, the missense 
mutations are predicted to affect the DNA binding capacity of p63, which results in 
impaired transactivation activity and altered regulation of transactivation. The premature 
stop codon introduced by the frameshift mutation does not affect the β- and γ-isotypes 
of p63, suggesting a major role for mutant p63α isotype(s) in the pathogenesis of EEC 
syndrome. After screening 10 exons (5 to 14) of the p63 gene, we have detected mutations 
in nine of 25 families, indicating that mutations in the p63 gene are a major cause of EEC 
syndrome.
 The localization of the genetic defect in EEC syndrome family Ams-1 to the 3q27 
region was unexpected, because in a previous study signiﬁcant support was obtained for a 
location on chromosome 19 (Table 1; O’Quinn et al., 1998). It is possible that the linkage 
detected at one of these loci is spurious. Alternatively, the identiﬁcation of linkage to two 
loci may be indicative for the involvement of genes from the corresponding chromosomal 
regions acting in concert in developmental processes that are disturbed in this family. A 
gene from chromosome 19 may thus act as a modiﬁer gene by modulating the phenotypic 
outcome of p63 mutations. 
P63 mutations in EEC syndrome correspond to p53 hot spot mutations in human tumors
All of the p63 missense mutations in EEC syndrome patients affect the core DNA-binding 
domain of the protein at amino acid residues that are strictly conserved among the other 
members of the p53 family (Figure 2; Kaghad et al., 1997; Schmale and Bamberger, 1997; 
Yang et al., 1998). Within this DNA-binding domain four evolutionary conserved regions 
can be distinguished, denoted regions II to V, which are critically important for the proper 
folding of the protein and for creation of the DNA-binding surface (Cho et al., 1994). All 
of the identiﬁed p63 missense mutations are located in regions III, IV and V, which in p53 
harbor the vast majority of somatic mutations seen in tumors. The p63 mutations found 
in the EEC patients occur at amino acids that are commonly altered in p53 proteins found 
in human malignancies (Hollstein et al., 1991; Hainaut et al., 1998; Walker et al. 1999). 
There is evidence that the high incidence of mutations at these amino acids in p53 is due 
to a combination of diverse environmental mutagens, that preferentially bind to CpG 
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dinucleotides, and a strong positive selection for mutations, especially for those in the 
DNA-binding domain (Sidransky et al., 1992).
 A similar mechanism of positive selection for mutations seems unlikely for p63. 
Examination of the nucleotide changes in the p63 gene reveals that six of nine mutations 
are C to T transversions at CpG dinucleotides either on the coding (Arg204Trp [3x], 
Arg304Trp) or on the non-coding strand (Arg204Gln, Arg279His). It thus seems possible 
that the codons for these amino acids are hot spots for mutations. An alternative explanation 
would be that mutation of speciﬁc residues such as Arg204 leads to the characteristic 
ectodermal and limb abnormalities seen in EEC syndrome, whereas mutations at other 
positions could lead to a different phenotype or have no consequences at all. Despite the 
amino acid homology between p53 and p63, and the ability of p63 to transactivate p53 
target genes (Shimada et al., 1999), there is no indication for an increased susceptibility 
for cancer development in EEC syndrome patients. Further studies in larger numbers of 
patients and families with EEC and EEC-like phenotypes (such as LMS) may clarify 
these issues and, eventually, may enable the identiﬁcation of genotype-phenotype 
correlations.
P63 missense mutations affect DNA-binding
The p63 structure model indicates that the observed mutations in EEC syndrome patients 
will partially or completely abolish DNA binding, either because the DNA contacting 
amino acids are mutated or because of disruption of the structural integrity of the DNA-
binding surface. As a consequence of the diminished DNA binding, the transactivation 
capacity of the mutant protein will also be reduced. Indeed, cell lysates containing the 
TA-p63γ isotype with the Cys306Arg mutation showed a total lack of transactivation 
activity, whereas lysates with the normal TA-p63γ isotype do activate transcription of a 
β-gal reporter gene under control of a minimal p53 binding site. Additional evidence that 
the Cys306Arg mutation results in a loss of DNA binding capacity is provided by the 
observation that the ΔN-p63αCys306Arg mutant isotype is unable to suppress p53-mediated 
transactivation, whereas wild-type ΔN-p63α efﬁciently competes with p53 for DNA target 
sites. The frameshift mutation does not have any apparent effect on the DNA binding 
capacity of p63, but the resulting truncation of the carboxy-terminal domain clearly has 
an effect on the normal transactivation (see below).
The dominant nature of p63 mutations
Both EEC syndrome and LMS are inherited in a dominant fashion. Since most mutations 
identiﬁed here in EEC syndrome are predicted to lead to amino acid substitutions, several 
pathogenic mechanisms are possible. It cannot be concluded yet which mechanism, 
haploinsufﬁciency, dominant-negative, or gain-of-function, is applicable. Also, the full 
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constellation of symptoms observed in EEC syndrome might be caused by a combination 
of these mechanisms, as was previously found for several p53 mutations in human tumors 
(for reviews see Zambetti and Levine, 1993; Ko and Prives, 1996; Levine, 1997). The 
existence of different p63 isotypes with different properties may complicate the effect of 
mutations even more.
 We feel, however, that haploinsufﬁciency is not a likely explanation, because patients 
with germ line deletions of chromosome 3q27-qter lack the deﬁning features of EEC/
LMS (Chitayat et al., 1996 and references therein). In addition, the p63 homozygous 
knockout mice that were recently created have severe ectodermal defects and limb 
anomalies which recall most of the characteristics of EEC/LMS, but heterozygous 
wt/- mice have no obvious phenotypic abnormalities (Mills et al., 1999; Yang et al., 
1999). It thus seems that the human p63 mutant proteins found in EEC syndrome exert 
a dominant-negative or a gain-of-function effect. The acquired transactivation activity 
of TA-p63α with the carboxy terminal truncation could be a gain-of-function (Figure 
5D). However, due to the ability of p63 isotypes to form homo- and heterooligomeric 
complexes, this mutation, like the Cys306Arg mutation, also has dominant-negative 
properties in other transactivation assays. Heterooligomeric complex formation underlies 
the normal suppressive and slightly stimulatory activities of the ∆N-p63α and ΔN-p63γ 
isotypes, respectively, towards TA-p63γ transactivation (Figure 5C; Yang et al., 1998). 
Incorporation of mutant isotypes may alter the properties of the entire complex. Indeed, 
the existence of such compromised complexes is suggested by our ﬁnding that mutant 
∆N-p63γCys306Arg has repressive effects towards TA-p63γ transactivation. ΔN-p63γCys306Arg 
has no effect towards transactivation by p53, with which it is unable to complex (Figure 
5). Likewise, the normal repressive activity of ΔN-p63α is converted into a stimulatory 
effect towards TA-p63γ, with which complex formation is possible, while it has retained 
its suppressive effect on p53-mediated transactivation. 
Causal heterogeneity of mechanisms leading to EEC syndrome 
An inherent consequence of the gene structure of p63 is that the mutations observed will 
affect the function of multiple p63 isotypes. The missense mutations are predicted to affect 
all six known p63 isotypes, resulting both in a loss of transactivation by TA-p63γ and to 
a disruption of repressive properties of other isotypes towards TA-p63γ. The frameshift 
mutation, which was found in a patient with a typical EEC syndrome, should not interfere 
with the production of either the p63β or p63γ variants Consequently, EEC syndrome 
is not due to a loss of p63 transactivation per se, since the transactivating isotype (TA-
p63γ) is left intact. Instead, the frameshift mutation results in a gain of transactivation 
activity for the truncated TA-p63α isotype. The missense and frameshift mutations appear 
to exhibit divergent effects on the regulation of transcriptional activity of p63 as well. 
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The Cys306Arg missense mutation suppresses the p63-mediated transactivation, whereas 
the frameshift mutation has a stimulatory effect. The above data suggest that both an 
increase and a decrease of transactivation by p63 lead to the developmental defects seen 
in EEC syndrome patients. Of course, this observation is based on transactivation studies 
with a target gene under control of a p53 response element. The effects in vivo on the 
transcriptional regulation of the normal p63 target genes may be dependent on additional 
factors such as the DNA binding sequence and the nuclear environment. 
The EEC phenotype resembles that of p63 knockout mice
A comparison of the phenotype of p63-/- mice with that of patients who have EEC 
syndrome shows a strikingly similar pattern of involved structures. A generalized 
ectodermal dysplasia is evident in these patients, which manifests as sparse hair, dry 
skin, pilosebaceous gland dysplasia, lacrimal duct obstruction, and oligodontia. Cleft lip 
with or without cleft palate occurs in the majority of EEC syndrome patients, which 
compares to the truncated secondary palate and hypoplastic maxilla and mandibula in 
p63-/-  mice (Mills et al., 1999; Yang et al., 1999). There is a wide variety of abnormalities 
of hand and feet, ranging from syndactyly to a severe defect of the central rays leading to 
a split hand/split foot malformation (Figure 6). It has been proposed that during evolution 
Figure 6
Limb defects in EEC syndrome patients with a mutation in p63.
Typical split-hand with dystrophic nails of the thumbs (A) and typical split-feet (B) from the EEC syndrome 
patient with a frameshift mutation in exon 13. (C) Cutaneous syndactyly of second and third ﬁngers of the 
right hand and (D) partial syndactyly of the third and fourth toes of the left foot of the girl with the Arg304Trp 
mutation (family Nij-1).
Appendix 2 - Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome
167
similar molecular signaling pathways have been recruited for the formation of structures 
as diverse as limbs, hair, teeth, and apocrine glands (Thesleff et al., 1995). How these 
different developmental programs are regulated is largely unknown, but it is of interest 
that all these structures are affected by heterozygous mutations of p63. What these 
structures have in common is that their development and morphogenesis depends on the 
signaling between specialized ectodermal cells and the underlying mesoderm. Epithelial-
mesenchymal interactions between the apical ectodermal ridge (AER) and the underlying 
mesenchyme, denoted the progress zone, are required for normal morphogenesis of the 
limb (Niswander, 1997). Indeed, the limb truncations in p63-/-  mice seem to be the result 
of a failure to maintain the AER (Yang et al., 1999). 
 Clinical variability is one of the hallmarks of EEC syndrome, with clinical expression 
ranging from severe distal truncations in split hand/split foot malformation (SHFM) to 
non-penetrance in obligate heterozygotes who are clinically normal. There are several 
possible explanations for this extreme variability of symptoms in EEC syndrome. First, 
stochastic processes may underlie the severity of the various defects. The complexity 
of interactions between mutant and wild-type isotypes of p63 could certainly account 
for this. Secondly, the extent of the defects may be determined by the action of modiﬁer 
genes and/or environmental factors. A precedent for modiﬁer genes is provided by the 
Dactylaplasia (Dac) mouse mutant, which is considered a model for human SHFM3. The 
Dac mouse shows central ray defects of the forelimbs due to excessive cell death of the 
AER (Seto et al., 1997). The severity of the limb defects in Dac+/- mice is dependent on a 
recessive mutation in a modiﬁer gene, denoted mdac (Johnson et al., 1995). By analogy, 
the various SHFM loci and other unknown genes may act as modiﬁers of phenotypic 
expression in EEC/LMS patients. This notion is supported by the possible involvement of 
two loci, p63 and a locus on chromosome 19, in one of the EEC families (O’Quinn et al., 
1998 and this report). The hypothesis of speciﬁc modiﬁer genes can be further pursued 
by molecular studies of large families with a single p63 mutation such as the LMS family 
reported earlier (van Bokhoven et al., 1999).
Experimental procedures
Linkage analysis
After obtaining informed consent, genomic DNA from EEC syndrome families was 
extracted from peripheral blood lymphocytes by a salt extraction procedure (Miller et 
al. 1988). The DNA concentration was measured by optical density (OD
260
) and purity 
checked by determining the OD
260/
OD
280
 ratio. Manual genotyping of microsatellite 
markers from chromosome 3q27 was carried out as described elsewhere (Kremer et 
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al. 1994). Two-point LOD scores were calculated by the LINKAGE package (Lathrop 
and Lalouel, 1984). Penetrance was arbitrarily determined at 95% and marker-allele 
frequencies were estimated by use of the ILINK option. Disease-gene frequency was 
deﬁned at 0.0001.
Physical map construction and localization of genes and ESTs
YAC clones from the critical region for LMS/EEC syndrome were selected by using the 
publicly available resources of the physical mapping project of the Whitehead institute 
(http://www-genome.wi.mit.edu/; Dib et al., 1996). Yeast cell culturing and DNA isolation 
was performed as described previously (Green and Olson, 1990). STS markers, ESTs, and 
genes were physically mapped to these YACs by PCR. Sequences of primers used for 
mapping of ESTs and genes are available upon request. 
Elucidation of the intron-exon boundaries of the p63 gene
Primer pairs that were predicted to match neighboring exons of the human p63 gene 
were used to amplify the intervening intron from YAC clone 745A12 or total human 
genomic DNA. Reactions were carried out in a 50 μl volume containing 20 mM Tris-
HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl
2
, 1 mM dNTPs, 250 ng of each primer and 
1.25 unit ExTaq (TaKaRa Biomedicals) under the following conditions: 1 min 94 oC, 30 
cycles consisting of 5 min 98 oC, 30 sec 50 oC and 15 min 68 oC, and 10 min 72 oC. 
PCR products were fractionated by electrophoresis in 2% agarose gels and visualized by 
staining with ethidium bromide. DNA fragments were excised from the gel and puriﬁed 
with the Qiaquick gel extraction protocol (Qiagen). Sequencing of these fragments was 
done with the BigDye Terminator chemistry (PE Applied Biosystems) and the use of 
exon-speciﬁc primers. Electrophoresis and analysis was performed on an ABI Prism 377 
(PE Applied Biosystems). In case the above exon-bridging strategy was unsuccessful, 
exon-intron boundaries were determined by direct sequencing with exon-speciﬁc primers 
and PAC DNA as template.
P63 mutation analysis 
Intron-speciﬁc primers were designed that are suitable for ampliﬁcation of exons 5 to 14 
of the p63 gene: 5F: 5’-GTT GGT TCT CTC CTT CCT TTC-3’; 5R: 5’-GCC CAC AGA 
ATC TTG ACC TTC-3’; 6F: 5’-CCA CCA ACA TCC TGT TCA TGC-3’; 6R: GTT CTC 
TCA AGT CTA CTC AGT CC-3’; 7F: 5’-GGG AAG AAC TGA GAA GGA ACA AC-3’; 
7R: 5’-CAG CCA CGA TTT CAC TTT GCC-3’; 8F: 5’-GTA GAT CTT CAG GGG ACT 
TTC-3’; 8R: 5’-CCA ACA TCA GGA GAA GGA TTC-3’; 9F: 5’-ATG CAT TAG TGC 
TTT AGA AGT G-3’; 9R: 5’-GAA GGT TAA AAT GAA GCA ACC-3’; 10F: 5’-TGA 
GGA TTG ACC ACA CTT CTA AC-3’; 10R: 5’-CAT CAA TCA CCC TAT TGC TGA 
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TC-3’; 11F: 5’-TGA NCA TCA TTT CCA TGT TTG TC-3’; 11R: 5’-TCA CAG AGT 
CTT GTC CTA AGC-3’; 12F: 5’-CAA GAT GGA CCA CTG GGA TG-3’; 12R: 5’-GGA 
CTA TAA CAG TAT CCG CCC-3’; 13F: 5’-CTT ATC TCG CCA ATG CAG TTG G-3’; 
13R: 5’-AAC TAC AAG GCG GTT GTC ATC AG-3’; 14F: 5’-GGG AAT GAT AGG 
ATG CTG TGG-3’; 14R: 5’-AAG ATT AAG CAG GAG TGC TT-3’. PCR reactions 
were carried out in a 25 μl volume containing 100 ng genomic DNA, 20 mM Tris-HCl 
(pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM dNTPs, 100 ng of each primer and 1 unit 
Taq polymerase (Gibco-BRL), using the following parameters: 1 min 94 oC, 2 min 55 
oC, 1 min 72 oC for 35 cycles. The resulting PCR products were directly sequenced as 
described above.
Sequence alterations were checked in the families of the corresponding patient and in 50 
control individuals by allele-speciﬁc oligonucleotide (ASO) hybridization or restriction 
enzyme digestion of PCR products from the relevant exons. ASO hybridization and 
washing was performed as described by Shuber et al. (1993). 
P63 protein modeling
A model of the DNA-binding domain of p63 was created by using the modeling methods 
described by Chinea et al. (1995) and the resolved structure of p53 as template (Cho et al., 
1994). Sequence alignment and homology modeling were done with the program WHAT 
IF (Vriend, 1990). 
Transactivation assays
Plasmid DNA from mammalian expression vectors containing the murine p63 sequence 
under control of a CMV promoter (Yang et al., 1998) was used as template for site-
directed mutagenesis using the QuikChangeTM procedure (Stratagene). To create the 
Cys306Arg mutation we used oligonucleotide 5’-TCC TGG GCA AGC ACG GAT CCG 
GGC CTC AA-3’ and the reverse complement of it. For construction of the frameshift 
mutation we employed oligonucleotide 5’-CAT CAT GTC TGG ACA TAT TTC ACG 
ACC CA-3’ and its reverse complement. Clones containing the mutation were selected 
for by digestion with BamHI, for which a recognition site was created by the mutation. 
The entire open reading frame of each clone was checked by sequencing. Transactivation 
assays were conducted as described previously (Yang et al., 1998).
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Summary
Robinow syndrome is a short-limbed dwarﬁsm characterized by abnormal morphogenesis 
of the face and the external genitalia, and vertebral segmentation1,2. The recessive form of 
Robinow syndrome (RRS; OMIM 268310), particularly frequent in Turkey3-6, has a high 
incidence of abnormalities of the vertebral column such as hemivertebrae and rib fusions, 
which is not seen in the dominant form. Some patients have cardiac malformations or 
facial clefting. We have mapped a gene for RRS to 9q21-q23 in 11 families. Haplotype 
sharing was observed between three families from Turkey, which localized the gene to 
a 4.9-cM interval. The gene ROR2, which encodes an orphan membrane-bound tyrosine 
kinase, maps to this region. Heterozygous (presumed gain of function) mutations in 
ROR2 were previously shown to cause dominant brachydactyly type B (BDB; ref. 7). 
In contrast, Ror2-/- mice have a short-limbed phenotype that is more reminiscent of 
the mesomelic shortening observed in RRS. We detected several homozygous ROR2 
mutations in our cohort of RRS patients that are located upstream from those previously 
found in BDB. The ROR2 mutations present in RRS result in premature stop codons and 
predict nonfunctional proteins.
Introduction, results and discussion
Prominent features of RRS are hypertelorism, short stature, mesomelic shortening of the 
limbs, hypoplastic genitalia, and rib and vertebral anomalies (Figure 1). The chromosomal 
Figure 1 
Phenotypic features of RRS.
a, Facial appearance of individual 1.7. showing hypertelorism, a broad nose, long philtrum, triangular mouth 
and frontal bossing. b, Three of the affected children from family 1. Note the mesomelic shorting of the limbs 
and the genital abnormalities. c, Micropenis in male 1.7. d, X-ray showing the vertebral and rib anomalies 
in a patient from family 7. The vertebral column is disorganized due to multiple hemivertebrae and other 
disturbances of segmentation. Also, the shape and number of the ribs are abnormal. 
 a  b  d c
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localization of both the dominant and recessive forms of Robinow syndrome is unknown. 
We used homozygosity mapping to localize the RRS gene in ﬁve consanguineous families. 
Homozygosity was ﬁrst detected for marker D9S197. Further testing in the complete 
sample of 11 families revealed that all patients were homozygous for a set of 14 markers 
spanning 14 cM in 9q21.3-q22 (Table 1). 
Table 1 Affected hyplotypes for chromosome 9q21-q23 markers in 11 Robinow syndrome 
families
Family 1 2 3 4 5 6 7 8 9 10 11 
Marker  
D9S278 4 4 2 2 2 2 1 1 7 7 2 2 7 7 2 2 7 7 1 7 2 2 
D9S283 2 2 6 6 3 3 6 6 2 2 1 1 1 1 3 3 2 2 1 3 1 1 
D9S1820 3 3 3 3 3 3 1 1 4 4 3 3 4 4 3 3 3 3 4 6 6 6 
D9S1796 8 8 6 6 6 6 1 1 6 6 5 5 6 6 2 2 − − − 
D9S1842 4 4 4 4 2 2 1 1 2 2 2 2 1 1 1 1 1 1 4 4 3 3 
D9S1781 4 4 5 5 6 6 6 6 6 6 6 6 7 7 5 5 5 5 5 5 4 4 
D9S1841 1 1 1 1 3 3 3 3 3 3 4 4 3 3 1 1 1 1 4 4 1 1 
D9S1815 4 4 5 5 7 7 7 7 7 7 5 5 4 4 8 8 7 7 8 8 3 3 
D9S1803 3 3 4 4 5 5 5 5 5 5 3 3 3 3 3 3 4 4 1 1 2 2 
D9S197 5 5 4 4 1 1 1 1 1 1 1 1 6 6 6 6 1 1 4 4 4 4 
D9S196 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 
D9S1816 1 1 3 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 4 1 1 
D9S1689 2 2 1 1 3 3 3 3 1 1 1 1 1 1 3 3 4 4 4 4 2 2 
D9S280 2 2 1 1 1 1 1 1 4 4 3 3 2 2 1 1 4 4 2 2 3 3 
D9S1851 2 2 1 1 1 1 1 1 4 4 6 6 1 1 3 3 2 2 3 3 2 2 
D9S287 5 5 5 5 4 4 4 4 3 3 3 3 4 4 4 4 4 4 2 2 3 3 
D9S1809 3 3 6 6 3 3 3 3 3 3 5 5 6 6 3 3 4 4 3 3 5 5 
D9S1786 7 7 6 6 5 5 5 5 5 5 7 7 6 6 1 1 7 7 8 8 5 5 
D9S176 2 6 3 3 8 8 8 8 3 3 3 3 10 10 2 2 2 2 2 2 2 2 
Mutation W720X  R205X R205X R205X C182X R396X Δ35 bp
ROR2 was localized between D9S1781 and D9S197 
Flanking markers were D9S257 and D9S176, based on recombinant events observed in 
family 1 (Figure 2). The maximum lod score was 11.25 at D9S1842 (θ = 0.0). Families 
3, 4 and 5 shared the same set of alleles for 7 consecutive markers (Table 1). A common 
ancestor is the most likely explanation for this ﬁnding, as the families, although not 
known to be related, all originate from the same town in Eastern Turkey. This observation 
reduced the critical region for RRS to the 4.9-cM region between D9S1842 and D9S1689. 
Appendix 3 - Mutation of a gene encoding the ROR2 tyrosine kinase causes autosomal recessive RS 
179
A partial YAC contig was used to map markers, ESTs and known genes as candidates. 
ROR2 mapped to YACs 949E10 and 951D10, indicating that it is located between 
D9S1781 and D9S197 and therefore in the RRS critical region.    
 Ror2-deﬁcient mice have defects reminiscent of those observed in RRS patients 
(Figure 1d), namely mesomelic shortening of the long bones, facial abnormalities and 
vertebral anomalies8,9. In addition, Ror2 is highly expressed in the developing nervous 
system, chondrocytes, rib and vertebral anlagen, branchial arches, heart and limb buds 
during mouse embryogenesis8-10. We hypothesized that homozygous null mutations of 
ROR2 may underlie RRS. We ampliﬁed exons 2-9 of ROR2 on genomic DNA from RRS 
Figure 2 
Genotyping results for markers from the long arm of chromosome 9 in RRS family 1. 
Haplotypes containing the putative Robinow syndrome mutation are boxed. The critical interval is deﬁned by 
recombination events with D9S257 on the proximal and D9S176 on the distal side.
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patients and directly analyzed the PCR products by sequencing (Figure 3). Homozygous 
mutations were detected in 7 of 11 RRS families. Of these mutations, four are single-
base changes that should lead to a premature termination of translation, namely W720X 
Figure 3 
ROR2 mutations in RRS families. 
a, Normal sequences (top) and sequences of the patients (bottom) from RRS families. Two nonsense mutations 
were found in exon 5: a transversion 545G>A (C182X) in family 6 and an identical transversion 613C>T 
(R205X) in families 3, 4 and 5. For family 7, an 1189C>T nonsense mutation (R396X) was found in exon 8. 
A 2160G>A transversion predicted to result in a W720X mutation was identiﬁed in individual 1.7 of family 1. 
A 35-bp deletion (1740-1774del) was identiﬁed in the patient from family 11, which gives rise to a frameshift 
at asparagine 580 and 123 novel amino acids. All mutations are homozygous.  b, Segregation of the W720X 
mutation in family 1. Individuals are presented by identiﬁers from Figure 2. Normal control individuals are 
designated ‘C’ on either side. The mutation introduces a DdeI site. DdeI digests the normal 525-bp allele into 
products of 301 bp and 224 bp. The novel DdeI site in the mutant allele causes clipping of the 301-bp product 
into fragments of 142 and 159 bp. c, RT-PCR analysis to examine the expression of mutant ROR2 alleles. Top, 
the 413-bp ROR2-speciﬁc product comprising exons 5-7. Bottom, a control PCR in which a portion of CHUK 
was ampliﬁed. Lanes contain the amplicons derived from a control individual (C) and from patients from 
families 3 (F3; R205X), 7 (F7; R396X), 1 (F1; W720X), and 2 (F2; no mutation detected). The lane marked 
‘M’ is a control experiment in which the same reactions were conducted without RNA template.  d, Position of 
the premature stop codon in family 1 relative to the position of most amino-terminal mutation in BDB and the 
C-terminal end of the tyrosine kinase domain. Highly conserved tyrosine kinase residues18 are in bold italics. 
Tyrosine 722 corresponding to the autophosphorylated tyrosine in the TRK nerve growth factor receptor17, 19,20 
is highlighted in red.
a
b c
d
CHUK
ROR2 
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in family 1, R205X in families 3, 4 and 5, C182X in family 6 and R396X in family 7. 
In addition, a 35-bp deletion, 1740-1774del, was identiﬁed in the patient from family 
11, which gives rise to 123 novel amino acids after asparagine 580. We conﬁrmed the 
mutations by sequencing (Figure 3a). The segregation of the W720X mutation in family 
1 was veriﬁed by restriction endonuclease digestion (Figure 3b). To investigate whether 
mutant RNAs are unstable or subject to nonsense-mediated decay, we performed  RT-
PCR using RNA from RRS lymphoblastoid cells as a template (Figure 3c). No ROR2-
speciﬁc PCR product was detected for the patient from family 2, in whom no mutation 
had been detected at the DNA level. This ﬁnding may reﬂect either a promoter mutation 
or an otherwise unstable RNA. In contrast, the R205X, R396X and W720X alleles were 
ampliﬁed, although the ampliﬁcation was less efﬁcient compared with that of the wild-
type allele. This result suggests that these three mutant alleles may produce ROR2 protein, 
but even so such truncated proteins are likely to be non-functional. 
 The ROR2 protein is a member of the ROR kinase family of orphan receptors 
with tyrosine kinase activity. This family includes human ROR1 (ref. 11), Drosophila 
melanogaster Dror (ref. 12) and Dnrk (ref. 13) , and Caenorhabditis elegans CAM-1 (ref. 
14). These receptors have a common structural arrangement consisting of an extracellular 
immunoglobulin-like motif  (IG), a cysteine-rich domain and a Kringle domain, which is 
also found in proteins involved in blood coagulation15 and in hepatocyte growth factor16. 
The intracellular carboxy-terminal portion contains the tyrosine kinase domain followed 
by two serine/threonine-rich domains (ST1 and ST2) and a proline-rich (PR) domain 
of unknown function. The potential autophosphorylation sites 641-YAADYY-646 and 
722-YALM-725 are located in the tyrosine kinase domain17. Both the RRS and BDB 
mutations predict truncated proteins7. All RRS mutations delete the tyrosine kinase 
domain, and hence predict a complete loss of function. In contrast, only the (gain of 
function) BDB mutations spare the tyrosine kinase domain, which is probably essential 
for receptor function. The most terminally located stop codon is in RRS family 1, where 
the W720X mutation removes the last 26 residues of the kinase domain, including 5 
amino acids that are almost invariably found in tyrosine kinases18. The most crucial 
of these may be tyrosine 722, which is affected by the W720X RRS, but not by the 
W749X BDB, mutation. This autophosphorylated amino acid is conserved among all 
TRK proteins, and the corresponding tyrosine in TRK nerve growth factor receptor is 
essential for substrate binding and activation17,19,20.  A simple loss-of-function model is 
also consistent with the ﬁnding that the heterozygous parents of our RRS patients have 
neither brachydactyly nor other clinical abnormalities. It has previously been established 
that ROR2 haploinsufﬁciency is not detrimental for skeletogenesis as there is no skeletal 
phenotype in individuals with a heterozygous deletion of 9q22 encompassing ROR2 (ref. 
7) or in Ror+/− heterozygous mice9,10. 
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 Neither the ligands nor the cellular transducers of the signal are known for the Ror-
family tyrosine kinases. Some mechanistic and phenotypic overlap can be recognized for 
mutations in genes encoding ﬁbroblast growth factor receptors (ref. 21), which share a 
similar extracellular IG-like domain. Heterozygous gain-of-function mutations in FGFR3 
underlie a variety of dwarﬁng conditions22-25 such as thanotophoric dysplasia  in humans 
and short-limbed skeletal dysplasia in mice26. In contrast, Fgfr3-deﬁcient mice have 
increased length of the vertebral column and long bones27. Thus, for genes encoding both 
families of receptor tyrosine kinases, homozygous null and gain-of-function mutations 
have phenotypic consequences, but haploinsufﬁciency does not. Further studies comparing 
ROR2 mutations in BDB and RRS patients may help to dissect the molecular basis of 
ROR2 action. Finally, it is now possible to test whether the recessive and autosomal 
dominant forms of Robinow syndrome1,2 are allelic due to ROR2 mutations.
 
METHODS
Subjects 
Families were ascertained through clinical genetics services. A diagnosis of RRS was 
based on the characteristic facial features, mesomelic shortening of the limbs, multiple 
vertebral anomalies and micropenis in males. Careful examination of the parents did not 
reveal any indication for minor manifestation of RRS symptoms or BDB. Families 1-10 
are of Turkish descent. Family 11 is from Pakistan. Except for family 10, the parents of 
affected individuals are consanguineous, mostly ﬁrst cousins. Turkish families originated 
from different regions of the country, namely from the Black Sea coast (families 1, 2, 6 
and 8), Eastern Turkey (families 3, 4 and 5), and Central Turkey (families 7, 9, and 10). 
This research was approved by the Medical Ethics Committee of the University Medical 
Centre Nijmegen.
Genotyping
After obtaining informed consent, we took a venous blood sample from which genomic 
DNA was extracted by salt extraction. The DNA concentration was measured by optical 
density (OD260) and purity checked by determining the OD260/OD280 ratio. We carried 
out genotyping of microsatellite markers as described28. Microsatellite markers were 
chosen with an average distance of 10 cM according to the Généthon linkage map29.
Linkage analysis
Initially, we genotyped only affected individuals from families 1-5 to detect homozygosity 
in a genome-wide scan. After typing approximately 30 markers in these individuals, 
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convincing evidence for linkage was obtained with markers from chromosome 9q. 
Subsequently, we used 10 markers in a 20 cM interval to narrow down the region of 
the genetic defect. The haplotype ﬁgures correspond to CEPH allele numbers (ftp://ftp.
genethon.fr/pub/Gmap/Nature-1995/alleles/all_chrom9). For D9S176, a novel allele of 
149 bp was identiﬁed (denoted 10 in Table 1). Two-point LOD scores were calculated by 
the LINKAGE package30. Marker-allele frequencies were estimated by use of the ILINK 
option. Disease-gene frequency was set at 0.01.
Mutation analysis
We designed primers for ampliﬁcation of exons 2-8 and ﬂanking intron sequences of  ROR2. 
Exon 9, encoding the entire tyrosine kinase domain and the ST1, PR and ST2 domains, 
was ampliﬁed in three portions. PCR products were analyzed upon electrophoresis in 
2% agarose gels. The DNA was puriﬁed either directly after PCR by using glass ﬁlters 
(Millipore) or by use of the Gel Extraction kit (Qiagen) for DNA fragments of the proper 
size excised from the gel. Both strands of the DNA fragments were sequenced using the 
BigDye terminator kit (PE) and analyzed on an ABI3700 capillary sequencer (PE Applied 
Biosystems).
 We conﬁrmed mutations by reampliﬁcation and sequencing of the relevant DNA 
fragment from the affected individual and of the available affected and unaffected 
relatives. The W720X mutation in family 1 was also veriﬁed by restriction endonuclease 
treatment. The 2359G>A transversion in this family leads to loss of a BstNI site and 
the creation of a DdeI site. The glass ﬁlter-puriﬁed 525 bp PCR product obtained with 
primers 6F and 6R (ref. 7) was divided in two portions, one of which was digested with 
BstNI and the other with DdeI. The resulting fragments were analyzed by electrophoresis 
in 2% agarose gels. The position of mutations is given with respect to Genbank entry 
M97639 with the A of the ATG startcodon as the ﬁrst nucleotide.
RT-PCR
We extracted total RNA from lymphoblastoid cell lines from RRS patients and control 
individuals. cDNA was synthesized from RNA (250 ng) by random priming with random 
hexamers and the use of MMLV reverse transciptase. The integrity of the RNA was checked 
upon electrophoresis in a 1.75% agarose gel and by conducting a control RT-PCR experiments 
for two highly expressed genes (PGK1 and GAPDH) and a gene with an average expression 
level in lymphoblastoid cells (CHUK). For the latter, a 404-bp  cDNA fragment was 
ampliﬁed with forward primer 5’-CTTGTCGCCTAGAGCTAAG-3’ and reverse primer 
5’-TGTACACAGACTTCCTTGATC-3’. For ampliﬁcation of ROR2 alleles, we used 
exon-speciﬁc primers matching exon 5 (forward, 5F, 5’-CCTCATTGGCAACCGGAC-
3’) and exon 7 (reverse, 7R, 5’-TGCCTGAGCCGTTATAGC-3’), which produce a 413- 
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bp PCR product. PCR products were analyzed on 1.5% agarose gels. The ampliﬁcation 
of the mutant alleles by checked PCR ampliﬁcation and sequencing. Products containing 
the R205X mutation were sequenced with primers 5F and 7R.
Genebank accession number. CHUCK, NM001278
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Summary
Esophageal atresia  (EA) is a common life-threatening congenital anomaly that occurs 
in 1/3,000 newborns. Little is known of the genetic factors that underlie EA. Oculod
igitoesophageoduodenal (ODED) syndrome (also known as “Feingold syndrome”) 
is a rare autosomal dominant disorder with digital abnormalities, microcephaly, short 
palpebral ﬁssures, mild learning disability, and esophageal/duodenal atresia. We studied 
four pedigrees, including a three-generation Dutch family with 11 affected members. 
Linkage analysis was initially aimed at chromosomal regions harboring candidate genes 
for this disorder. Twelve different genomic regions covering 15 candidate genes (~15% 
of the genome) were excluded from involvement in the ODED syndrome. A subsequent 
nondirective mapping approach revealed evidence for linkage between the syndrome and 
marker D2S390 (maximum LOD score 4.51 at recombination fraction 0). A submicroscopic 
deletion in a fourth family with ODED provided independent conﬁrmation of this genetic 
localization and narrowed the critical region to 7.3 cM in the 2p23-p24 region. These 
results show that haploinsufﬁciency for a gene or genes in 2p23-p24 is associated with 
syndromic EA.  
Introduction
Esophageal atresia (EA) is a common life-threatening congenital condition. EA occurs 
in ~1/3,000 newborns (David and O’Callaghan 1975; Szendrey et al. 1985). EA is 
frequently associated with other congenital anomalies. Of these, the most common 
are other gastrointestinal atresias or stenoses, anomalies of the urinary tract, and heart 
defects (Kimble et al. 1997). This combination of features is often referred to as the 
“VATER association” (MIM 192350). In some cases, EA is associated with chromosomal 
abnormalities, such as deletions of 22q11 (Digilio et al. 1999), trisomy 18, and trisomy 
21 (Beasley et al. 1997). A recent compilation of data on chromosomal deletions failed 
to identify any region that is speciﬁcally associated with EA (Brewer et al. 1998). 
Nonsyndromic EA is considered to be a multifactorial trait whose pathogenesis and 
causation are ill deﬁned. The recurrence of EA in some families (van Staey et al. 1984) 
suggests a contribution of genetic factors. In addition, several families with dominantly 
inherited forms of syndromic EA have been reported. To identify a gene involved in 
EA, we are studying families with the autosomal dominant oculodigitoesophageoduod
enal (ODED) syndrome (MIM 164280). This syndrome has been described under the 
following names: microcephaly-oculo-digito-esophageal-duodenal (MODED) syndrome, 
microcephaly mesobrachyphalangy and tracheoesophageal ﬁstula (MMT) syndrome, 
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and Feingold Syndrome. The principal features of ODED syndrome are clinodactyly of 
the 2nd and 5th ﬁngers; toe syndactyly, typically of the 4th and 5th toes; microcephaly; 
short palpebral ﬁssures; and esophageal/duodenal atresia (Feingold 1975; König  et al. 
1990; Brunner and Winter 1991; Courtens et al. 1997; Feingold et al. 1997; Frydman 
et al. 1997; Innis et al. 1997). EA or duodenal atresia is present in ~33% of patients 
with ODED, whereas minor digital abnormalities are present in all (Brunner and Winter 
1991). We conducted a linkage study of ODED syndrome in a large Dutch family with 
11 affected members, as well as in three other small families. We ﬁrst excluded several 
chromosomal regions containing candidate genes. We then started a genome wide scan 
on the remaining parts of the genome that were not covered by our candidate genes. Our 
results clearly indicate the presence of the ODED-syndrome gene in the p23-p24 region 
of human chromosome 2.
Subjects
The four families with syndromic EA that we analyzed in this study all showed autosomal 
dominant inheritance of the ODED-syndrome phenotype, including toe syndactyly, 
microcephaly, and esophageal and/or duodenal atresia (for pedigrees, see Figures 1 and 
2 ). Family A was described by Brunner and Winter (1991); family B was described by 
Innis et al. (1997); and family C was described by Frydman et al. (1997). Family D is 
an unreported family whose records were contributed by R. Hennekam. Four additional 
isolated patients and small families with ODED syndrome (König et al. 1990; Courtens 
et al. 1997; H.K. and J.T., unpublished data) were examined for mutations of the human 
SIX2 gene. In these small families, as well as in the isolated patients, the core features 
of ODED syndrome—namely, microcephaly, limb abnormalities, and EA or duodenal 
atresia—were present.
 The family with non-syndromic EA (Figure 3) lacked all other ODED-syndrome 
characteristics (speciﬁcally, microcephaly, short palpebral ﬁssures, and limb abnormalities) 
and was evaluated by L.C.P.G.
Material and Methods
Material from patients
After informed consent was obtained, venous blood samples were collected from affected 
and unaffected family members. The DNA used in this study was isolated from peripheral 
blood lymphocytes of patients and relatives, as described elsewhere (Miller et al. 1988).
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Figure 1
Pedigrees used in the DNA-markers studies.
Segregation of chromosome 2 markers is seen in the three-generation Dutch family with ODED syndrome 
(family A). The blackened bar indicates the haplotype that segregates with the disease.  Affected patients III:5 
and III:7 show recombination at markers D2S352 and D2S131, respectively. Pedigrees of the two smaller 
families with ODED syndrome (families B and C)  conﬁrm linkage to the 2p23-p24 region. A recombination at 
D2S390 in individual II:3 (family C) deﬁnes the proximal border of the linkage interval.
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Microsatellite PCR and data analysis
Polymorphic markers used were derived mainly from the Généthon genetic map (Dib et 
al. 1996). PCR reactions were performed in a 12-µl volume containing 50 ng of DNA; 30 
ng of each primer; 200 µM dATP, dGTP, and dTTP; 2.4 µM dCTP; 0.6 µCi [α32P]dCTP; 
10 mM Tris-HCl pH9.0; 50 mM KCl; 1.5 mM MgCl
2
; 0.1% Triton-X100; and 0.3 U of 
Taq DNA polymerase (GIBCO-BRL Life Technologies). After initial denaturation at 94 
°C for 5 min, 30 cycles of ampliﬁcation at 94°C for 1 min, 55°C for 2 min, and 72°C 
for 1 min, and a ﬁnal extension at 72°C for 6 min were performed in a 96-well termal 
cycler (M.J. Research).  Ampliﬁed products were electrophoresed in 6.6% denaturing 
polyacrylamide gels and were visualized by autoradiography on Kodak X-OMAT ﬁlms.
 Linkage calculations were performed, by use of the LINKAGE package (version 5.03), 
on the basis of autosomal dominant inheritance, with full penetrance for the families 
with ODED syndrome, and with incomplete penetrance (50%) for the family with non-
syndromic EA. The frequency of the mutant allele was set at 0.00001. Penetrance was set 
at 100% for the families with ODED, in accordance with other estimates (Brunner and 
Winter 1991). All patient with ODED have, at least, microcephaly and limb abnormalities. 
As for the setting of penetrance to 50% in the family with nonsyndromic EA, this was 
deduced from the pedigree, and it is in agreement with the penetrance of intestinal atresia 
in ODED syndrome. 
DNA sequence analysis 
Exon1 of the SIX2 gene was ampliﬁed from genomic DNA, with the use of overlapping 
primers designed to amplify the six domain from the N terminus of the gene (Six2D + 
Six2B) and the homeobox domain (Six2A + Six2B). The primer sequences were as follows: 
Six2A, GCG TGC TCA AGG CCA AGG CCG TGG; Six2B, CCT GTC GCG CTG CCG 
CCG GTT CT; and Six2D, GCC ACC ATG TCC ATG TTG CC. PCR reactions were 
performed in a 50-µl volume containing 100 ng of DNA, 5 µM of each primer, 0.2mM of 
each dNTP, 1.5 mM of MgCl
2
, 1 x PCR buffer (200 mM Tris-HCl pH 8.4, and 500 mM 
KCl) (Gibco-BRL Life Technologies), and 1 U of Taq DNA polymerase (Gibco-BRL Life 
Technologies). After initial denaturation at 94°C for 2 min, 35 cycles of ampliﬁcation 
at 94°C for 30 sec, 70°C for 1 min, 72°C for 1 min and a ﬁnal extension at 72°C of 6 
min were performed in a PE 480 DNA thermal cycler (PE Biosystems). Products were 
sequenced with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit mix and 
were analysed with a semiautomated sequencer, Applied biosystems model 377 (ABI/PE 
Biosystems). 
Fluorescence in situ hybridization (FISH)
Four DNA probes were applied in our experiments; all were derived from the WC2.2 
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YAC contig of the Whitehead Institute for Biomedical Research/MIT Center for 
Genome Research. To identify chromosome 2, a chromosome paint for 2q was used. 
FISH procedures were applied as described elsewhere (Suijkerbuijk et al. 1992). In brief, 
the probes were labeled with biotin-14-dATP (GIBCO-BRL Life Technologies) while 
paint 2q was labeled with digoxigenin-11-dUTP (Boehringer), by use of standard -nick-
translation.  YACs were precipitated with human Cot.1 DNA (Life Technologies), were 
dissolved in hybridization solution (2 x SSC, 10% dextran sulfate, 1% Tween-20, and 
50% formamide, pH 7.0), and were heat denaturated. Slides were then incubated with the 
probes for 35 h, followed by immunochemical detection by means of avidin FITC and 
successive steps with rabbit anti-FITC and mouse anti-rabbit FITC-conjugated antibodies. 
Slides were evaluated in a Zeiss epiﬂuorescence microscope, and hybridization signals 
and the chromosome counterstained with 4,6-diamidino-2-phenylindole were analyzed 
with the Biological Detection Systems-image software package (ONCOR-Image).
Cloning and mapping of human SIX2
An 884-bp-long human SIX2 cDNA fragment containing the ATG and TAG codons was 
obtained by reverse-transcriptase (RT)-PCR, with the use of primers derived from the 
mouse Six2 gene sequence and of total RNA prepared, by means of the guanidinium 
thiocyanate method (Chomczynski and Sacchi 1987), from 31-wk-old human embryonic 
eyes. RT was performed with the use of oligo-(dT) as a primer and with Moloney murine 
leukemia virus RT. Conﬁrmation that the sequence obtained was indeed human SIX2 was 
obtained by the comparison of its predicted amino acid sequence with the sequences of 
the human SIX1 and the mouse Six1 and Six2 genes. Mapping of the human SIX2 gene 
was performed with the Stanford Human Genome Center G3 Radiation Hybrid Panel 
(Research Genetics), by means of primers derived from the intronic sequences of the 
SIX2 gene.
Results
To uncover the genetic basis of ODED, we started our mapping efforts by focussing 
on chromosomal regions containing candidate genes. Candidate genes were selected on 
the basis of gene-expression patterns, the effect of knockout mutations in mouse, and 
the physiological role of the corresponding proteins. We selected a total of 15 candidate 
genes on the basis of their prominent expression in developing esophagus and limb (e.g., 
PAX9; see Peters et al. 1997), on the basis of occurrence of EA in a knockout animal (e.g., 
Hoxc4;  see Boulet et al. 1996), or because mutations in these genes caused other forms 
of intestinal atresias (e.g., ITGα6; see Pulkkinen et al. 1997). Genes  encoding proteins 
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involved in retinoic-acid metabolism—such as CRABP, RAR and RXR—were considered 
candidates because of their role in apoptotic processes in early development (Båvik et 
al. 1997; Brickell et al. 1997;  Dickman et al. 1997). We also tested genomic regions 
in which deletions are associated with limb abnormalities that match those of ODED 
syndrome (13q14-qter and 2q24-q31) (Brunner and Winter 1991; Boles et al. 1995). 
In total, 12 different regions of the genome were selected. These loci were tested with 
markers at intervals of 5-10 cM in family A shown in ﬁgure 1. No linkage was detected, 
which allowed us to exclude ~15% of the genome. We then started a genomewide linkage 
analysis in family A, to cover those areas not excluded by our candidate gene-directed 
screening. Linkage was almost immediately detected with marker D2S170 (maximum 
LOD score [Z
max
] 3.91 at recombination fraction [θ] 0) from the 2p23-p24 region. Positive 
LOD scores were also found with markers D2S390, D2S149, D2S352, and D2S168 (Table 
1). Linkage was then conﬁrmed for two smaller families (families B and C) (Figure 1). 
Families A-C together give Z
max
 = 4.51 at θ = 0 for D2S390 (Table 1). This cumulative 
Figure 2 
CA-repeat analysis of the microdeletion in 2p23-p24 in family D with ODED syndrome. 
In this family, the genotypes in the affected mother and daughter are inconsistent with Mendelian inheritance 
for the markers between D2S2199 and D2S320. In the affected daughter, these markers show only the father’s 
allele and not the allele that is present in the mother. The mother is also hemizygous for these markers. Note that 
marker D2S2267 is either homozygous or hemizygous in individual II:1.
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Table 1 Combined maximum LOD scores for families A-C with ODED syndrome
  intervala (cM)    Marker   Zmax   Theta
    -   D2S168   1.614   0.143
  3.7   D2S2200   2.047   0.108
  0.0   D2S131   3.393   0.050
  2.9   D2S149   3.608   0.001
12.3   D2S144   3.007   0.001
  2.7   D2S170   2.891   0.064
  0.7   D2S390   4.510   0.001
  6.4   D2S352   2.342   0.106
a Between marker indicated and that on line below.
two point linkage results were conﬁrmed by multipoint linkage analysis that showed 
the presence of association with the disease, between markers D2S131 and D2S390, 
with Z
max
 = 5.1 at marker D2S144. Haplotype analysis in family A (Figure 1) showed 
a recombination event between the disorder and marker D2S131 in affected individual 
III:7, which demarcates the distal border of the linkage interval. Recombination at marker 
D2S352 in an affected male (individual III:5) established the proximal border of the 
region. Haplotype analysis of the two other small families with ODED syndrome showed 
a recombination event between markers D2S170 and D2S144 in an unaffected sibling 
(individual II:2) in family C. With the assumption of complete penetrance, this crossover 
event restricts the linkage area to 18 cM between D2S170 and D2S131. The haplotype 
of family C also showed a recombination within the minimal linkage region at marker 
D2S170 in II:3 (Figure 1). In family D, initial analysis showed that the chromosome 
2 marker alleles in the affected mother and daughter are inconsistent with Mendelian 
inheritance for marker D2S149 (Figure 2). Alternative primers were designed for marker 
D2S149. Identical results were obtained, indicating that this apparently null allele could 
not be explained by a polymorphism in the primer sequences. Absence of a maternally 
inherited allele in individual II:1 was also detected for markers D2S2267, D2S149, 
D2S2295, D2S2346, D2S2155, and D2S332. The mother and the daughter each carried 
only a single allele for these markers. These data are consistent with the presence of a 
microdeletion of 2p23-p24, inherited by an affected daughter from her affected mother 
(Figure 2). The microdeletion was conﬁrmed by in situ hybridization, by use of YACs 
953G11, 916C7, and 875B11 (Figure 3 and data not shown). Each of these YACs gave 
only a single hybridisation signal.  We also tested these YACs for the presence of markers 
used in the marker study: D2S2346 was present in YAC 953G11; D2S312 gave signal 
in YAC 916C7 and in YAC 875B11. Other markers used in this study that have been 
reported to be present in these YACs (Whitehead Institute for Biomedical Research/MIT 
Center for Genome Research) are markers D2S2155 and D2S332, which are present in 
YAC 953G11, and marker D2S2346, which is present in YAC 916C7. 
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 For markers D2S2199 and D2S320, two alleles were present in the affected child 
as well as in the mother. Therefore, these markers are outside the deletion, on either 
side (Figure 2). Marker D2S2267 showed only a single allele in the affected daughter. 
Whether this represents homozygosity or hemizygosity cannot yet be determined. The 
combined data from the linkage analysis in families A-C and the microdeletion in family 
D are consistent with a localization of the ODED-syndrome gene in 2p23-p24, between 
markers D2S2199 and D2S320.
 It is currently unknown whether ODED syndrome is due to a mutation in a single 
gene or whether it might represent a contiguous-gene syndrome. Our ﬁnding of a small 
submicroscopic deletion in family D is consistent with both hypotheses. We decided 
to explore the hypothesis of a contiguous-gene syndrome by examining a family with 
nonsyndromic EA, for linkage to 2p23-p24. Interestingly, haplotype analysis in this small 
family with nonsyndromic EA (Figure 4) is also consistent with an assignment to 2p23-
p24. However, the small size of this family precludes more-deﬁnitive conclusions, and 
the LOD score is only 0.35. 
 We identiﬁed the SIX2 gene as a possible candidate based on homology mapping. The 
Six2 gene is a member of the expanding family of homologues of the Drosophila sine 
oculis gene (Oliver et al. 1995). The Six2 gene was originally cloned in the mouse (Oliver 
et al. 1995). Six2 maps on mouse chromosome 17, between Lhcgr (luteinizing hormone/
choriogonadotropin receptor) and Sos1, both of which map to 2p21-p22 in humans. This 
suggested that the human SIX2 gene might also map to this region. The pattern of mRNA 
expression during embryogenesis of Six2 in the mouse is strikingly similar to what 
might be expected for the ODED-syndrome gene. Six2 has prominent expression in the 
esophagus, pyloric region, hindbrain, and interdigital mesenchyme (Oliver et al. 1995). 
Figure 3 
FISH characterization of the microdeletion in 2p23- p24 in family D with ODED syndrome. 
FISH with YAC probe 953G11 from 2p23-p24 shows only a single signal in a patient with ODED syndrome 
(patient II:1 in family D).
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Figure 4 
Pedigree of family E with nonsyndromic familial EA. 
Marker D2S149 segregates with the nonsyndromic form of familial EA. A recombination in individual IV:1 
excludes markers proximal to D2S144.
Figure 5 
Human SIX2 partial cDNA sequence. 
Primers used are in italic lowercase type; start and stop codons are in boldface type; the SIX domain is 
underlined; and the homeobox domain is underlined twice.
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We used primers to amplify 546 bp of the human SIX2 cDNA sequence containing the Six 
and homeobox domains (Figure 5). The analysis failed to identify any abnormalities in a 
panel of eight unrelated patients with ODED syndrome. Mapping of the human SIX2 gene 
was performed with the Stanford Human Genome Center G3 Radiation Hybrid Panel 
(Research Genetics), by use of primers derived from the intronic sequences of the SIX2 
gene. The statistical evaluation of the results conﬁrmed the predicted location for SIX2 
and placed it on chromosome 2, 20 cM from sequence-target-site marker SHGC-11647 
(LOD score 5.76), within the 5.2-cM interval deﬁned by the Généthon markers D2S119 
and D2S288. This is outside the ODED-syndrome critical region. These mapping results, 
as well as our failure to identify mutations in the two major domains of the SIX2 gene, 
exclude it as the ODED-syndrome gene.
Discussion
We report the assignment of a gene for the autosomal dominant syndrome of EA, 
syndactyly, and microcephaly (ODED or Feingold syndrome) to the short arm of 
chromosome 2. Signiﬁcant evidence for linkage was obtained in a large Dutch kindred. 
Analysis of two smaller kindreds conﬁrmed the original assignment and narrowed the 
interval to a 18.3-cM region between markers D2S131 and D2S170.
 In a smaller family, an apparently null allele for markers D2S2267, D2S149, 
D2S2295, D2S2346, D2S2155, and D2S332 was inherited by an affected daughter from 
her affected mother. These ﬁndings are best explained by a microdeletion in 2p23-p24. 
This interpretation was supported by FISH analysis which indicated the presence of a 
single copy of probes from 2p23-2p24. The combined data from the linkage analysis and 
from the microdeletion suggest that the critical region for the ODED-syndrome gene lies 
in a 7.3-cM region between markers D2S2199 and D2S320 (Figure 6). 
 The SIX2 gene appeared a strong candidate, on the basis of its expression pattern during 
mouse development (Oliver et al. 1995) and its localization in a mouse chromosome 17 
region that is syntenic to human 2p21-p22. However, the lack of mutations in SIX and 
homeobox domains of SIX2 in 8 unrelated ODED-syndrome families and the subsequent 
localization of SIX2 outside the ODED-syndrome critical interval, by means of radiation-
hybrid mapping, excluded SIX2 as the ODED-syndrome gene. 
 The ODED linkage region contains the locus for syndecan-1 precursor (SYND1), 
which is a possible positional candidate gene. The syndecans are a family of cell-
surface heparan sulfate proteoglycans that interact with adesion molecules, growth 
factors, and a variety of other molecules. SYND1 is thought to function as a receptor 
for extracellular-matrix components and growth factors that are differentially expressed 
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during development (David et al. 1993). Synd1 is strongly expressed in esophageal, facial, 
and digital mesenchyme in mouse embryos (Mitsiadis et al. 1995). Fine mapping of the 
SYND1 gene will be required in order to establish whether the gene is contained within 
the deletion area in family D.
 Study of  knockout mice may help to unravel the pathways that are involved in 
normal esophageal development. Several such targeted mutations have been reported to 
be associated with EA, but none of these genes map to the ODED-syndrome critical 
region. EA is present in mice mutants carrying nonfunctional alleles of Hoxc4 (Boulet 
and Capecchi 1996) and in mice that have a homozygous null mutation for the Gli2 
gene (Motoyama et al. 1998). The human GLI2 gene is located in 2q14, which is well 
outside the ODED-syndrome region identiﬁed here. Similarly, the occurrence of EA in 
mice that have a homozygous null mutation of the sonic hedgehog (Shh) gene (Litingtung 
Figure 6 
Comparison of linkage intervals for families A–C with ODED syndrome, the microdeletion in family D (the 
diagonally barred area indicates possible reduction of the deleted area; see text), and the cosegregating haplotype 
in nonsyndromic family E. In family E, the linkage interval continues more distally. Distances (in cM) between 
each marker and the next are indicated and are computed on the basis of average distances on the Généthon map 
for chromosome 2 (Dib et al. 1996).
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et al. 1998) does not provide a likely explanation for EA in humans. The SHH gene is 
located on chromosome 7q36 in humans, and mutations are speciﬁcally associated with 
holoprosencephaly (Roessler et al. 1996).  
 Like many other structural malformations in humans, isolated EA is probably a 
multifactorial disorder. A number of familial cases have been identiﬁed (Casteels et al. 
1993), but the actual recurrence risk is only ~1% in sporadic cases (van Staey et al. 1984). 
Because ODED syndrome carries a 30% risk of EA and/or duodenal atresia and because 
ODED syndrome is probably still underdiagnosed, it is possible that most cases of familial 
EA are in fact due to this syndrome. We have already identiﬁed four families  with ODED 
syndrome from the Netherlands alone, indicating that the syndrome may not be extremely 
rare. Also, the microcephaly associated with the syndrome is mild and is associated with 
minimal learning disability or even normal intelligence (Brunner and Winter 1991; 
Feingold et al. 1997; Kawame et al. 1997). Some cases lack the distinctive toe syndactyly 
(Feingold et al. 1997) and may easily be misdiagnosed as nonsyndromic EA. Our ﬁnding 
of a microdeletion in 2p23-p24 in family D raises the possibility that ODED syndrome 
could represent a contiguous-gene syndrome. In this regard, it is of interest that the results 
of haplotype analysis conducted on a small family with nonsyndromic familial EA are 
consistent with a causative gene in 2p23-p24 (Figure 4). Families with autosomal dominant 
microcephaly (Rossi et al. 1987) and families with autosomal dominant EA (Pletcher et 
al. 1991) but without other ODED-syndrome characteristics have been reported. If such 
families are also consistent with linkage to 2p23-p24 this would strengthen the hypothesis 
that ODED syndrome is in fact a microdeletion syndrome. 
 The best name for the syndrome studied here remains to be found. In view of the 
expanding phenotype, which now includes deafness and kidney anomalies  in some cases, 
we suggest that the term “Feingold syndrome” be used, in preference to the acronyms 
“ODED”, “MODED”, or “MMT”. 
 In conclusion, haploinsufﬁciency of a gene or genes in 2p23-p24 causes syndromic 
EA (Feingold or ODED syndrome). Cloning of the ODED-syndrome gene should shed 
light on a signiﬁcant proportion of inherited EA.
Acknowledgments
This study was supported by the Dutch Foundation for Scientiﬁc Research (Nederlandse 
Organisatie voor Wetenschappelijk Onderzoek) grant 901-04-183 (to H.G.B.), and the 
Dutch Liver-Gut Foundation, grant WS 97-81 (to H.v.B.). The skillful assistance of 
Saskia van de Velde-Visser, Lisbeth Boender-van Rossum, Bellinda van der Helm, Gerard 
Merkx, and Irene Janssen is gratefully acknowledged. We thank Dr. Hans Scheffer, 
Appendix 4 - Familial syndromic esophageal atresia maps to 2p23-p24
201
Rijkuniversiteit Groningen, for chromosome 13 mapping.
Electronic-Database Information
Accession numbers and URLs for data in this article are as follows:
Généthon, Human Genome Research Center, http://www.genethon.fr/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/   
 (for VATER association [MIM 192350] and ODED syndrome  [MIM 164280])
Stanford Human Genome Center, http://www-shgc.stanford.edu
Whitehead Institute for Biomedical Research/MIT Center for Genome Research, 
 http://www-genome.wi.mit.edu
References
Bavik C, Ward SJ, Ong DE (1997) Identiﬁcation of a mechanism to localize generation 
of retinoic acid in rat embryos. Mech Dev 69:155-167
Beasley SW, Allen M, Myers N (1997) The effects of Down syndrome and other 
chromosomal abnormalities on survival and management in oesophageal atresia. Pediatr 
Surg Int 12:550-551
Boles RG, Pober BR, Gibson LH, Willis CR, McGrath J, Roberts DJ, Yang Feng TL 
(1995) Deletion of chromosome 2q24-q31 causes characteristic digital anomalies: case 
report and review. Am J Med Genet  55:155-160
Boulet AM, Capecchi MR  (1996) Targeted disruption of hoxc 4 causes esophageal 
defects and vertebral transformations. Dev Biol 177:232-249
Brewer C, Holloway S, Zawalnyski P, Schinzel A, FitzPatrick D (1998) A chromosomal 
deletion map of human malformations. Am J Hum Genet 63:1153-1159
Brickell P, Thorogood P (1997) Retinoic acid and retinoic acid receptors in craniofacial 
development. Seminars in Cell and Developmental Biology 8:437-443 
Brunner HG, Winter RM  (1991) Autosomal dominant inheritance of abnormalities of 
the hands and feet with short palpebral ﬁssures, variable microcephaly with learning 
disability, and oesophageal/duodenal atresia. J Med Genet 28:389-394
Casteels K, Devlieger H, Lerut T, Eggermont E (1993) [Familial occurrence of 
esophageal atresia]. Tijdschr Kindergeneeskd 61:100-102
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction.  Anal Biochem 162:156-168,
Courtens W, Levi S, Verbelen F, Verloes A, Vamos E (1997) Feingold syndrome: report 
of a new family and review. Am J Med Genet 73:55-60
Resolving the molecular basis of human malformation syndromes
202
David G, Bai XM, Van der Schueren B, Marynen P, CassimanJJ, Van den Berghe H 
(1993) Spatial and temporal changes in the expression of ﬁbroglycan (syndecan-2) 
during mouse embryonic development. Development 119:841-854
David TJ, O’Callaghan SE (1975) Oesophageal atresia in the South West of England. J 
Med Genet 12:1-11
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, et al. (1996) A 
comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 
380:152-4
Dickman ED, Thaller C, Smith SM (1997) Temporally regulated retinoic acid depletion 
produces speciﬁc neural crest, ocular and nervous system defects. Development 
124:3111-3121
Digilio MC, Marino B, Bagolan P, Giannotti A, Dallapiccola B (1999) Microdeletion 
22q11 and oesophageal atresia. J Med Genet 36:137-139
Feingold M (1975) Case report 30. Synd Ident 3:16-17
Feingold M, Hall BD, Lacassie Y, Martinez Frias ML  (1997) Syndrome of 
microcephaly, facial and hand abnormalities, tracheoesophageal ﬁstula, duodenal atresia, 
and developmental delay. Am J Med Genet 69:245-249
Frydman M, Katz M, Cabot SG, Soen G, Kauschansky A, Sirota L (1997) MODED: 
microcephaly oculo digito esophageal duodenal syndrome. Am J Med Genet 71:251-257
Innis JW, Asher JH Jr, Poznanski AK, Sheldon S (1997) Autosomal dominant 
microcephaly with normal intelligence, short palpebral ﬁssures, and digital anomalies. 
Am J Med Genet 71:150-155
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, et al. 
(1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. 
Science 272:1668-1671
Kawame H, Pagon RA, Hudgins L (1997) Digital anomalies, microcephaly, and normal 
intelligence: new syndrome or Feingold syndrome? Am J Med Genet 69:240-244
Kimble RM, Harding J, Kolbe A (1997) Additional congenital anomalies in babies with 
gut atresia or stenosis: when to investigate, and which investigation. Pediatr Surg Int 
12:565-570
König R, Selzer G, Stolp A, Fuchs S (1990) Microcephaly, mesobrachyphalangy, and 
tracheoesophageal ﬁstula: MMT syndrome. Dysmorphol Clin Genet 4:83-86
Litingtung Y, Lei L, Westphal H, Chiang C (1998) Sonic hedgehog is essential to foregut 
development. Nat Genet 20:58-61
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for exctracting 
DNA from human nucleated cells. Nucleic Acid Res 16:1215
Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, Lehtonen E, 
Jalkanen M, et al. (1995) Expression of the heparin-binding cytokines, midkine (MK) 
and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions 
during fetal development and organogenesis. Development 121:37-51
Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC (1998) Essential function of Gli2 
and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet 20:54-57
Appendix 4 - Familial syndromic esophageal atresia maps to 2p23-p24
203
Oliver G, Wehr R, Jenkins NA, Copeland NG, Cheyette BN, Hartenstein V, Zipursky SL, 
et al.  (1995) Homeobox genes and connective tissue patterning. Development 121:693-
705
Peters H, Schuster G, Neubuser A, Richter T, Hoﬂer H, Balling R (1997) Isolation of the 
Pax9 cDNA from adult human esophagus. Mamm Genome 8:62-64
Pletcher BA, Friedes JS, Breg WR, Touloukian RJ (1991) Familial occurrence of 
esophageal atresia with and without tracheoesophagel ﬁstula: report of two unusual 
kindreds. Am J Med Genet. 39:380-384
Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J (1997) Homozygous 
alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal 
atresia. Hum Mol Genet 6:669-674
Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, et al. (1996) 
Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 
14:357-360
Rossi LN, Candini G, Scarlatti G, Rossi G, Prina E, Alberti S (1987) Autosomal 
dominant microcephaly without mental retardation. Am J Dis Child 141:655-659
Suijkerbuik RF, Looijenga L, Jong B de, Oosterhuis JW, Cassiman JJ, Geurts van Kessel 
A (1992) Veriﬁcation of isochromosome 12p and other chromosome 12 aberrations 
in gonadal and extragonadal human germ cell tumors by bicolor ﬂuorescence in situ 
hybridization. Cancer Genet Cytogenet 63:8-16
Szendrey T, Danyi G, Czeizel A (1985) Etiological study on isolated esophageal atresia. 
Hum Genet 70:51-58
Van Staey M, De Bie S, Matton MT, De Roose J (1984) Familial congenital esophageal 
atresia. Personal case report and review of the literature. Hum Genet 66:260-266
Resolving the molecular basis of human malformation syndromes
204
Jacopo Celli, Hans van Bokhoven, and Han G. Brunner
University Medical Center Nijmegen, Department of Human Genetics, 
Nijmegen, the Netherlands
American Journal of Madical Genetics (2003) 122A(4): 294-300
Appendix 5
Feingold Syndrome:
Clinical Review and Genetic Mapping
Resolving the molecular basis of human malformation syndromes
206
American Journal of Medical Genetics 122A:294–300 (2003)  © 2003 Wiley-Liss, Inc.
Appendix 5 - Feingold syndrome: clinical review and genetic mapping
207
Summary
Feingold syndrome is characterized by autosomal dominant inheritance of microcephaly 
and limb malformations, notably hypoplastic thumbs, and clinodactyly of second and 
ﬁfth ﬁngers. Syndactyly frequently involves the second and third, as well as of the fourth 
and ﬁfth toes. Approximately one in three Feingold syndrome patients have esophageal 
or duodenal atresia or both. Anal atresia has been reported in a single case. At least 
79 patients in 25 families have been reported. The syndrome has autosomal dominant 
inheritance with full penetrance, and variable expressivity. Vertebral anomalies, cardiac 
malformations, and deafness have been noted in a minority of patients. Here, we report a 
patient with hydronephrosis of one kidney and cystic dysplasia of the other, necessitating 
nephrectomy. The overall pattern of malformations in Feingold syndrome shows 
considerable overlap with the VATER/VACTERL association.  The gene for Feingold 
syndrome maps to 2p23-p24, but it remains to be identiﬁed. Comparison of the pattern 
of anomalies that occurs in the Feingold syndrome in humans and malformations that are 
present in mice with mutations of genes in the sonic hedgehog signaling pathway suggest, 
that the elusive Feingold syndrome gene may be involved in this signaling pathway as 
well.
Introduction: monogenic causes of intestinal atresias
Few monogenic causes of intestinal atresias are known in humans. The empiric risks of 
recurrence of nonsyndromic esophageal atresia, duodenal atresia, and anal atresia are 
all very low and only a limited number of families have been reported, in which the 
inheritance pattern is compatible with monogenic or polygenic inheritance [Benawra et 
al., 1981; Best et al., 1989; Pletcher et al., 1991; Landau et al., 1997; Robb and Teebi 
1998]. One exception is the autosomal recessive inheritance of  junctional epidermolysis 
bullosa with congenital duodenal atresia which is due to mutations of  the alpha6 integrin 
gene [Pulkkinen et al., 1997]. 
 Considerable evidence shows that some cases of the apple peel form of small bowel 
atresia are inherited as an autosomal recessive condition [Farag et al., 1993]. Yet, we 
have seen typical apple peel atresia in a child with absent toes, which is suggestive of an 
embryonic disruption of circulation. Similarly, apple peel atresia has been observed in 
patients with amyoplasia, another nongenetic condition that likely reﬂects an intrauterine 
vascular disruption [Reid et al., 1986].
 VATER or VACTERL association is the most frequent diagnosis made in patients 
with multiple congenital abnormalities involving esophageal, duodenal, or anal atresia. 
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Recurrence of VACTERL association in a family is extremely rare, and it is reasonable 
to assume that it is normally a nongenetic condition. Recent results using mouse models 
suggest that defects of either sonic hedgehog or GLI signalling may cause VACTERL-type 
abnormalities [Kim et al., 2001]. Other studies have shown that adriamycin administration 
in rats on embryonal day 10 causes abnormalities of the notochord which is streched, 
split or tethered to the foregut. This ultimately results in esophageal atresia. Since the 
notochord secretes sonic hedgehog as an important patterning factor, both processes may 
be linked [Orford et al., 2001].
 Esophageal atresia may occur as a feature of CHARGE association, which is commonly 
regarded as a monogenic disorder or possible microdeletion syndrome. However, recent 
studies using comparative genomic hybridisation or microsatellite markers failed to 
detect a microdeletion in CHARGE association, and this hypothesis remains unproven 
[Sanlaville et al., 2002; Lalani et al., 2003]. 
At least three children with an interstitial deletion of the long arm of chromosome 17 
and esophageal atresia have been reported. The smallest critical region is 17q2-q23.3 
[Marsh et al., 2000]. Other features included microcephaly, facial anomalies, proximal 
by placed thumbs, and developmental delay. Some had congenital heart defects. Several 
patients had  symphalangism, which may be due to the presence of the Noggin gene in 
17q22 [Gong et al., 1999]. This far, no systematic study of this locus has been performed 
in patients with nonsyndromic esophageal atresia.
 A number of monogenic causes of anal atresia are known. These include Pallister-
Hall syndrome, Townes-Brocks syndrome, and Currarino triad due to either mutation 
or deletion of the HLXB9 homeobox gene at 7q36. The Currarino triad consists of anal 
stenosis or atresia, anterior meningocele, and sacral agenesis. 
 The syndrome originally delineated by Townes and Brocks [1972] is characterized 
by imperforate anus, triphalangeal thumbs, abnormal ears and deafness inherited as 
an autosomal dominant condition. The SALL1 gene that is mutated in Townes-Brocks 
syndrome encodes a zinc-ﬁnger protein thought to act as a transcription factor that is 
activated in response to sonic hedgehog signalling [Kohlhase et al., 1998]. Only completely 
inactivating mutations in the SALL1 gene cause Townes-Brocks syndrome. Missense 
mutations have not been detected which raises the possibility that such mutations may 
cause a variant phenotype [Kohlhase, 2000]. It can be speculated that milder mutations 
of SALL1 might be involved in nonsyndromic anal atresia. Speciﬁcally, in the normal 
population there is considerable allelic variation of a complex serine/glycine repeat 
amino-terminal to the ﬁrst double zinc-ﬁnger. This far, no studies of the SALL1 gene in 
nonsyndromic patients with anal atresia appear to have been performed.
 The FG syndrome combines mental retardation, and characteristic facial anomalies 
inherited in an X-linked fashion [Opitz and Kaveggia, 1974]. Many patients with FG 
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syndrome have constipation, which can be due to anal stenosis. Anal atresia occurs less 
frequently.
 Anal atresia is frequently noted in patients with distal deletions of the long arm of 
chromosome 13 [Walsh et al., 2001]. This appears to be the most frequent chromosomal 
abnormality detected in patients with syndromic anal atresia after Down syndrome. A 
speciﬁc association with anal atresia and transposition of the genitalia has been reported 
[Bartsch et al., 1996].  The critical region has been delineated as 13q32.2-q34.
Feingold syndrome
The syndrome originally described by Feingold [1975] is characterised by autosomal 
dominant inheritance of microcephaly and limb malformations, notably hypoplastic 
thumbs, and brachymesophalangy with clinodactyly of second and ﬁfth ﬁngers. 
Syndactyly variably involves the second and third, as well as of the fourth and ﬁfth toes. 
Approximately, one in three have esophageal or duodenal atresia or both [Brunner and 
Winter, 1991;  Feingold et al., 1997]. Anal atresia has been reported in a single case 
[Büttiker et al., 2000].
 The syndrome has been reported under several different names including oculo-
duodeno-esophageal-digital syndrome (OMIM 164280), microcephaly-oculo-duodeno-
esophageal-digital syndrome, and microcephaly-mesobrachyphalangy-tracheoesophageal 
ﬁstula syndrome. Because of the ever expanding phenotype which now includes renal, 
cardiac, and inner ear malformations, we have previously suggested the term Feingold 
syndrome after its discoverer  [Celli et al., 2000]. We have seen several unrelated patients, 
and would suggest that Feingold syndrome is the most frequent monogenic cause of 
esophageal and duodenal atresia.
 Feingold syndrome was ﬁrst reported in 1975 [Feingold, 1975]. Since then, 79 patients 
in 25 families have been reported. The syndrome has autosomal dominant inheritance with 
full penetrance, and variable expressivity.  More females than males have been reported 
but this is unexplained. The gene for Feingold syndrome maps to 2p23-p24, but it remains 
to be identiﬁed [Celli et al., 2000].
 Here we provide an update on the clinical characteristics of the syndrome. We highlight 
its overlap with the VATER association and discuss the possibility that the genetic defect 
resides in a gene in the sonic hedgehog signaling pathway. We further review our progress 
in cloning the responsible gene in chromosome 2p23-p24.
Phenotype
A summary of the ﬁndings in 79 patients from 25 families is found in Table 1, including 
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Table 1 Clinical ﬁndings in Feingold syndrome in 79 patients from 25 families
Families 25
M 31 39%
F 48 61%
Microcephaly 69/79 86%
Learning disability 24/58 41%
Short palpebral ﬁssures 36/63 57%
Brachy-mesophalangy 72/76 95%
Syndactyly toes 47/59 80%
Thumb hypoplasia 13/72 18%
Gastrointestinal atresia 30/79 38%
      TE 20/79 25%
      DA/DO 13/79 16%
      Annular pancreas 3/79
      JA 1/79
      AA 1/79
Renal 4/76 5%
Heart 10/70 14%
      PDA 8/70 11%
      Other cardiac abnormality 3/70 4%
Deafness 4/58 7%
Asplenia/polysplenia 2/79
The data are from published reports [Feingold, 1975, 1978; Konig et al., 1990; Brunner and 
Winter, 1991; Courtens et al., 1997; Feingold et al., 1997; Frydman et al., 1997; Innis et al., 1997; 
Kawame et al., 1997; Dodds et al., 1999; Büttiker et al., 2000; Piersall et al., 2000; Roeder et 
al., 2002] and include the patient reported here. TE, esophageal atresia or tracheo-esophageal 
ﬁstula; DA/DO, duodenal atresia/duodenal obstruction; JA, jejunal atresia; AA, anal atresia. 
published reports [Feingold, 1975, 1978;  Konig et al., 1990; Brunner and Winter, 1991; 
Courtens et al., 1997; Feingold et al., 1997; Frydman et al., 1997; Innis et al., 1997; 
Kawame et al., 1997; Dodds et al., 1999; Büttiker et al., 2000; Piersall et al., 2000; Roeder 
et al., 2002] and the patient reported here.
 Digital abnormalities and mild-to-moderate microcephaly form the core phenotype 
and usually allow for instant recognition of the syndrome. Intestinal atresias and other 
malformations of internal organs occur frequently and are the main reason for referral to 
the geneticist.
 Almost all individuals with Feingold syndrome have characteristic short middle 
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phalanges of the second and ﬁfth ﬁngers (Figure 1B). Many have either hypoplastic 
thumbs [Brunner and Winter, 1991; Courtens et al., 1997; Alessandri et al., 2000], or 
ﬂexion, limitation, or  hyperextensibility of the thumbs [Feingold et al., 1997; Frydman et 
al., 1997]. Camptodactyly of  one or more ﬁngers, cubitus valgus, or limitation of elbow 
extension may all be present [Brunner and Winter, 1991; Frydman et al., 1997; Roeder 
et al., 2002]. Most patients have syndactyly of the toes, either second and third, or more 
characteristically of the fourth and ﬁfth toes (Figure 1C). Approximately, 85% of reported 
cases have had congenital microcephaly, which in some cases become more pronounced 
after the neonatal period. Mild mental retardation or learning disability has been reported 
in about half of those with microcephaly. The original patients reported by Feingold 
[1975, 1978] were considered to be of normal intelligence. At a later time, reevaluation 
demonstrated that they did, in fact, have consistent learning disability [Feingold et al., 
1997]. We have previously suggested that those with the smallest head circumference 
may have more severe learning disability [Brunner and Winter, 1991]. Nonetheless, some 
cases with very small head size and apparently normal development have been reported 
[Innis et al., 1997]. Feingold syndrome patients tend to have short palpebral ﬁssures 
(Figure 1A). In others, the eyes appear normal. 
Figure 1
Phenotype of a patient with Feingold syndrome. 
This patient is the ﬁrst child of healthy nonconsanguineous Dutch parents. Two maternal half-siblings are healthy. 
He was born with esophageal atresia and tracheo-esophageal ﬁstula. At the age of 18 months, OFC was 46.5 
cm (<3rd centile). Height and weight are both at the 10th centile for age. His development is normal and at the 
age of 6 years, he attends regular school. Further evaluation during the neonatal period showed a nonfunctional 
small left dysplastic kidney, and slight right hydronephrosis. A: Facial features of Feingold syndrome at age 4 
years. Note microcephaly and short palpebral ﬁssures. B: Short middle phalanges of the second and ﬁfth ﬁngers 
bilaterally. There is camptodactyly of the left second ﬁnger. Note slightly small thumbs. C: Feet of patient with 
Feingold syndrome and dysplastic kidney. Note bilateral syndactyly of the second and third toes, and syndactyly 
of the right fourth and ﬁfth toes. Note the gap between the left ﬁrst and second toes.
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VATER type malformations in Feingold syndrome
Intestinal atresias
A gastrointestinal atresia is present in almost 40% of cases of Feingold syndrome. 
Esophageal atresia with or without tracheo-esophageal ﬁstula was most frequent (25%). 
The second most frequent is duodenal atresia or stenosis. During surgery, the latter may 
sometimes be caused by an annular pancreas [Brunner and Winter, 1991; Dodds et al., 
1999]. A single case of multiple jejunal atresias and another with anal atresia have also 
been reported [Büttiker et al., 2000; Roeder et al., 2001]. 
Cardiovascular anomalies
Cardiac abnormalities are rarely severe. At least eight patients (10%) had patent ductus 
arteriosus. Only three had other heart defects. One patient died in the neonatal period of 
tricuspid atresia, VSD, and interrupted aortic arch [Brunner and Winter, 1991]. Another 
had mild tricuspid stenosis [Piersall et al., 2000]. One patient had a small VSD and patent 
foramen ovale [Büttiker et al., 2000].  
Renal anomalies
Renal anomalies appear to be uncommon, although their frequency may be an 
underestimate. Mild dilatation of the renal pelvis [Frydman et al., 1997],  small kidneys 
[Büttiker et al., 2000], and extrarenal pelvis [Piersall et al., 2000] represent minor variants. 
However, our recent patient (Figure 1A-C) had hydronephrosis on one side, and cystic 
dysplasia on the other, necessitating nephrectomy.
Vertebral abnormalities
Absence of the 5th sacral vertebra and fusion of C
5
-C
7
 were detected in one child and 
her father,  respectively [Piersall et al., 2000]. Another patient had only 11 pairs of ribs 
[Büttiker et al., 2000].
Other abnormalities
At least 4 reported patients had deafness. Two cases had unilateral complete deafness 
[Brunner and Winter, 1991; Courtens et al., 1997], and one case had bilateral low-tone 
hearing loss [Frydman et al., 1997]. Another patient had bilateral complete deafness 
attributed to absence of the auditory nerve [Dodds et al., 1999].
 In one family an affected female had two small accessory spleens, whereas her mother 
had asplenia [Courtens et al., 1997].
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VACTERL type malformations and the sonic hedgehog signaling pathway
Several authors have noted that abnormalities of the trachea, esophagus, kidneys, vertebrae, 
and heart all occur in mice with mutations of  sonic hedgehog  or its downstream effectors 
Gli2 and Gli3 [Kim et al., 2001; de Santa Barbara, 2002]. Among these, maldevelopment 
of the gastrointestinal tract is especially striking. Sonic hedgehog knockout mice may 
have esophageal atresia, anal atresia, anal stenosis, cloaca, midgut malrotation, duodenal 
atresia, and annular pancreas [Lichtingtung et al., 1998; Romalho-Santos et al., 2000; Mo 
et al., 2001]. In addition, other malformations within the VATER/VACTERL spectrum 
have been reported including cardiac defects, solitary kidney, and lack of the vertebral 
column [see Kim et al., 2001 for review]. Defects in the genes encoding the downstream 
effectors of sonic hedgehog also cause a number of similar abnormalities [Motoyama et 
al., 1998; Kim et al., 2000; Mahalapuu et al., 2001].
 Heterozygous mutations of the sonic hedgehog gene in humans do not cause any 
limb abnormalities [Roessler et al., 1996]. Nonetheless, there is considerable evidence 
to implicate hedgehog signalling in malformations of the limb, including syndactyly. 
Human disorders caused by inborn errors of cholesterol biosynthesis, such as the Smith-
Lemli-Opitz syndrome, include limb malformations that are observed at high frequency 
in some disorders indicating a pivotal role of cholesterol in limb morphogenesis. It has 
been demonstrated that cholesterol can modulate the activity of the hedgehog proteins, 
that act as morphogens to regulate the precise patterning of many embryonic structures, 
among which the developing limbs. A recent study demonstrated that treatment with a 
distal inhibitor of cholesterol biosynthesis results in an imbalance of Indian Hedgehog 
expression in the forming cartilage, ultimately leading to reduced interdigital apoptosis 
and syndactyly [Gofﬂot et al., 2003].
 Homozygous Shh-/- mutations in mice result in polydactyly, and heterozygous disruption 
of a long-range cis-acting regulator for SHH similarly causes preaxial polydactyly in 
humans [Lettice et al., 2002]. 
Other Feingold syndrome features that may involve sonic hedgehog 
signalling
Sensorineural deafness and microcephaly are both recurrent features of Feingold 
syndrome. In one case, the auditory nerve appeared to be lacking bilaterally [Dodds et al., 
1999]. Shh knockout mice similarly have maldevelopment of the inner ear. Speciﬁcally, 
ventral otic derivatives, including the cochlear duct and cochleo-vestibular ganglia, failed 
to develop in the absence of Shh [Riccomagno et al., 2002].
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In humans, homozygous inactivation of the sonic hedgehog gene (SHH-/-) has not yet 
been reported. Heterozygous deletions and mutations of the sonic hedgehog gene (SHH+/-) 
have been shown to cause holoprosencephaly, but not other malformations [Roessler et 
al., 1996]. 
 Heterozygous mutations of the downstream GLI3 gene cause a number of related 
syndromes that involve polydactyly, syndactyly, anal atresia, facial abnormalities, and 
sometimes developmental brain anomalies [Hall et al., 1980; Baraitser et al., 1983; 
Biesecker 1997; Kang et al., 1997].
 Microcephaly reﬂects reduced growth and development of the dorsal telencephalon. 
There is increasing evidence that sonic hedgehog signalling is critical for multiple aspects 
of growth and development of the brain. Shh-/- mice can have holoprosencephaly which 
indicates an embryonal disturbance of development of the ventral telencephalon  [Chiang 
et al., 1996]. Mice Gli3-/- have abnormal development of the telencephalon. The data are 
consistent with a role for the sonic hedgehog signaling cascade in brain growth, notably 
the cerebellum and the dorsal telencephalon [Britto et al., 2002; Marti and Bovolenta, 
2002; Ruiz i Altaba et al., 2002]. Thus, the phenotypic effects of various sonic hedgehog 
mutations and its downstream effectors in both humans and mice, show remarkable 
overlap with the overall pattern of malformations in Feingold syndrome.
Mapping of the gene for Feingold syndrome to 2p23-p24
The gene for Feingold syndrome was previously localized to a 7.3 cM region on the short 
arm of chromosome 2 [Celli et al., 2000]. Three families showed signiﬁcant evidence for 
linkage to this site. A fourth family had a microdeletion of the critical region in 2p23-p24, 
conﬁrmed by FISH. 
 We have further narrowed the critical region for Feingold syndrome to a 2.2 cM 
region encompassed by microsatellite markers D2S2295 and D2S320 (Figure 2). The 
critical recombinant  occurred in a family that was previously reported  [Büttiker et al., 
2000]; recombination occurred in the critical region of chromosome 2, where only the 
centromeric portion of the chromosome is shared between the two affected siblings. 
This region contains three known genes: visinin-like (VSNL1), a potassium channel 
(KCNS3), and a DNA repair gene (SMC6L1). Two predicted genes map to this interval: 
DKFZP566A1524 and FLJ40869. The SARA-like sequence is likely to be a pseudogene. 
The mesogenin1-like gene is either a pseudogene or an intronless gene.
Mutation analysis was carried out for DKFZP566A1524 (12 exons), SARA-like (1 exon), 
VSNL1 (4 exons), SMC6L1 (28 exons), KCNS3 (3 exons) in a panel of 10 independent 
families, but no mutations were found. Mutation analysis for FLJ4086 (7 exons) and 
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mesogenin1-like (1 exon) is in progress.
The accurate mapping of the gene for Feingold syndrome to a 1.97  megabase region in 
2p23-p24 between D2S320 and D2S2295  should allow the identiﬁcation of the underlying 
gene within the near future. Since linkage analysis in a family with nonsyndromic 
esophageal atresia was also compatible with this locus [Celli et al., 2000], it may be worth 
examining the hypothesis that hypomorphic mutations of the Feingold syndrome gene 
could also be responsible for apparent nonsyndromic forms of esophageal or duodenal 
atresia.
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Figure 2 
Critical region for the Feingold syndrome gene in 2p23-p24. 
Data were derived from the Human Genome Browser freeze of April 2003 (http://genome.cse.ucsc.edu). 
Figures above the line indicate distances separating adjacent markers in megabases. Figures below the line 
indicate positions in centimorgans. Flanking markers are D2S2295 (distal) and D2S230 (proximal) spanning 
a 1.97 megabase interval. This region contains three known genes: visinin-like (VSNL1), a potassium channel 
(KCNS3), and a DNA repair gene (SMC6L1). Two predicted genes map to this interval: DKFZP566A1524 and 
FLJ40869. The SARA-like sequence is likely to be a pseudogene. The mesogenin1-like sequence may be either 
a true gene or a pseudogene. Mutation analysis by direct sequencing was carried out for DKFZP566A1524 
(12 exons), SARA-like (1 exon),VSNL1 (4 exons),SMC6L1 (28 exons), KCNS3 (3 exons) in a panel of 10 
independent families with Feingold syndrome, but no mutations were found. Mutation analysis for FLJ4086 (7 
exons) and mesogenin1-like (1 exon) is in progress.
Resolving the molecular basis of human malformation syndromes
216
Helm is also thanked.
References
Alessandri J, Graber D, Tiran-Rajoefera I, Montbrun A, Pilorget H, Samperiz S, Attali T, 
de Npoli-Cocci S (2000): Syndrome de Feingold. Arch Pédiatr 7:637-40.
Baraitser M, Winter RM, Brett EM (1983): Greig cephalopolysyndactyly: report of 13 
affected individuals in three families. Clin Genet 24:257-65.
Bartsch O, Kuhnle U, Wu LL, Schwinger E, Hinkel GK (1996): Evidence for a critical 
region for penoscrotal inversion, hypospadias, and imperforate anus within chromosomal 
region 13q32.2q34. Am J Med Genet Oct 28;65(3):218-21.
Benawra R, Puppala BL, Mangurten HH, Booth C, Bassuk A (1981):  Familial 
occurrence of congenital colonic atresia. J Pediatr Sep;99(3):435-6.
Best LG, Wiseman NE, Chudley AE (1989): Familial duodenal atresia: a report of two 
families and review. Am J Med Genet Nov;34(3):442-4.
Biesecker LG (1997): Strike three for GLI3. Nat Genet 17:259-60.  
Britto J, Tannahill D, Keynes R (2002): A critical role for sonic hedgehog signaling in 
the early expansion of the developing brain. Nature Neuroscience 5:103-110.
Brunner H, Winter RM (1991): Autosomal dominant inheritance of abnormalities of 
the hands and feet with short palpebral ﬁssures, variable microcephaly with learning 
disability, and oesophageal/duodenal atresia. J Med Genet 28:389-394.
Büttiker V, Wojtulewicz J, Wilson M (2000): Imperforate Anus in Feingold Syndrome. 
Am J Med Genet 92:166-169.
Celli J, van Beusekom E, Hennekam RCM, Gallardo ME, Smeets DFCM, de Cordoba 
SR, Innis JW, Frydman M, Konig R, Kingston H, Tolmie J, Govaerts LCP, van 
Bokhoven H, Brunner HG (2000): Familial syndromic esophageal atresia maps to 2p23-
p24. Am J Hum Genet 66:436-444.
Chiang C, Ying LTT, Lee E, Young KE, Corden JL, Westphal H, Beachy PA (1996); 
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. 
Nature 383: 407-413.
Courtens W, Levi S, Verbelen F, Verloes A, Vamos E (1997): Feingold Syndrome: Report 
of a New Family and Review. Am J Med Genet 73:55-60.
de Santa Barbara P, van den Brink G, Roberts D (2002): Molecular etiology of gut 
malformations and diseases. Am J Med Genet 115:221-230.
Dodds A, Ramsden R, Kingston, H (1999): Feingold Syndrome – a cause of profound 
deafness.  J  Laryngol Otol 133:919-921.
Farag TI, al-Awadi SA, el-Badramany MH, Usha R, el-Ghanem M (1993):  Second 
family with “apple peel” syndrome affecting four siblings: autosomal recessive 
inheritance conﬁrmed. Am J Med Genet Aug 1;47(1):119-21.
Feingold M (1975): Case Report 30. Syndrome Identiﬁcation 3:16-17.
Feingold M (1978): An unusual microcephaly. Hosp Pract 13:44-49.
Appendix 5 - Feingold syndrome: clinical review and genetic mapping
217
Feingold M, Hall B, Lacassie Y, Martínez-Frías ML (1997): Syndrome of Microcephaly, 
facial and hand abnormalities, tracheoesophageal ﬁstula, duodenal atresia, and 
developmental delay. Am J Med Genet 69:245-249.
Frydman M, Katz M, Cabot S, Soen G, Kauschansky A, Sirota L (1997): MODED: 
Microcephaly-Oculu-Digito-Esophageal-Duodenal syndrome. Am J Med Genet 71:251-
257.
Gofﬂot F, Hars C, Illien F, Chevy F, Wolf C, Picard JJ, Roux C (2003): Molecular 
mechanisms underlying limb anomalies associated with cholesterol deﬁciency during 
gestation: implications of Hedgehog signalling. Hum Mol Genet 12:1187-98.
Gong YQ, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, 
Cremers CW, Cremers FPM, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman 
FR, Reardon W, Patton M, Francomano CA, Warman ML (1999): Heterozygous 
mutations in the gene encoding noggin affect human joint morphogenesis. Nature Genet 
21:302-304.
Hall JG, Pallister PD, Clarren SK, Beckwith JB, Wiglesworth FW, Fraser FC, Cho S, 
Benke PJ, Reed SD (1980): Congenital hypothalamic hamartoblastoma, hypopituitarism, 
imperforate anus and postaxial polydactyly--a new syndrome? Part I: clinical, causal, and 
pathogenetic considerations. Am J Med Genet 7:47-74.
Innis J, Asher J, Poznanski A, Sheldon S (1997): Autosomal dominant microcephaly 
with normal intelligence, short palpebral ﬁssures, and digital anomalies. Am J Med Genet 
71:150-155.
Kang S, Allen J, Graham JM Jr, Grebe T, Clericuzio C, Patronas N, Ondrey F,
Green E, Schaffer A, Abbott M, Biesecker LG (1997): Linkage mapping and phenotypic 
analysis of autosomal dominant Pallister-Hall syndrome. J Med Genet 34:441-6.
Kawame H, Pagon R, Hudgins L (1997): Digital anomalies, microcephaly, and normal 
intelligence: New syndrome or Feingold Syndrome? Am J Med Genet 69:240-244.
Kim JH, Kim PCW, Hui CC (2001): The VACTERL association: lessons from the sonic 
hedgehog pathway. Clin Genet 59:306-315.
Kim SK, Hebrok M, Li E, Oh SP, Schrewe H, Harmon EB, Lee JS, Melton DA (2000): 
Activin receptor patterning of foregut organogenesis. Genes and Development 14:1866-
1871.
Kohlhase J (2000): SALL1 mutations in Townes-Bocks syndrome and related disorders. 
Human Mutation 16:460-466.
Kohlhase J, Wischermann A, Reichenbach H, Froster U, Engel W (1998): Mutations in 
the SALL1 putative transcription factor gene cause Townes-Bocks syndrome. Nature 
Genet 18:81-83.
Konig R, Selzer G Stolp A, Fuchs S (1990): Microcephaly, mesobrachyphalangy, and 
tracheoesophageal ﬁstula: MMT syndrome. Dysmorph Clin Genet 4: 83-86.
Lalani SR, Stockton DW, Bacino C, Molinari LM, Glass NL, Fernbach SD, Towbin JA,
Craigen WJ, Graham JM Jr, Hefner MA, Lin AE, McBride KL, Davenport SL, Belmont
JW (2003): Toward a genetic etiology of CHARGE syndrome: I  A systematic scan for 
submicroscopic deletions. Am J Med Genet Apr 30;118A(3):260-6.
Landau D, Mordechai J, Karplus M, Carmi R (1997): Inheritance of familial congenital 
isolated anorectal malformations: case report and review. Am J Med Genet Aug 
22;71(3):280-2.
Resolving the molecular basis of human malformation syndromes
218
Lettice LA, Horikoshi T, Heaney SJ, van Baren MJ, van der Linde HC, Breedveld
GJ, Joosse M, Akarsu N, Oostra BA, Endo N, Shibata M, Suzuki M, Takahashi E,
Shinka T, Nakahori Y, Ayusawa D, Nakabayashi K, Scherer SW, Heutink P, Hill RE,
Noji S (2002): Disruption of a long-range cis-acting regulator for Shh causes preaxial
polydactyly. Proc Natl Acad Sci U S A 99:7548-53.
Litingtung Y, Lei L, Westphal H, Chiang C (1998): Sonic hedghog is essential to foregut 
development. Nature Genet 20:58-61.
Mahlapuu M, Enerbäck S, Carlsson P (2001): Haploinsufﬁciency of the forkhead gene 
Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. 
Development 128:2397-2406.
Marsh AJ, Wellesley D, Burge D, Ashton, M, Browne CE, Dennis NR, Temple IK 
(2000): Interstitial deletion of chromosome 17 (del(17)(q2q23.3)) conﬁrms a link with 
oesophageal atresia. J Med Genet 37:701-704.
Martí E, Bovolenta P (2002): Sonic hedgehog in CNS development: one signal, multiple 
outputs. Trends in Neuroscience 25-2.
Mo R, Hong Kim J, Zhang J, Chiang C, Hui C, Kim PCW (2001): Animal Model. 
Anorectal malformations caused by defects in Sonic Hedgehog signaling. Am J of Path 
159-2.
Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC (1998): Essential function of Gli2 
and Gli3 in the formation of lung, trachea and esophagus. Nature Genet 20:54-57.
Opitz, JM, Kaveggia,EG (1974): The FG syndrome: an X-linked recessive syndrome of 
multiple congenital anomalies and mental retardation. Z Kinderheilk 117: 1-18.
Orford J, Manglick P, Cass DT, Tam PPL (2002): Mechanisms for the development of 
esophageal atresia. J Pediatr Surg 36:985-994.
Piersall L, Dowton S, McAlister W, Waggoner D (2000): Vertebral anomalies in a new 
family with ODED syndrome. Clin Genet 57:444-448.
Pletcher BA, Friedes JS, Breg WR, Touloukian RJ (1991): Familial occurrence of 
esophageal atresia with and without tracheoesophagel ﬁstula: report of two unusual 
kindreds. Am J Med Genet 39:380-4.
Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J (1997): Homozygous 
alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal 
atresia. Hum Mol Genet 6:669-74.
Ramalho-Santos M, Melton DA, McMahon AP (2000): Hedgehog signals regulate 
multiple aspects of gastrointestinal development. Development 127: 2763-2772.
Reid CO, Hall JG, Anderson C, Bocian M, Carey J, Costa T, Curry C, Greenberg F, 
Horton W, Jones M, et al (1986): Association of amyoplasia with gastroschisis, bowel 
atresia, and defects of the muscular layer of the trunk. Am J Med Genet 24:701-10.
Riccomagno M, Martinu L, Mulheisen M, Wu D, Epstein D (2002): Speciﬁcation of the 
mammalian cochlea is dependent on Sonic hedgehog. Genes and Development 16:2365-
2378.
Robb L, Teebi AS (1998): Further evidence of autosomal dominant inheritance of the 
nonsyndromal anorectal malformations. Am J Med Genet Oct 12;79(5):400.
Appendix 5 - Feingold syndrome: clinical review and genetic mapping
219
Roeder E, van Galen P, Ali-Khan Catts Z, Curry C, Brunner H (2002): Feingold 
Syndrome: Report of an Additional Family and Unusual Intestinal Manifestations Proc 
Greenwood Genet 21:125.
Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, et al (1996): 
Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nature Genet 
14:357-360.
Roessler E, Du Y, Mullor JL, Casas E, Allen WP, Ellis I, Gillesen-Kaesbach G, Roeder E, 
Ming JE, Ruiz i Altaba A, Muenke M (2002): Loss-of-function mutations in the human 
Gli2 gene cause holoprosencephaly and familial panhypopituitarism. Am J Hum Genet 
71 (Suppl):190.
Ruiz i Altaba A, Palma V, Dahmane N (2002): Hedgehog-Gli signaling and the growth of 
the brain. Nat Rev Neurosci 3:24-33
Sanlaville D, Romana SP, Lapierre JM, Amiel J, Genevieve D, Ozilou C, Le Lorch M, 
Brisset S, Gosset P, Baumann C, Turleau C, Lyonnet S, Vekemans M (2002):  A CGH 
study of 27 patients with CHARGE association. Clin Genet Feb;61(2):135-8.
Townes PL, Brocks ER (1972): Hereditary syndrome of imperforate anus with hand, 
foot, and ear anomalies. J Pediatr 8:321-326.
Walsh LE, Vance GH, Weaver DD (2001): Distal 13q Deletion Syndrome and the 
VACTERL Association: Case report, literature review, and possible implications. Am J of 
Med Genet 98:137-144.
Resolving the molecular basis of human malformation syndromes
220
  
■ From chromosome (cytogenetic location) to genetic location
■ From genetic location to physical map (markers)
■ From physical map to clones and sequence
■ From clone/sequence to gene
■ From gene to protein 
■ From protein to function
■ Miscellaneous
Appendix  6
 List of Free Web Databases
 (categorised according to their role in different 
steps of molecular analysis)
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From phenotypic characteristics to candidate genes
Phenotype - genotype correlations
Link Web address Description
OMIM Home Page
http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=OMIM
Online Mendelian Inheritance 
in Man
GeneCards 
http://bioinfo.weizmann.ac.il/cards/index.
shtml
Genecards: genes, proteins 
and diseases
The Genome Database http://gdbwww.gdb.org/gdb/gdbtop.html Genome Database
The Dysmorphic Human-
Mouse Homology Database 
http://www.hgmp.mrc.ac.uk/DHMHD/
dysmorph.html
Mouse/human malformation 
syndromes & mouse/human 
syntenic regions
PubMed
http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=PubMed
Literature Search
Combined Mouse/Human 
Phenotypes
http://mgd.wehi.edu.au:8080/searches/
noforms_mlc_omim.cgi
Simultaneous keyword 
searches of the Mouse Locus 
Catalog and McKusick’s 
Online Mendelian Inheritance 
in Man
Geneclinics http://www.geneclinics.org/
Medical Genetics Knowledge 
Base
From chromosome (cytogenetic location) to genetic location
General
Link Web address Description
Entrez Genome view http://www.ncbi.nlm.nih.gov/mapview/ NCBI Map Viewer
GDB http://gdbwww.gdb.org/gdb/gdbtop.html Human genome database
Linkage analysis software http://linkage.rockefeller.edu/
Web resources of genetic 
linkage analysis
Ensembl http://www.ensembl.org/
Annotation on metazoan 
genomes
Marshﬁeld
http://research.marshfieldclinic.org/
genetics/Genotyping_Service/mgsver2.
htm
Mammalian genotyping 
service
Biocarta http://www.biocarta.com/
Genes/proteins/pathways 
with clickable maps
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General Cytogenetics
Link Web address Description
Atlas Chromosome in 
Cancer 
ht tp: / /www.infobiogen.fr /services/
chromcancer/
Atlas of Genetics and 
Cytogenetics in Oncology 
and Haematology
The Cancer Genome 
Anatomy Project
http://cgap.nci.nih.gov/
Project to determine the gene 
expression proﬁles of normal, 
pre-cancer, and cancer cells
Mitelman Database of 
Chromosome Aberrations 
in Cancer
http://cgap.nci.nih.gov/Chromosomes/
Mitelman
Relates chromosomal 
aberrations to tumor 
characteristics
Pathways http://cgap.nci.nih.gov/Pathways
Alphabetically indexed 
pathways
Human Cytogenetic 
Abnormalities 
http://bip.weizmann.ac.il/mb/db/human/
cyto_abnormalities.html
Cytogenetic abnormalities 
database
Resources for Molecular 
Cytogenetics 
http://www.biologia.uniba.it/rmc/
BAC/PAC collections, 
tutorials, examples
RHMC - Protocols 
http://www.biologia.uniba.it/rmc/0-1a_
pagina/2_2_Protocols.html
Cytogenetics protocols
Human BAC Resource 
http://www3.ncbi.nlm.nih.gov/genome/
cyto/hbrc.shtml
Integration of cytogenetic 
landmarks into the draft 
sequence of the human 
genome
Linkage Centers
Link Web address Description
Généthon - INFOCLONE http://www.cephb.fr/infoclone.html Get YAC/STS information 
From genetic location to physical map (markers)
General
Link Web address Description
NCBI     , http://www.ncbi.nlm.nih.gov/
General starting point for 
genetic data
Entrez Genome view http://www.ncbi.nlm.nih.gov/mapview/ NCBI Map Viewer
CEPH / Généthon Map
http://www.cephb.fr/ceph-genethon-map.
html
The CEPH-Généthon 
integrated map
EBI http://www.ebi.ac.uk/
Databases of biological 
data including nucleic acid, 
protein sequences and 
macromolecular structures
The Sanger Centre http://www.sanger.ac.uk/ Genomes databases
(continued on next page)
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General (continued)
Link Web address Description
The Genome Database http://www.gdb.org/ Human genome database
Human Genome Browser http://genome.cse.ucsc.edu/
Human genome project 
working draft
Ensembl http://www.ensembl.org/
Annotation on metazoan 
genomes
Whitehead/MIT Genome 
Research
http://www.broad.mit.edu/
Genome maps, cancer 
genomics, genome 
sequencing
From physical map to clones and sequence
General
Link Web address Description
NCBI http://www.ncbi.nlm.nih.gov/
General starting point for 
genetic data
HGMP http://www.hgmp.mrc.ac.uk/
Human Genome Mapping 
Project
TBR 
http://www.hgmp.mrc.ac.uk/CCP11/
index.jsp
Bioinformatics Resource
EBI http://www.ebi.ac.uk/
Databases of biological 
data including nucleic acid, 
protein sequences and 
macromolecular structures
The I.M.A.G.E. Consortium http://image.llnl.gov/
World’s largest public 
collection of genes
BAC/PAC Resources http://bacpac.chori.org/home.htm BAC - PAC - cDNA libraries
Human Genome Browser http://genome.cse.ucsc.edu/
The Human Genome Project 
Working Draft
Ensembl/genome central http://www.ensembl.org/genome/central/
Spring board for Human 
genome data
    The Sanger Centre http://www.sanger.ac.uk/ Genome research centre 
TIGR  http://www.tigr.org/tdb/
Collection of curated 
databases
SRS6 @Infobiogen 
http://www.infobiogen.fr/srs71bin/cgi-
bin/wgetz?-page+srsq2+-noSession
Sequence oriented databases 
integration motor 
The Genome Channel http://compbio.ornl.gov/channel/ Collection of analysis tools
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At the Massachsetts Institute of Technology
Link Web address Description
Search for an STS by Name  
http://www.broad.mit.edu/cgi-bin/contig/
sts_by_name?database=release
STS databae
Search for a YAC by its 
Address
http://www.broad.mit.edu/cgi-bin/contig/
yac_info
YAC database
Look Up Contigs by Name  
http://www.broad.mit.edu/cgi-bin/contig/
lookup_contig?database=release
Contig database
From clones/sequence to gene
General
Link Web address Description
Human Genome  Browser http://genome.cse.ucsc.edu/ The Human Genome Project Working Draft
BLAT search http://genome.cse.ucsc.edu/cgi-bin/hgBlat?command=start
Search the human genome 
freeze
ENSBL http://www.ensembl.org/ Annotation on metazoan genomes
CMBI http://www.cmbi.kun.nl/ Bioinformatic services, tools and databases
BLAST http://services.bioasp.nl/blast/cgi-bin/blast.cgi
Basic Logical Alignment 
Search Tool
BLAST http://www.ncbi.nlm.nih.gov/BLAST/
BLASTN, BLASTP, PSI-
BLAST, PHI-BLAST, 
BLASTX, TBLASTN, 
TBLASTX
Lab On Web http://www.labonweb.com/ Cyber lab
Fetch http://www.ch.embnet.org/software/fetch.html Sequence retrival
Fetch a database entry h t t p : / / b ioweb .pas t eu r. f r / s eqana l /interfaces/golden.html
Data retrival tool for several 
databases
ESTscan http://www.ch.embnet.org/software/ESTScan.html ESTs retival
Repeat Masker http://ftp.genome.washington.edu/index.html
Screens DNA sequences for 
interspersed repeats and low 
complexity DNA sequences.
Vector sequence 
identiﬁcation 
http://www.ncbi.nlm.nih.gov/VecScreen/
VecScreen.html
Tool for the identiﬁcation of 
vector sequences 
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Gene Prediction
Link Web address Description
Genscan  
h t t p : / / b ioweb .pas t eu r. f r / s eqana l /
interfaces/genscan.html
Gene prediction tool
Genscan http://genes.mit.edu/GENSCAN.html Gene prediction tool
GrailEXP http://grail.lsd.ornl.gov/grailexp/ Gene prediction tool
Grail v1.3 http://compbio.ornl.gov/Grail-1.3/ Gene prediction tool
GenQuest 
ht tp: / /compbio.ornl .gov/Grail-bin/
EmptyGenquestForm/
Gene prediction tool
Fgenes, FgenesH http://www.softberry.com/berry.phtml
Gene/splice site/exons 
prediction tool
GeneID http://www1.imim.es/geneid.html Gene prediction tool
GENIE 
http://www.fruitfly.org/seq_tools/genie.
html
Drosophila gene prediction 
tool
HMMgene 
h t t p : / / w w w. c b s . d t u . d k / s e r v i c e s /
HMMgene/
Gene prediction tool
Grail2exons 
h t t p : / / b ioweb .pas t eu r. f r / s eqana l /
interfaces/grailclnt.html
Exon prediction tool
Xpound 
h t t p : / / b ioweb .pas t eu r. f r / s eqana l /
interfaces/xpound.html
Exon prediction tool
NETGENE2. 
ht tp: / /genome.cbs.dtu.dk/services/
NetGene2/
Predicts splice sites in human, 
C.elegans and A. thaliana 
DNA using neural networks
fmtseq
h t tp : / / b ioweb .pas t eu r. f r / s eqana l /
interfaces/fmtseq.html
Sequence conversion 
Sequence Analysis 
http://bioweb.pasteur.fr/seqanal/genes/
intro-uk.html
Search genes and coding 
regions 
The PredictProtein Server 
h t t p : / / w w w. e m b l - h e i d e l b e rg . d e /
predictprotein/predictprotein.html
Protein prediction tool
The PredictProtein Server 
h t t p : / / w w w. c m b i . k u n . n l / b i o i n f /
predictprotein/
Protein prediction tool
Sequence Comparison
Link Web address Description
Biology Workbench http://workbench.sdsc.edu/
Search protein and nucleic 
acid sequence databases. 
Access to a wide variety of 
analysis and modeling tools
ClustalW http://www.ebi.ac.uk/clustalw/ Multiple sequence alignment
TCoffee 
http://www.ch.embnet.org/software/
TCoffee.html
Multiple sequence alignment
(continued on next page)
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Sequence Comparison (continued)
Link Web address Description
BOXSHADE 
http://www.ch.embnet.org/software/
BOX_form.html
Multiple sequence alignment
LALIGN 
http://www.ch.embnet.org/software/
LALIGN_form.html
Local sequence alignment
BLAST 2 sequences 
http://www.ncbi.nlm.nih.gov/blast/
bl2seq/bl2.html
Align any two sequences
Pipmaker http://pipmaker.bx.psu.edu/pipmaker/ Compare genomic DNA
Promoter Prediction
Link Web address Description
Drosophila Genome - 
Promoter Prediction  
h t tp : / /www.frui t f ly.org/seq_tools /
promoter.html
Predict promoter sites in 
Drosophila and other species
Eukaryotic Pol II promoter 
prediction 
http://bimas.dcrt.nih.gov/molbio/proscan/
Predict polymerase II 
promoter sites
Promoter 2.0 prediction 
server  
http://www.cbs.dtu.dk/services/Promoter/
Vertebrate polymerase II 
promoter
From gene to protein
General
Link Web address Description
ORF identiﬁcation 
http://www.ncbi.nlm.nih.gov/gorf/gorf.
html
Finds all open reading frames 
of a selectable minimum size. 
Can also be used to fetch 
contig fragments
Justbio translator http://www.justbio.com/tools.php DNA to protein translation
Translate tool http://www.expasy.org/tools/dna.html DNA to protein translation
Translation machine http://ir2lcb.cnrs-mrs.fr/d_fsed/fsed.html DNA to protein translation
Frameshift error detection 
Analysis of newly 
determinated sequences 
before their submission to the 
databases
Backtranslation 
h t t p : / / w w w. e n t e l e c h o n . c o m / e n g /
backtranslation.html
Protein to DNA translation
Genewise http://www.ebi.ac.uk/Wise2/index.html
Compares a protein sequence 
to a genomic DNA sequence
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From protein to function
General
Link Web address Description
PubMed 
http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=PubMed
Literature search
PDB http://www.rcsb.org/pdb/ Protein Databank
Predict protein 
h t t p : / / w w w. e m b l - h e i d e l b e rg . d e /
predictprotein/predictprotein.html
Sequence analysis, and 
structure prediction.
GQserve http://jura.ebi.ac.uk:8765/gqsrv/submit
Functional annotation for 
protein sequences
Transmembrane Regions
Link Web address Description
TMpred   
http://www.ch.embnet.org/software/
TMPRED_form.html
Prediction of Transmembrane 
Regions and Orientation
DAS http://www.sbc.su.se/%7Emiklos/DAS/
Transmembrane prediction 
server
Transgenic knockouts
Link Web address Description
CRE mice dbase     http://www.mshri.on.ca/nagy/cre.htm Transgenic database
MGI http://www.informatics.jax.org/mgihome/ Mouse Genome Informatics
Lexicon omnibank
http://omnibank.lexgen.com/blast_frame.
htm
Knockout mouse embryonic 
stem cell library
MUTATION DATABASES 
h t t p : / / a r i e l . u c s . u n i m e l b . e d u . a u /
%7Ecotton/dblist.htm
Mutation databases and 
clinical & patient aspects 
databases 
TBASE http://tbase.jax.org/
The transgenic/targeted 
mutation database
Multiple alignments
Link Web address Description
Multiple alignments 
introduction 
http://bioinformatics.weizmann.ac.il/
%7Epietro/Making_and_using_protein_
MA/
Introduction to 
making and using 
protein multiple alignments
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Structure & modelling
Link Web address Description
Bio Molecular Modelling http://www.bmm.icnet.uk/
Software and databases for 
proteins and nucleic acids 
modelling
Protein Data Bank Search 
Fields 
http://www.rcsb.org/pdb/cgi/queryForm.
cgi
3-D macromolecular structure 
data search
Protein Data Bank http://www.rcsb.org/pdb/
3-D biological 
macromolecular structure 
data
UMBER http://www.bioinf.man.ac.uk/dbbrowser/ Jump-page
Subcellular Location Prediction
Link Web address Description
Protein families database http://www.sanger.ac.uk/Software/Pfam/
Protein families database 
of alignments and Hidden 
Markov Models
TargetP http://www.cbs.dtu.dk/services/TargetP/
Prediction of subcellular 
location
Molecular modelling 
http://www.arc.unm.edu/%7Earoberts/
main/molmod.htm
Molecular modelling 
databases and software
PRINTS 
http://www.bioinf.man.ac.uk/dbbrowser/
PRINTS/index.html
A compendium of protein 
ﬁngerprints
YASARA http://www.yasara.com/
An interactive real-time 
molecular  
dynamics program
Mutations
Link Web address Description
The Human Gene Mutation 
Database
http://www.hgmd.org/
Collection of data on germ-
line mutations in nuclear 
genes associated with human 
inherited disease
Miscellaneous
Metabolic pathways and cellular regulation
Link Web address Description
KEGG http://www.genome.jp/kegg/
Encyclopaedia of Genes and 
Genomes
EcoCyc http://www.ecocyc.org
Escherichia Coli 
encyclopaedia of genes and 
metabolism
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Model organisms
Link Web address Description
Entrez taxonomy http://www.ncbi.nlm.nih.gov/Entrez/ organisms in GenBank
MGI http://www.informatics.jax.org/ Mouse Genome Informatics
RGD http://rgd.mcw.edu/ Rat Genome Database
ZFIN http://zﬁn.org/
Zebraﬁsh Information 
Network
Xenbase http://www.xenbase.org/ Xenopus web resources
Flybase http://ﬂybase.bio.indiana.edu/
Drosophila Genome 
Database
BDGP http://www.fruitﬂy.org/
Drosophila Genome 
Database
Flybrain 
http://flybrain.neurobio.arizona.edu/
Flybrain/html/index.html
Drosophila Nervous System
Wormbase http://www.wormbase.org/
Caenorhabditis elegans 
database
Bio-Jump pages
Link Web address Description
NAR Bioinfo links    http://www3.oup.co.uk/nar/database/c/ Database categories list
ABIM Online analysis tools 
http://www.up.univ-mrs.fr/%7Ewabim/
english/logligne.html
Analysis tools for DNA and 
proteins
Highveld http://highveld.com/f/ﬁndex.html
The Internet Directory of 
Molecular Biology and 
Biotechnology
BARcodes http://privat.swol.de/GerhardKresbach/
Links to life science news, 
resources & databases
CMBI http://www.cmbi.kun.nl/
Bioinformatic services, tools 
and databases
ENSEMBL http://www.ensembl.org/ Ensembl Genome Server
ExPASy - Tools 
(Proteomics) 
http://www.expasy.org/tools/
Proteomics tools
BioHunt http://www.expasy.org/BioHunt/
Molecular biology search 
engine
Harvard BioLinks http://mcb.harvard.edu/BioLinks.html Biology Links
HUM-MOLGEN http://www.hum-molgen.de/
International communication 
forum in human molecular 
genetics
(continued on next page)
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Bio-Jump pages (continued)
Link Web address Description
Justbio  http://www.justbio.com/
Molecular Biology online 
tools
Research Tools 
http://www.nih.go.jp/%7Ejun/research/
body.html
Links to miscellaneous 
research tools
The Biotoolkit
http://www.biosupplynet.com/cfdocs/btk/
btk.cfm
Annotated directory of links 
to online molecular biology 
resources
Gene Finding 
ht tp: / /www.hgc. ims.u- tokyo.ac. jp/
%7Ekatsu/geneﬁnding/programs.html
Gene ﬁnding programs
Electronic literature
Link Web address Description
BioNews Bioinformatics 
Forum    
http://bioinfo.weizmann.ac.il/bionews.
html
Discussion groups and 
selectable ﬁelds news
BIOSCI bionet Newsgroup 
Archives 
http://www.bio.net/archives.html Newsgroup archives
PubMed 
http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=PubMed
Literature search
Protocols
Link Web address Description
Molecular Biology links 
http://www2.hawaii.edu/bio/gemmap/
molecular.html
Links molecular biology sites 
Molecular Biology 
Protocols 
http://highveld.com/f/fprotocols.html Protocols
The Original CPC 
http://www.dartmouth.edu/~ambros/
protocols.html
Comprehensive Protocol 
Collection
Resources
Link Web address Description
BAC-PAC RESOURCES      http://bacpac.chori.org/
information on BAC and PAC 
genomic DNA libraries, high-
density colony hybridization 
ﬁlters, and BAC and PAC 
cloning vectors
CABRI http://www.cabri.org/
Common Access to Biological 
Resources and Information
Caltech OncoBAC 
Resource 
http://informa.bio.caltech.edu/Bac_onc.
html
BAC corresponding to known 
oncogenes and other genes 
responsible for interesting 
biological processes such as 
signal transduction pathways
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Summary
With the unveiling of the human genome, the speed at which new genes are discovered has 
dramatically increased. For this reason, disease gene identiﬁcation is rapidly changing, 
moving from the cloning of unknown genes towards the mutation analysis of suitable 
candidate genes that have already been cloned. In the quest to resolve the genetic basis 
underlying several monogenic syndromes of multiple congenital anomalies (MCA) we 
have used systematic phenotype analysis in combination with analysis of gene-speciﬁc 
information available through the internet.  
 Multiple congenital anomalies are the most common cause of infant mortality in 
western society. Identifying the molecular causes of the monogenic forms is particularly 
important because of their high risk of recurrence. Moreover the identiﬁcation of the 
genetic aetiology of MCA can have the dual role of broadening our knowledge of 
embryological development, and of providing us diagnostic or counselling tools, and 
in a future eventually preventing congenital abnormalities. Furthermore, molecular 
analysis of human defects can also provide greater insights in human evolution. Many 
developmental genes have been found thanks to studies of human syndromes and related 
animal models.
 Since the identiﬁcation of the ﬁrst genes responsible for human diseases four main 
strategies for identifying human monogenic disease genes have been developed: functional 
cloning, positional cloning, positional candidate and position-independent candidate gene 
strategies. Functional cloning is based on the knowledge of the normal cellular function 
of the protein. Positional cloning is the cloning of the gene responsible for a disease solely 
by knowing its chromosomal localisation. The most common methods to determine the 
initial localisation are linkage analysis, chromosomal aberrations and, for cancer genes, 
loss of heterozygosity screening. In the case of linkage analysis different methods can be 
used. 
 In the positional candidate strategy the selection of candidate genes in a speciﬁc critical 
chromosomal region relies on the availability of information from previously isolated 
genes or ESTs. This strategy is based on the expression pattern during development, on 
gene function, on the presence of animal models and also on homology to other human 
or non-human genes. As the knowledge on gene function, position and expression grows, 
classical positional cloning is gradually replaced by the positional candidate approach. 
With the completion of the Human Genome Project the search for disease causing genes 
“in silico” has become an integral part of the positional candidate gene strategy (Appendix 
1). The current availability of various types of information in databases that are accessible 
via the Internet (an extensive list is shown in Appendix 6) has revolutionised the whole 
procedure of gene searching. 
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Position-independent candidate strategies rely on known characteristics of a gene, such as 
expression, function, homology to other genes, and existence of animal models, without 
making use of the chromosomal position of the gene.
Here we present different genetic approaches in the search for MCA genes (Chapters 
2-4 and Appendices 1-5). Our hypothesis was that, by combining systematic phenotype 
analysis and gene-speciﬁc information available through the Internet, the causative genes 
underlying such syndromes could be identiﬁed rapidly and effectively. 
A ﬁrst test was done searching the gene expression database (GXD) using syndrome-
speciﬁc patterns of organ involvement in syndromes for which the genes were already 
known. The majority (4 of 7) of disease genes could be identiﬁed in this way (Appendix 
1). 
 Chapter 2 and Appendix 2 describe the identiﬁcation of gene involved in ectrodactyly 
ectodermal dysplasia and cleft lip/palate (EEC), TP63. Because of phenotype similarities 
between EEC syndrome and LMS a limited linkage analysis tom the LMS locus on ﬁve 
families with EEC was performed. The colocalisation of EEC and LMS suggested the 
existence of a common causative gene present in this region. At that stage a positional 
candidate approach seemed the most logic strategy. Candidate genes were tested for 
mutations in LMS and EEC patients, and TP63 involvement in EEC was identiﬁed. TP63 
is the last discovered member of the prototype oncogene p53 family. TP63 contains 15 
exons and encodes at least 6 different proteins that are the result of alternative splicing 
(α, β, and γ isoforms) and use of an alternative promoter (TA and ∆N variants). TP63 
seem to have a tissue-speciﬁc role in cell growth and differentiation. The expression 
of the different TP63 isoforms varies in and within different tissues. Moreover levels 
of different isoforms may vary during different stages of growth and differentiation. 
TP63 plays a major role in ectodermal differentiation and development. ∆N-TP63 forms 
are reported to have an oncogenic role. A role in stem cell regeneration is also strongly 
suggested. Molecular interactions, signalling pathway and the molecular mechanisms 
that underlying the involvement of TP63 in EEC are also discussed in this chapter.
 Chapter 3 (and Appendix 3) describes the identiﬁcation of a gene involved in autosomal 
recessive form of Robinow syndrome (RRS). The availability of consanguineous families 
affected with RRS suggested the use of the homozygosity mapping approach for the search 
of a RRS gene. The sharing of seven consecutive alleles between three unrelated families 
allowed an additional reduction of the critical interval. Fine mapping of genes, ESTs and 
markers in the RRS critical region was obtained by construction of a YAC contig.  Due 
to the still relative large size of the RRS critical region (≈ 4.9 cM) and to the relatively 
high concentration of genes in this interval, a selection of candidate genes was needed. A 
positional candidate approach was taken and ROR2 looked the most appropriate candidate, 
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due to the presence of an animal model that showed strikingly similarities with the human 
phenotype. Mutation analysis conﬁrmed the presence of homozygous mutations in our 
cohort of patients. ROR2 (together with ROR1) is a member of the ROR-family, a novel 
family of receptor tyrosine kinases (RTKs). Molecular characteristics and pathways of 
ROR2 and the mechanisms underlying its role in RRS are also discussed in this chapter.
 Chapter 4 (and Appendices 4 and 5) describes the quest for a gene involved in 
oesophageal atresia (OA). OA is a common life-threatening congenital anomaly with 
an incidence of 1 in 3000 newborns. OA can be non-syndromic or associated with other 
congenital anomalies. Autosomal dominant inheritance occurs in the Oculodigitoesoph
agoduodenal syndrome (ODED; MIM 164280), or Feingold syndrome. In an attempt 
to identify an OA gene, we ﬁrst searched for candidate genes upon querying gene-
speciﬁc databases retrieved from the internet with search parameters that accurately 
described the prominent phenotypic features of the syndrome of interest. We identiﬁed 
14 candidate genes, selected because of their pattern of expression during development 
(PAX9, WEE1, CLU and MEOX1), the effect of knockout mutations in mouse (HOXC4), 
and the physiological role of the corresponding proteins (genes encoding components of 
the retinoic acid metabolism). We performed a limited linkage analysis, on a large three 
generation pedigree with ODED syndrome, aimed at the chromosomal regions to which 
the candidate genes have been mapped. Chromosome regions deleted in patients showing 
several of the typical features of ODED were also analysed. No linkage was found and 
about the 15% of the entire genome was excluded for involvement in ODED syndrome. 
After the addition of other families a genome wide scan of the remaining parts of the 
genome was performed. Presence of the ODED syndrome gene was clearly detected in 
the 2p23-p24 region. The ﬁnding of a family with non-syndromic OA linking to the same 
area supports the idea that this is the region of a gene involved in OA and raised the 
possibility of ODED being a contiguous gene syndrome, or that certain alleles of the 
ODED gene are a risk factor for non-syndromic OA. Further restricted linkage analysis 
on a panel of 20 families allowed us to reduce the critical region to about 1 cM. Positional 
candidate genes were selected after constructing physical maps “in silico”. Up to now all 
candidate genes in the critical area have been excluded by combined dosage and mutation 
analysis methods. Apparently, current information on genes in the critical region is still 
not sufﬁcient to detect an ODED/OA gene. This situation is likely to improve in the 
coming time. Therefore a positional cloning approach can be performed with reasonable 
hope of success.
The aim of this research was the identiﬁcation of the genetic basis underlying several 
syndromes of multiple congenital anomalies. In each case we attempted to use a 
candidate gene analysis as the preferred method. As shown the “in silico” candidate gene 
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approach has given positive results in some instances and failed to identify candidate 
genes in others. Not surprisingly, the failures are mainly due to incomplete information 
in the databases at the time of the research. Undoubtedly the “in silico” candidate gene 
approach will become more and more important for disease gene discovery. The potential 
of a candidate gene approach is very large and we would advocate this approach as an 
optimal starting point for the search of a gene causing multiple congenital abnormalities, 
especially when it is possible to integrate the position-independent candidate strategy 
with positional information.  
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Samenvatting
De opheldering van het humane genoom heeft de snelheid waarmee nieuwe genen ontdekt 
worden enorm versneld. Daardoor is de manier waarop ziektegenen geïdentiﬁceerd worden 
in een groot tempo aan het veranderen. Er is een verschuiving aan het plaatsvinden van 
het kloneren van onbekende genen naar de mutatie analyse van geschikte kandidaatgenen 
die al gekloneerd zijn. Om de genetische basis die ten grondslag ligt aan enkele monogene 
syndromen met meervoudig aangeboren afwijkingen (MAA) op te helderen, hebben wij 
gebruik gemaakt van systematische fenotype analyse in combinatie met analyse van 
genspeciﬁeke informatie die beschikbaar is op het internet.
 Meervoudig aangeboren afwijkingen zijn de meest voorkomende oorzaak van 
kindersterfte in de westerse wereld. Opheldering van de moleculaire oorzaken van de 
monogene vormen is in het bijzonder belangrijk vanwege het hoge herhalingsrisico. 
Bovendien speelt de opheldering van de genetische etiologie van MAA een tweeledige 
rol. Het verbreedt onze kennis over de embryonale ontwikkeling en het levert ons 
diagnostische en counseling middelen op, zodat in de toekomst aangeboren afwijkingen 
voorkomen kunnen worden. Verder verschaft de moleculaire analyse van humane 
afwijkingen meer inzicht in de humane evolutie. Veel ontwikkelingsgenen zijn gevonden 
dankzij onderzoek aan humane syndromen en gerelateerde diermodellen.
 Sinds de identiﬁcatie van de eerste genen die verantwoordelijk zijn voor humane 
ziekten, zijn er vier hoofdstrategieën ontwikkeld voor de identiﬁcatie van humane 
monogene ziektegenen: functionele klonering, positionele klonering, positionele 
kandidaatgen en positie-onafhankelijke kandidaatgen strategieën. Functionele klonering 
is gebaseerd op de kennis van de normale cellulaire functie van het eiwit. Positionele 
klonering is de klonering van het gen verantwoordelijk voor een ziekte, uitsluitend op 
basis van de kennis van de chromosomale lokalisatie van dat gen. De meest voorkomende 
methoden om de initiële lokalisatie te bepalen zijn koppelingsonderzoek, chromosomale 
afwijkingen en, voor kankergenen, loss of heterozygosity onderzoek. In het geval van 
koppelingsonderzoek kunnen verschillende methoden worden gebruikt.
 Bij de positionele kandidaat strategie wordt de selectie van kandidaatgenen in een 
speciﬁek kritisch chromosomaal gebied gestuurd door de beschikbare informatie over 
eerder geïsoleerde genen of EST’s. Deze strategie is gebaseerd op het expressiepatroon 
tijdens de ontwikkeling, genfunctie, diermodellen en homologie met andere humane of 
niet-humane genen. Naarmate de kennis over genfunctie, -positie en -expressie toeneemt, 
wordt klassieke positionele klonering geleidelijk vervangen door de positionele kandidaat 
aanpak. Met het gereed komen van het Humane Genoom Project is het “in silico” zoeken 
naar ziekte veroorzakende genen een integraal gedeelte geworden van de positionele 
kandidaatgen strategie (appendix 1). De huidige beschikbaarheid van verscheidene 
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typen informatie in databanken die via het internet beschikbaar zijn (een uitgebreide lijst 
is weergegeven in appendix 6) heeft de hele procedure van het zoeken naar een gen 
gerevolutioneerd.
 Positie-onafhankelijke kandidaat strategieën zijn gebaseerd op bekende karakteristieken 
van een gen, zoals expressie, functie, homologie met andere genen en diermodellen, 
zonder gebruik te maken van de chromosomale positie van het gen.
Hier presenteren wij verschillende genetische strategieën op zoek naar MAA genen 
(hoofdstukken 2-4 en appendices 1-5). Onze hypothese was dat de oorzakelijke genen 
voor dergelijke syndromen sneller en effectiever geïdentiﬁceerd kunnen worden door 
systematische fenotype analyse te combineren met gen-speciﬁeke informatie beschikbaar 
op het internet.
 Een eerste test werd gedaan door de genexpressie databank (GXD) te doorzoeken met 
syndroom-speciﬁeke patronen van orgaanbetrokkenheid voor syndromen waarvoor de 
genen al bekend waren. De meerderheid van de ziektegenen (4 van de 7) konden op deze 
manier niet geïdentiﬁceerd worden (appendix 1). 
 Hoofdstuk 2 en appendix 2 beschrijven de identiﬁcatie van het gen betrokken 
bij ectrodactyly, ectodermale dysplasie en gespleten lip/gehemelte (EEC), TP63. 
Omdat EEC syndroom en LMS fenotypische gelijkenis vertonen, werd een beperkt 
koppelingsonderzoek gedaan met vijf EEC families in het LMS locus. De co-lokalisatie 
van EEC en LMS suggereerde het bestaan van een gemeenschappelijk oorzakelijk gen in 
deze regio. In die fase leek een positionele kandidaat aanpak de meest logische strategie. 
Kandidaatgenen werden getest voor mutaties in LMS en EEC patiënten en het TP63 
gen werd geïdentiﬁceerd voor EEC syndroom. TP63 is het laatst ontdekte lid van de 
familie waartoe het prototype tumor-suppressor gen p53 behoort. TP63 bestaat uit 15 
exonen en codeert voor tenminste 6 verschillende eiwitten als gevolg van alternatieve 
splicing (α, β en γ isovormen) en gebruik van een alternatieve promoter (TA en ∆N 
varianten). TP63 lijkt een weefsel-speciﬁeke rol te spelen bij celgroei en differentiatie. De 
expressie van verschillende TP63 isovormen varieert in en tussen verschillende weefsels. 
Bovendien zouden de expressie niveaus van verschillende isovormen kunnen variëren 
tijdens verschillende fasen van groei en differentiatie van het embryo. TP63 speelt een 
belangrijke rol bij ectodermale differentiatie en ontwikkeling. ∆N-TP63 isovormen 
spelen een oncogene rol. Een rol in stamcel regeneratie wordt ook sterk gesuggereerd. 
Moleculaire interacties, signaal pathways en moleculaire mechanismen die ten grondslag 
liggen aan de betrokkenheid van TP63 in EEC syndroom worden ook bediscussieerd in 
dit hoofdstuk.
 Hoofdstuk 3 en appendix 3 beschrijven de identiﬁcatie van een gen betrokken bij 
de autosomaal recessieve vorm van Robinow syndroom (RRS). De beschikbaarheid 
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van consanguine families met RRS suggereerde een koppelingsonderzoek gebaseerd op 
homozygotie analyse voor het zoeken naar een RRS gen. Het kritieke gebied werd nog 
verder gereduceerd doordat drie ongerelateerde families zeven opeenvolgende allelen 
gemeenschappelijk hebben. Genen, EST’s en markers in de RRS kritische regio werden 
nauwkeuriger gelokaliseerd door de constructie van een fysische kaart. Door de nog 
steeds relatief grote omvang van de RRS kritische regio (≈ 4.9 cM) en de relatief hoge 
dichtheid van genen in dit interval, was een selectie van kandidaatgenen noodzakelijk. 
Een positionele kandidaat strategie werd gekozen en ROR2 leek de beste kandidaat, 
omdat een diermodel opvallende overeenkomsten vertoonde met het humane fenotype. 
Mutatie analyse bevestigde de aanwezigheid van homozygote mutaties in onze groep van 
patiënten. ROR2 (samen met ROR1) is een lid van de ROR familie, een nieuwe familie 
van receptor tyrosine kinases (RTK’s). Moleculaire karakteristieken en pathways van 
ROR2 en de mechanismen die ten grondslag liggen aan de rol van ROR2 in RRS worden 
ook bediscussieerd in dit hoofdstuk.
 Hoofdstuk 4 en appendices 4 en 5 beschrijven het zoeken naar een gen betrokken 
bij slokdarm atresie (OA). OA is een veelvoorkomende levensbedreigende aangeboren 
afwijking met een incidentie van 1 op 3000 pasgeborenen. OA kan niet-syndromaal zijn of 
geassocieerd met andere aangeboren afwijkingen. Autosomaal dominante overerving komt 
voor bij het Oculodigitoesophagoduodenal (ODED; MIM 164280) of Feingold syndroom. 
In een poging om een OA gen te identiﬁceren zochten we eerst naar kandidaatgenen in gen-
speciﬁeke databanken op het internet met zoekparameters die de prominente fenotypische 
eigenschappen van het betreffende syndroom nauwkeurig beschrijven. Wij identiﬁceerden 
14 kandidaatgenen, geselecteerd op basis van expressiepatroon tijdens de ontwikkeling 
(PAX9, WEE1, CLU en MEOX1), het effect van knock-out mutaties in de muis (HOXC4) en 
de fysiologische rol van de corresponderende eiwitten (genen coderend voor componenten 
van retinoic acid metabolisme). Wij deden een beperkt koppelingsonderzoek op een grote 
drie-generatie stamboom met ODED syndroom, gericht op de chromosomale regio’s 
waar de kandidaat genen in kaart gebracht zijn. Chromosomale regio’s die gedeleteerd 
waren in patiënten met enkele typische kenmerken van ODED werden ook geanalyseerd. 
Koppeling werd niet gevonden en ongeveer 15% van het gehele humane genoom werd 
uitgesloten voor betrokkenheid bij ODED syndroom. Na toevoeging van andere families 
werd een koppelingsonderzoek voor de rest van het genoom uitgevoerd. Aanwezigheid 
van het ODED syndroom gen werd duidelijk gedetecteerd in de 2p23-p24 regio. De vondst 
van een familie met niet-syndromale OA die in hetzelfde gebied koppelt, ondersteunt het 
idee dat dit de regio is van een gen betrokken bij OA. Mogelijk is ODED een contiguous 
gene syndrome of vormen bepaalde allelen van het ODED gen een risicofactor voor niet-
syndromale OA. Verder koppelingsonderzoek op een panel van 20 families stelde ons in 
staat om de kritieke regio te reduceren tot ongeveer 1 cM. Positionele kandidaatgenen 
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werden geselecteerd na “in silico” constructie van fysieke kaarten. Tot nu toe werden alle 
kandidaatgenen in het kritisch gebied uitgesloten door gecombineerde dosis en mutatie 
analyse methoden. Blijkbaar is de huidige informatie over genen in de kritieke regio niet 
voldoende om een ODED/OA gen te identiﬁceren. Deze situatie zal in de nabije toekomst 
waarschijnlijk verbeteren. Een positionele klonering aanpak kan daarom uitgevoerd 
worden met gegronde hoop op succes.
Het doel van dit onderzoek was de identiﬁcatie van de genetische basis voor enkele 
syndromen met meervoudig aangeboren afwijkingen. In elk geval probeerden wij een 
kandidaatgen analyse te gebruiken als geprefereerde methode. Zoals aangegeven leidde 
de “in silico” aanpak in sommige gevallen tot positieve resultaten en faalde het om 
kandidaatgenen te identiﬁceren in andere gevallen. Het is niet verrassend dat het falen van 
sommige gevallen voornamelijk komt door de incomplete informatie in de databanken 
op het moment van onderzoek. Ongetwijfeld zal de “in silico” kandidaatgen aanpak in 
toenemende mate belangrijker worden voor ziektegen ontdekking. De potentie van de 
kandidaatgen aanpak is heel groot en wij pleiten ervoor dat deze strategie een optimaal 
startpunt is voor het zoeken naar een gen dat meervoudig aangeboren afwijkingen 
veroorzaakt, zeker wanneer het mogelijk is om de positie-onafhankelijke kandidaat 
strategie te integreren met positionele informatie.
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